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1

CHAPTER 1
NEW INLET AND VACUUM IONIZATION METHODS
FOR MASS SPECTROMETRY

1.1 Introduction
Mass spectrometry (MS) is an important analytical tool because of its wide
applicability, dynamic range, sensitivity, specificity, speed of analysis, and the ability to
simultaneously observe many constituents in a mixture. Its advancement in analyzing
nonvolatile and large biological molecules has made a huge impact in the area of
biological research. Key to this advancement is the development of two commonly used
ionization methods in MS: electrospray ionization (ESI) [1] and matrix-assisted
laser/desorption ionization (MALDI) [2,3] to ionize nonvolatile and high-mass
compounds such as peptides and proteins. ESI, with the production of multiply charged
ions from solution at atmospheric pressure (AP), has gained much attention because of
the simplicity to interfaced with chromatographic and electrophoretic liquid-phase
separation techniques.[4] In addition, the formation of higher charge states can extend
the mass range of high resolution mass range limited mass spectrometers and provide the
advantage of better fragmentation for structural characterization and identification. On
the other hand, MALDI with time-of-flight (TOF) mass analyzers [3,5] rapidly gained its
popularity for analyzing large biomolecules. The production of predominantly singly
charged ions makes data interpretation simpler.

MALDI-TOF-MS, due to its high
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sensitivity and analysis directly from the surface, is the chosen analytical tool for
molecular tissue imaging [6,7], important for biomedical applications [8].
A long term interest of our research group is the analysis of solubility restricted
materials, especially directly from surfaces.

ESI is limited to samples that can be

solubilized. It is in this area where ESI-MS has challenges when dealing with poorly
soluble and insoluble compounds such as membrane proteins. Although MALDI can
analyze directly from the surface, structural characterization is challenging because of
poor fragmentation using singly charged ions. The limitation of ESI to analyze directly
from the surface and the difficulty of MALDI to provide better fragmentation are reasons
to develop ionization techniques that have the benefits of ESI and MALDI. Ionization
developments described in this dissertation demonstrate the ability to detect and
characterize compounds directly from a surface such as tissue, and use gas phase ion
mobility separation to reduce complexity and improve the dynamic range of the
experiment.
1.2 Motivation
Cellular membranes are important in the area of biological research to understand
diseases associated with it. The available analytical tools have limitations in analyzing
these compounds because of their complexity and limited solubility. Membrane proteins
are an example of solubility restricted compounds in the cellular membrane for which the
current understanding in relation to disease is limited because of the inability of current
analytical technologies to unravel the chemical make-up of this complex system.[9,10]
Approximately 70% of drugs are said to target membrane proteins and 20 to 30% of the
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human genome encodes membrane proteins but less than 1% of the proteins of known
structure are membrane proteins.[9,11,12] Diseases related to the membrane architecture
are Alzheimer’s disease (AD), Huntington’s diseases, Parkinson’s disease, and
misfolding/aggregation (e.g. prion disease).[13-18]
Advances needed to better analyze membrane proteins include improved sample
preparation to solubilize intact proteins, instrumentation to allow characterization and
identification especially of protein isoforms, and better liquid chromatographic (LC)
performance involving bottom up and top-down proteomics.[9,19] MS has been a
powerful analytical approach in developing comprehensive analysis of membrane
proteins. ESI and MALDI are the most used MS techniques in determining the molecular
weights of intact proteins followed by enzyme digestion, separation, and tandem MS/MS
for characterizing and identifying the proteins.[20] However, the approach of bottom up
or shotgun proteomics which involves the use of high performance LC combined with
MS requires solubilization of these compounds. In addition, analyzing membrane
proteins directly from their native environment requires new analytical technologies
especially when dealing with complex systems such as tissue which is important for
pharmacology and disease treatments. Efficient ionization of these compounds still
remains an issue due to their limited solubility.
AP-MALDI has been demonstrated [21] and offers advantages over vacuum
MALDI, including speed of analysis and compatibility with instruments built for
atmospheric pressure ionization (API) [22]; however, vacuum MALDI offers better
sensitivity and the analysis of large biomolecules [23] than AP-MALDI. AP-MALDI is
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limited in mass range because of the mass-to-charge (m/z) limitations of API instruments
and the production of predominately singly charged ions. Thus, methods that have
attributes of AP-MALDI, but provide improved sensitivity and/or multiply charged ions
are needed. Sheehan and Willoughby modeled AP ionization and reported that if a high
electric field is present in the AP region, >90% of the ions are lost to the walls (rim
losses) entering the AP to vacuum orifice.[24] Willis and Grosu demonstrated a laser
ablation experiment using the backside approach where the laser beam passes through the
glass sample holder causing an explosive expansion of the material irradiated.[25] The
feasibility of a backside (transmission geometry, TG) approach in AP-MALDI for laser
ablation using a glass plate as a sample holder positioned close (1-3 mm) to the mass
spectrometer ion entrance was also previously demonstrated.[26] Combining these
configuration with field-free (FF) conditions was anticipated to ensure high transmission
of ions into the mass analyzer. An ionization source was configured for AP-FF-TG
MALDI.[27,28] The sample holder was a glass plate and the laser illuminates from the
backside so the sample holder can be placed close (1-3 mm) in front of the MS orifice.
This back-side laser ablation approach desorbs/ionizes similar to the front side (reflectron
geometry, RG) approach. The laser ablates the matrix/analyte crystals from the surface
and the expanding matrix plume brings them sufficiently close to the MS ion entrance
inlet so that they become flow entrapped in the air entering the inlet to the vacuum of the
mass spectrometer. With this transmission geometry (TG) approach, the spatial
resolution is improved because shorter laser focal lengths can be used to provide a
smaller laser spot at the point of ablation. Imaging can be achieved by moving the
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sample through the laser beam focused on the sample and aligned with the MS inlet.
Most important, however, was the discovery that multiply charged ions, similar to what is
observed with ESI, were produced using laser ablation of a MALDI matrix. Initially, the
methods was deemed to be a MALDI method,[27,28] but later was termed laser spray
ionization (LSI) [29]. This initial discovery is the starting point of the research presented
here in which a number of ionization methods were uncovered. For some, ionization
occurs in a heated inlet and for others in vacuum.
1.3 LSI Inlet and Vacuum Ionizations
The newly discovered ionization methods are summarized in Scheme 1.1. LSII,
the first inlet ionization method produces multiply charged ions similar to ESI at AP
(Scheme 1.1.IA) but directly from the solid state similar to MALDI.[30] Ionization
occurs in a heated inlet tube between AP and vacuum. Since LSII has similar attributes to
MALDI, which uses a matrix to produce ions, initial understanding on the ion formation
for LSII is that the laser results in a free jet expansion of the matrix producing highly
charged matrix/analyte clusters that become desolvated in the heated inlet capillary of a
mass spectrometer (Scheme 1.1.IA).
To understand the fundamental aspects of LSII, the ablated material was collected
on a glass plate before it enters the ion entrance of the mass spectrometer and analyzed
using microscopy. Microscope image of this ablated material shows particles and
formation of liquid droplets [31] similar to what has been experimentally observed in
vacuum MALDI [32-34] and theoretically shown through dynamic molecular modeling
studies [35-38]. In addition, a temperature study on the heated inlet transfer capillary
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shows that ion abundance of the multiply charged ions increased significantly as the
transfer capillary is heated from 100 to ~350 C.[29] Contrary to MALDI, a laser is not
required as identical mass spectra were obtained by physical means (e.g. tapping) of
transferring the matrix/analyte crystals into the heated transfer capillary of the mass
spectrometer. This approach is called matrix assisted ionization inlet (MAII) (Scheme
1.1.IB).[39]

Scheme 1.1. (I) Inlet ionizations: (A) LSII and (B) MAII, and (II) Vacuum ionizations:
(A) LSIV and (B) MAIV.
In addition, a study of over 200 small molecule matrices showed that aromaticity and
functionality

similar

to

that

of

common

UV-MALDI

matrices

(e.g.,

2,5-

dihydroxyacetophenone, 2,5-DHAP and 2,5-dihydroxybenzoic acid, 2,5-DHB) (Scheme
1.2) is not a requirement to produce multiply charged ions since matrixes that are linear,
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or aromatic compounds with no other functionality, produces multiply charged ions so as
long as it is heated at ~450 C.[40] A number of these matrixes worked at temperatures
as low as 50 C. Because LSII and MAII produce ions within a heated tube linking AP to
the first vacuum region of the mass spectrometer and the ionization occurs within the
heated inlet tube, these methods have been termed ‘inlet ionizations’.
O

NO2

OH

HO

OH

OH

HO
A) 2,5-Dihydroxybenzoic acid

O

CH3

OH
C) 2-Nitrophloroglucinol
NO2

OH

HO
B) 2,5-Dihydroxyacetophenone

CN
D) 3-Nitrobenzonitrile

Scheme 1.2. Structures of LSII (A,B,C), LSIV (B,C) and MAIV (D) matrixes.
A number of these matrixes that have lower thermal requirement were tested on a
SYNAPT G2 vacuum MALDI source that operates at intermediate pressure (IP) and the
source uses RG laser alignment. The TG approach in LSII is not a limitation in the
production of multiply charged ions because RG had previously been demonstrated using
an AP-MALDI source for LSII.[41] With the vacuum MALDI source, the only source of
thermal energy is the laser ablation event. The pressure drop for LSII still applies to this
setup because the source operates from IP to vacuum. Two matrixes, 2,5-DHAP and 2nitrophloroglucinol (2-NPG) (Scheme 1.2) were shown to produce multiply charged ions
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in the IP-MALDI vacuum source with the use of a laser, similar to what has been
obtained using LSII. This approach was thus called laserspray ionization vacuum (LSIV)
(Scheme 1.1.IIA).[42,43] 2-NPG also produces stable multiply charged ions in high
vacuum MALDI-TOF instruments.[44,45] Among the few matrixes that produced
multiply charged ions at 50 C, 3-nitrobenzonitrile (3-NBN) (Scheme 1.2) astonishingly
produces multiply charged ions just by exposing the matrix/analyte crystals to the
vacuum of the IP-MALDI source of the mass spectrometer without initiating the laser.
This method is called matrix assisted ionization vacuum (MAIV) (Scheme 1.1.IIB)
[46,47] in analogy to MAII. The classification defines the main driving force for the
formation of the analyte ions by using a heated inlet (Scheme 1.1.I) or by the vacuum
(Scheme 1.1.II) of the mass spectrometer.
This dissertation presents the results, application, and insights to the fundamental
aspects of the three new ionization methods developed during the course of the work
described here: LSII, LSIV, and MAIV in ten published papers. Chapter 2 describes
general experimental procedures including the materials, sample preparation, set-up,
acquisition conditions, and instrumentation involved. Experimental methods relevant to
each chapter are included in the chapter. Chapters 3-7 shows the results obtained for
LSII on three different mass spectrometers: Thermo Scientific Orbitrap Exactive
[28,29,48] and LTQ Velos [48], and Waters SYNAPT G2 [49,50] documented in five
published papers. Chapter 3 reports the first FF-TG-AP-MALDI experiments using a
2,5-DHB, a matrix common to MALDI, to produce multiply charged ions. Singly or
multiply charged ions can be selectively produced by changing the matrix or sample
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preparation conditions for 2,5-DHB. Using 2,5-DHB matrix, multiply charged ions are
produced from angiotensin I using solvent-based sample preparation while singly charged
ions are formed using solvent-free sample preparation. ESI-like mass spectra are
observed by applying as low as attomole amounts of the analyte with the matrix on the
target plate. The production of multiply charged ions similar to ESI extends the mass
range of high resolution mass spectrometers that have limited mass-to-charge (m/z) ratio
(4000).
Chapter 4 discusses briefly the fundamental aspects and the conditions for LSII
in producing ESI-like ions in MALDI-like sample preparation. ESI produces multiply
charged ions by a mechanism involving highly charged solvent/analyte droplets.[1,51-53]
In MALDI, the dominant production of singly charged ions was postulated to occur from
multiply charged matrix:analyte clusters by the “lucky survivor” model [54] and latter
modified to formation of singly charged ions from clusters [55]. Multiply charged cluster
formation has been proposed in MALDI by a mechanism similar to ESI.[54,56,57] For
LSII, the formation of liquid droplets and clusters of the laser ablated material was shown
from the microscopy studies [31] at AP. These observations are similar to the droplets or
cluster formation by MALDI and has been experimentally observed [32-34] and
theoretically demonstrated thru molecular modeling studies [35-37]. For LSII, these
liquid droplets and clusters are believed to be highly charged and with appropriate
desolvation condition as shown from the temperature study of the heated transfer
capillary produces abundant multiply charged ions. In vacuum MALDI, it is proposed
that charged droplets/clusters are produced by laser ablation, but for LSII after the
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discovery of MAII, it is shown that removing charged droplets/particle/ions with high
voltage before they enter the inlet does not significantly alter the ion abundance in LSII.
The tapping method to demonstrate MAII clearly shows that the charges are produced in
the inlet for LSII. With the production of ESI-like mass spectra by LSII, the first protein
fragmentation is reported from a MALDI-like sample preparation using electron transfer
dissociation (ETD) [58]. Fundamental aspects in producing multiply charged ions by
LSII includes the field-free and proper desolvation conditions using a heated transfer
capillary in the presence of a pressure drop region from AP to vacuum.
MS methods are limited to the separation of ions measured and displayed by m/z
ratios and ion intensities thus it becomes a challenge to analyze complex systems such as
tissue by MS due to its complexity including solubility, volatility, hydrophobicity,
isobaric, and isomeric compositions. Current technologies employ liquid based separation
approaches coupled to MS, but perform poorly with solubility restricted materials
[10,30]. Ion mobility spectrometry (IMS) MS has been noted for the ability to separate
ions in the gas-phase according to the number of charges and cross-section defined by
size and shape.[59-67] IMS-MS has many advantages compared with even highresolution mass spectrometers because of its ability to extend the dynamic range and
separate isomeric composition.[64-67]
With the ability of LSII to produce multiply charged ions, Chapter 5 presents the
results of LSII coupled to a Waters SYNAPT G2 mass spectrometer with IMS-MS
capability. The Waters SYNAPT G2 has a source that can only be heated up to 150 C.
Fabrication of a desolvation device mounted on the z-spray ESI skimmer cone of the
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SYNAPT G2 mass spectrometer provides the external heat needed to desolvate
efficiently the 2,5-DHB matrix from the highly charged matrix/analyte clusters to
produce the multiply charged molecular ions.[29] The total ion current displays almost
no ion abundance when the external heat supply is off. With the IMS dimension, one can
readily observed the separation of the components in the mixture from the pictorial
snapshot [66] as displayed from the 2-dimensional plot of drift time vs. m/z. The 2-D plot
display allows the extraction of drift time and/or m/z which is very useful for the
separation of components in a complex mixture. In the absence of a heated inlet, another
approach to efficiently desolvate the highly charged matrix/analyte clusters is to lower
the thermal requirement of the matrix for the desolvation process.
Chapter 6 reports the use of 2,5-DHAP matrix that allows the operation of
Waters SYNAPT G2 mass spectrometer at 150 °C without applying external heat to the
fabricated desolvation device. The multiply charged ions produced from an isomeric
mixture are well separated in the drift time dimension. Distinguishig isomers by MS
alone is currently not possible. The extracted drift time information using LSII shows
baseline separation of the isomeric mixture. The LSII drift times obtained from a surface
are identical to the extracted drift times using solution ESI suggesting similar softness.
Conditions that lower the thermal requirement in the formation of multiply charged ions
by LSII are very important in retaining the structure of proteins during ionization and
when coupled with IMS, provide the benefits of efficient separation and characterization
of protein mixture including isomers as well as cross section analysis from surfaces
which is important for biomedical application involving tissue samples.
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Chapter 7 reports for the first time the detection of intact peptides and proteins of
up to ~20 kDa by LSII directly from mouse brain tissue mounted on a microscopy glass
plate and spotted with 2,5-DHAP matrix. The multiple charging of LSII allows the
analysis of proteins from the mouse brain tissue on a high performance mass
spectrometer that has limited m/z. The use of a high resolution mass spectrometer
provides the mass accuracy which is useful in identifying the protein from the measured
molecular weight. With sufficient ion abundance of the multiply charged ions from the
tissue, ETD fragmentation is demonstrated for the first time directly from the tissue
providing sequence coverage and identification of an endogenous peptide when
combined with the high mass resolution and mass accuracy data obtained from the same
tissue samples. With the TG approach for LSII, improved spatial resolution for tissue
imaging can be attained. As shown in this study , ~15 µm diameter laser ablated areas on
the tissue are seen thru microscopy images. In addition, the AP condition allows the
analysis of tissue at ambient conditions and speed of analysis beneficial for tissue
imaging.
Chapter 8 reports the first example of the production of highly charged ions in
vacuum similar to LSII, thus termed LSIV using the commercial IP-MALDI vacuum
source of the SYNAPT G2.

In the absence of a heated inlet, important factors

influencing the production of multiply charged peptide/proteins ions in a vacuum
MALDI source at IP are the use of a suitable matrix and the appropriate settings and
acquisition conditions (e.g. laser power, voltages) for ion acceleration and transmission.
With IMS dimension, singly charged lipid ions are well separated from multiply charged
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peptide/protein ions detected from mouse brain tissue. The extracted drift times of the
identified endogenous peptide directly from the mouse brain tissue are identical to the
synthesized standard using LSII and ESI confirming the presence of the endogenous
peptide in the tissue.
In a search for more matrixes that have low thermal requirements for desolvation
in the absence of a heated inlet, Chapter 9 introduces another matrix, 2-NPG, that
produces higher charge states than 2,5-DHAP in vacuum. Spotting 2-NPG on a delipified
mouse brain tissue allows the detection of higher mass compound in the tissue than 2,5DHAP using LSIV. The use of 2-NPG for tissue imaging by LSIV, which was not
possible for 2,5-DHAP, shows the first example of images of multiply charged ions from
delipified mouse brain tissue.
Another matrix, 3-NBN, produces multiply charged ions with high ion abundance
even at very low temperature using MAII. Chapters 10-12 reports for the first time the
production of ions in vacuum without the use of a laser by using 3-NBN as the matrix on
the IP-MALDI vacuum source of a SYNAPT G2 mass spectrometer.

Chapter 10

introduces this new ionization as MAIV and shows the ability to ionize a variety of
samples from small molecule, lipids, peptides, to proteins up to ~66 kDa by simply
exposing the matrix/analyte crystals to the vacuum of the mass spectrometer without the
use of the laser. MAIV ionizes both in positive and negative mode measurements. Low
femtomole concentration can be analyzed without optimization for small proteins. This
new ionization in vacuum without the use of a laser is softer than MALDI for the analysis
of fragile molecules, post translational modification, and molecular complexes. The
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sublimation process makes it possible for MAIV to improve the spatial resolution in
analyzing tissue samples since matrix deposition on the tissue can be miniaturized.
Chapter 11 presents a brief mechanistic aspect on the ion formation by MAIV.
The conversion of the matrix/analyte crystals into gas-phase ions without the use of laser
suggests that the ion formation is via a sublimation process in which 3-NBN has the
property to sublime.[68] In addition, 3-NBN is a triboluminescence compound [69,70]
that produces a strong dinitrogen discharge emission as a result of the high electric field
created during crystal fracturing leaving the opposing surfaces having opposite charges.
This phenomenon also explains the ability of 3-NBN to ionize molecules both in positive
and negative ion mode detection. Thus, the formation of ions by MAIV in vacuum using
3-NBN is hypothesized to be a sublimation driven triboluminescence process. Different
surfaces can be used for MAIV including filter paper, foil, thin layer chromatography
plates, and paper currency. Basic small molecules are ionized with less or no chemical
background which is an advantage in comparison to MALDI for small molecule analysis.
Sensitivity of basic small molecule is achieved at very low femtomol and with MS/MS
high attomole concentrations in the positive ion mode. Analysis of mixture of lipid,
peptides, and proteins by MAIV ionizes efficiently all the components in the mixture and
with the IMS dimension are well separated and the charge state distribution are readily
observed from the pictorial snapshot. Because ions are formed by using a suitable matrix,
e.g. 3-NBN, and by exposing the matrix/analyte crystals to the vacuum of the mass
spectrometer, MAIV extends its utility using a custom modified ESI source.[46,47,71]
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Chapter 12 reports the utility of MAIV for real time applications in combination
with IMS for ionization, separation, and characterization of small molecule such as drugs
to lipids, peptides, and proteins. Mixtures of small molecules are ionized instantaneously
by MAIV and separated by IMS. Characterization by MS/MS without precursor ion
selection makes the method rapid for clinical applications. MAIV is very specific in
ionizing small molecules such as drugs as shown from the results obtained from drug
treated mouse brain tissue, and drugs with their metabolites from biological fluids such as
urine. MAIV ionizes efficiently both in positive and negative mode measurements, and
with IMS dimension, comparison of extracted drift times can be compared between
positive and negative mode, and with ESI. Identical drift times are observed between
MAIV from the surface and ESI from solution. The production of higher charge states is
advantageous to improve fragmentation by CID. With IMS dimension, multiply charged
ions formed from isomeric mixture are baseline separated and with IMS, characterized by
MS/MS in the transfer region. The sublimation process in the ionization allows
miniaturization of matrix deposition on the tissue and detection of the higher mass
compounds from mouse brain tissue in vacuum compared to LSIV. MAIV stands out
among the three ionization methods, but currently has its limitation for tissue imaging.
Both LSII and LSIV have the potential for tissue imaging and with LSII improving the
spatial resolution. The quest in searching for an ionization method to efficiently ionized
solubility restricted materials directly from the surface leads to a discovery that
encompasses both the benefits and advantages of the traditional ionization methods in
mass spectrometry.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Materials and Sample Preparation
Salts, sugars, lipids, peptides, and proteins were purchased from Sigma Aldrich
(St. Louis, MO) unless otherwise noted. Amyloid peptides were purchased from
American Peptide Co. (Sunnyvale, CA), other lipids from Cayman Chemicals (Ann
Arbor, MI), synthesized N-acetylated myelin basic protein fragment (MBP) from
Anaspec (Fremont, CA), modified peptides from Protea Biosciences (Morgantown, WV),
clozapine from Santa Cruz Biotechnology (Santa Cruz, CA), and commonly used illicit
drugs from Cerilliant (Round Rock, TX). Waters Co. (Milford, MA) provided leucine
encephalin, [Glu1]-fibrinopeptide (GFP), and myoglobin. The matrixes were purchased
from Sigma Adrich except for 2,5-DHAP which was obtained from Fisher Scientific Inc.
(Pittsburg, PA). Solvents used were purchased from Fisher Scientific Inc. (HPLC grade
water, acetonitrile (ACN), methanol (MeOH), ethanol, acetic acid, and trifluoroacetic
acid (TFA)). Purified water was purchased from Millipore (Billerica, MA) acetic acid
and ammonium hydroxide from Mallinckdrodt Chemicals (Phillipsburg, NJ), and HPLC
grade water and methanol from EMD Chemicals (Gibbstown, NJ). Microscopy glass
slides used was from Gold Seal (about 80% transmission) Products (Portsmouth, NH).
Stock solutions of peptides and proteins were prepared as 1 mg mL-1 in water
except for bovine insulin in 1:1 by volume methanol/water with 1% acetic acid. Lipids
and drugs were prepared in either 100% ACN, methanol, or ethanol. Salts were dissolved
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in water to make 1 M concentration. Peptides and proteins were diluted in 100% water or
1:1 ACN/water with or without 0.1% acid. Lipids and drugs were diluted in 100% water
or 1:1 methanol/water or ACN/water. Most of the matrixes were dissolved in 1:1
ACN/water. For solvent-based matrix/analyte preparation, the dried droplet method [3]
was used. Both the matrix and analyte were dissolved separately in a common solvent,
mixed by vortexing, placed 1 μL of the matrix/analyte mixture on the microscope glass
slide or target plate, and air dried or using a heat gun (low heat). A layer method was
also used by placing 1 μL of the analyte on the glass slide, added 2 μL of the matrix
solution and mixing before allowing to air dry or blow dry using a heat gun. The method
for solvent-free sample preparation is described elsewhere.[72,73]
Mouse Brain Tissue - The mouse brain tissue sections were provided by Dr. Ken Mackie
from Indiana University (Bloomington, IN). Twenty week old C57 Bl/6 mice were
euthanized with CO2 gas and perfused transcardially with ice-cold 1X phosphate-buffered
saline (150 mM NaCl, 100 mM NaH2PO4, pH 7.4) for 5 min to remove red blood cells.
The brains were frozen at -22 °C and sliced into 10 µm sections in sequence using a
Leica CM1850 cryostat (Leica Microsystems Inc., Bannockburn, IL). The tissue sections
were placed onto a pre-chilled plain or matrix pre-coated microscopy glass slides that
were briefly warmed with the finger from behind to allow sections to relax and attach.
Care was taken to avoid water condensation by storing at -20 °C. The tissue-mounted
glass slides were placed in an airtight box containing desiccant and transported under dry
ice.
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For drug treated mouse brain, the mouse received 50 mg kg-1 of clozapine by
intraperitoneal introduction for 90 min before it was sacrificed. For peptides and protein
analysis, the mouse brain tissue sections mounted on the glass plate were washed to
remove the lipids according to a published procedure.[74] Before washing the tissue
twice with ethanol, the glass slide with the mounted mouse brain tissue was dried in the
desiccator. In the first wash, the glass slide with the mounted tissue was immersed in a
glass Petri dish filled with 70% ethanol, swirled for 30 s, and removed carefully. The
glass slide was then tilted to remove the solvent for about 10 s and immediately washed
with 95% ethanol in another Petri dish for an additional 30 s. After the second wash, the
glass slide was allowed to dry in the desiccator for 20 min prior to analysis or stored at
-20 °C until use or shipment under dry ice.
2.2 Laserspray Ionization Inlet (LSII)
Laserspray ionization inlet (LSII) operates at AP in FF-TG. The laser, a Spectra
Physics, VSL-337ND-S nitrogen laser, is aligned at approximately 180 to the mass
spectrometer inlet. The beam is focused using a focusing lens on to the matrix/analyte
spot applied to a glass microscope at about 1-3 mm distance from the ion entrance
(Scheme 1.1.IA). The laser fluence must be sufficient to ablate the matrix/analyte
crystals from the surface. The fluence is substantially higher than that used with most
MALDI experiments (typically on the order of 1-2 J cm-2). The higher laser fluence does
not result in detrimental effects on the observed mass spectra, including resolution. The
LSII set up was used on an Orbitrap Exactive and LTQ Velos from Thermo Scientific
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(Scheme 2.1) (Bremen, Germany) and SYNAPT G2 (Scheme 2.2) from Waters Co.
(Manchester, UK).
Orbitrap Exactive - The Ion Max source was removed to have open access of the inlet of
the mass spectrometer by overriding the interlocks. External voltages were set to zero and
there were no external gas flow. ESI tuning condition was used for capillary voltage
(typically 20-140 V) and the tube lens voltage (typically 80-150 V). Necessary precaution
was exercised so that no potential hazardous exposure to the laser beam or hot surfaces
near the ion entrance orifice. The ion transfer capillary was heated up to ~400C.
Resolution was set at 100,000 (m/z 200, full width at half height definition) and the
maximum ion inject time was set at 500 ms. Positive ion mass spectra were obtained for
1 s giving 100,000 mass resolution.

Scheme 2.1 Representation of FF-TG AP-MALDI (now called LSII) Source Design.[28]
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LTQ Velos – Similar to the Orbitrap Exactive, the Ion Max source was removed and the
interlocks were overridden to perform LSII, or with the Ion Max source with the removal
of the front window for the laser beam to pass thru and aligned 180 C to the mass
spectrometer ion entrance. Also, the side window was removed so that the glass plate can
be placed in front of the ion entrance. The temperature at the heated inlet ranged from
150-350 C. Xcalibur 2.1.0 was used for data analysis.
LTQ Velos ETD - Fluoranthene was used as the electron transfer reagent and a mixture
of ultrapure helium and nitrogen (25% helium and 75% nitrogen; purity, ~99.995%) was
used as the reaction gas to perform the ETD experiments.
SYNAPT G2 – The Nanolockspray ion source of Waters SYNAP G2 was used to set up
LSII.[49] This was achieved by removing the lockspray motor. In addition, the ion
entrance orifice of the skimmer of the SYNAPT G2 mass spectrometer was modified
since the source temperature can be heated only up to 150 C. To have a source
temperature above 150 C, external heat was supplied to a fabricated external tube
attached to the skimmer cone. A 1/8 in. outer diameter x 1/16 in. inner diameter x 1 in.
length copper tubing was sanded on one end to fit through the cone gas nozzle (outer
cone) and fitted on the ion entrance of the sample cone (inner cone) of the skimmer
(Scheme 2.2). The copper tubing coated with Sauereisen cement (Insolute Adhesive
Cement Powder no. P1), dried and 24 gauge nichrome wire (Science Kit and Boreal
Laboratories, Division of Science Kit, Inc., Tonawanda, NY, USA) was coiled around the
coated tube and again coated with a layer of Sauereisen cement and allowed to dry. The
coated copper tubing was then attached to the skimmer and held to the cone gas nozzle
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with a layer of Sauereisen cement. Both ends of the coiled nichrome wire were connected
with alligator clips to the insulated copper wire from a variac (Powerstat Variable
Transformer type 116). The copper desolvation device was heated by application of up to
12 V from the variac. The temperature measured on the outside of the device was > 200
°C. The nitrogen laser was placed 180 C to the outer end of the attached copper tubing
so that the laser beam fires at TG and focused on the sample. The x,y,z-stage of the
Nanolockspray ion source was used to move the glass microscope slide with the
matrix/analyte spot relative to the outer end of the copper tube and the laser beam.

Skimmer cone
To
vacuum

180

Laser
beam
(TG)

Glass Plate

~1-3 mm

Matrix/analyte clusters
Matrix/
analyte
crystals

Pressure drop

Flow entrapment

Variac

Scheme 2.2 Schematic representation of laserspray ionization inlet (LSII) with the
fabricated desolvation device used on Waters SYNAPT G2 mass spectrometer.[49]
The SYNAPT G2 instrument was operated in positive and resolution modes. The
sample cone was set at 40 V and the extraction cone at 4 V. The source temperature was
set at 150 °C. The scan time was set for 1 s. All acquisitions were obtained up to 2 min at
a scan time of 1 sec although sampling of the spot was frequently completed in a shorter
time period. The gas used for the drift time (td) separation was nitrogen with a flow set at
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22 mL min-1. The IMS wave velocity was set at 650 m s-1 with a wave height of 40 V.
The pressure in the drift cell of ~3.2 mbar was recorded. Acquisition was set in mobilityTOF mode on the SYNAPT G2 mass spectrometer to obtain both the m/z ratio and drift
times. After acquisition, the mass spectrum was extracted using MassLynx 4.1 (Waters
Corp., Manchester, UK) and 2-D plots of td vs. m/z ratio using DriftScope ver. 2.1
(Waters Corp., Manchester, UK).
2.3 Laserspray Ionization Vacuum (LSIV)
A commercial intermediate pressure MALDI source of SYNAPT G2 mass
spectrometer from Waters Co. (Manchester, UK) equipped with an IMS and operated
using a Nd:YAG laser (355 nm) in reﬂection geometry mode (Scheme 1.1.IIA) was used
in this study. Acquisition mode was set using mobility-TOF and operated in positive ion
and sensitivity mode (also referred as V mode) with the following settings: 0 V sample
plate, 10 V “extraction”, 10 V “hexapole bias”, and 5 V “aperture 0”. LSI (ESI-like, 0 V
sample plate) and/or MALDI (20 V sample plate) settings were used.[42,45] The laser
fluence ranged from “50” to “500” (1.33 – 45.84 J cm-2) [45] at a firing rate set at 200
Hz. The laser operates with an average power of 20 mW and a pulse energy of 100 μJ.
The sample plate once loaded was under vacuum conditions of ~0.2 mbar (ca 0.16 Torr)
[75]. Scan time was set at 1 sec and acquisitions were summed for 1 to 2 min. Nitrogen
gas was used for the drift time separation with a flow set at 22 mL min-1. The IMS
pressure in the drift cell was ~3.2 mbar. The wave velocity used ranges from 550 to 650
m s-1, and the wave height was at 40 V. After acquisition, MassLynx 4.1 and DriftScope
ver. 2.1 software were used for data processing.
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2.4 Matrix Assisted Ionization Vacuum (MAIV)
MAIV was performed on an IP-MALDI vacuum and custom modified ESI
sources. By simply mixing the analyte solution with the matrix, 3-NBN, and expose the
matrix/analyte crystals to the vacuum of the mass spectrometer, molecular ions are
formed.
MAIV on a Commercial Vacuum MALDI Source - The commercial IP-MALDI source
of Waters SYNAPT G2 with IMS capability conventionally operated with an Nd:YAG
laser (355 nm) was employed with the laser off (Scheme 1.1.IIB). Matrix/analyte sample
was prepared using 3-NBN as matrix similar to MALDI sample preparation protocols [3]
and spotted 1 µL on a sample plate. The source pressure when the sample plate was
loaded was ~0.2 mbar. Ions are observed from the matrix and the analyte once the sample
plate with the matrix/analyte spot is positioned near the extraction lens, a process that
takes ca. 2 min (Scheme 2.3). The TOF mass analyzer was operated in positive or
negative ion V mode (also referred to as sensitivity mode). “MALDI” or “LSI” settings
[42,45] were used to perform MAIV-IMS-MS measurements. Acquisition times in MS
and MS/MS ranged from 30 s to 2 min for standard samples and up to 4 min for the
mouse brain tissue section sample, but single scan acquisitions were sufficient for most
analytes. Mobility-TOF measurements were acquired with a drift cell pressure of ~3.2
mbar, wave velocity at 650 m s-1, and wave height at 40 V.The nitrogen gas used for the
drift time separation was set at 22 mL min-1. MassLynx 4.1 and DriftScope ver. 2.1
software were used for data processing.
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Multiply
charged
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Scheme 2.3 (A) Representation on the ion formation of MAIV using an intermediate
pressure vacuum MALDI source without the laser. (B) Screenshot during MAIV
acquisition using the intermediate pressure vacuum MALDI source showing formation of
multiply charged ions without the use of the laser.[47,71]
MAIV on Commercial Atmospheric Pressure ESI Source SYNAPT G2- MAIV on the
ESI source of the SYNAPT G2 mass spectrometer was performed by modifying the
skimmer cone of the z-spray. The outer cone aperture of the skimmer was widened to
about ~4.5 mm to allow a metal ferrule to form a gas-tight seal with the inner skimmer
cone (Scheme 2.4). Non-standard inner cone with ~3 mm inner diameter inlet aperture
was used and assembled to the modified outer skimmer cone with the ferrule attached.
The glass plate with the matrix/analyte spot was placed on the ferrule facing the source
entrance, and once the vacuum isolation valve was opened, the glass plate was held to the
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ferrule by the vacuum of the mass spectrometer. Ions were observed until the matrix was
no longer visible. The ion source temperature for the experiments was set at 50 °C. The
instrument was operated in mobility-TOF and sensitivity (‘V’) modes acquiring in both
positive and negative ion detection. ESI default settings were used with 40 V sample
cone and 4 V extraction cone voltages using mobility-TOF settings as described above.
MassLynx 4.1 and DriftScope ver. 2.1 software were used for data processing.
A Inside: matrix:analyte crystals

Glass plate

Ferrule

B

Outer cone
Rough
pump

Modified
outer cone

Ferrule

Modified
inner cone

To mass
Vacuum
Inner
analyzer
seal
cone
Skimmer cone assembly
AP
Vacuum

C

Scheme 2.4 MAIV on the ESI source of Waters SYNAPT G2: (A) Representation of the
simple modification of the skimmer cone simply by inserting a ferrule, (B) picture of
components of home-built modified skimmer cone (left to right): connecting ferrule,
outer and inner skimmer cones, and (C) photographs of typical operation: (1) vacuum
valve closed, (2) glass on, (3) vacuum valve open, (4) matrix/analyte sample enters
readily mass spectrometer by vacuum forces.[46,47]
MAIV on Commercial Atmospheric Pressure ESI Source LTQ Velos - The Ion Max
source was removed and the interlocks were overridden to have open access of the mass
spectrometer inlet. The outer end of the transfer capillary was modified by inserting a
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ferrule on the outer opening of the inlet tube to hold the glass plate. Nonstandard 750 µm
inner diameter inlet capillary was used (Scheme 2.5). MAIV-ETD fragmentation for
peptide sequencing used conditions similar to those described in a previous report [48].
Mass spectra were acquired using a maximum injection time of 50 ms and 2 microscans
with an inlet capillary tube temperature of 150 °C. ETD acquisition was set at 1 m/z
isolation width and 100 ms activation time. Xcalibur 2.1.0 was used for data analysis.
Inlet
capillary
tube

ferrule

Analyte:matrix
spot on glass
plate

Scheme 2.5 MAIV on the ESI source of Thermo Scientific LTQ Velos. The outer end of
the inlet capillary is inserted with the ferrule with wider opening. The sample plate with the
matrix/analyte spot is held by the vacuum of the mass spectrometer thru the ferrule.
2.5 Microscopy Measurement
Optical microscopy (Nikon Eclipse LV100) was performed to obtain qualitative
information on the ablated area of matrix/tissue ablated per laser shot after mass spectral
analysis of the tissue using LSII. Various magnification conditions were used, ranging
from 5x to 100x, providing detailed views to ~1 µm resolution.
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CHAPTER 3
MATRIX-ASSISTED

LASER

DESORPTION/IONIZATION

MASS

SPECTROMETRY METHOD FOR SELECTIVELY PRODUCING EITHER
SINGLY OR MULTIPLY CHARGED MOLECULAR IONS “Reprinted (adapted)
with permission from (Trimpin, S.; Inutan, E.D.; Herath, T.N.; McEwen, C.N. Anal.
Chem. 2010, 82, 11-15). Copyright (2010) American Chemical Society.”

Introduction
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS),
along with electrospray ionization (ESI), has had an enormous impact on science because
of the capability to ionize nonvolatile and high-mass compounds such as peptides and
proteins.[2,3] MALDI is characterized by the production of low-charge state ions with
singly charged ions being dominant, especially for compounds with molecular weights
below

10-20 kDa, while ESI [1] is characterized by much higher charge states

sometimes reaching hundreds of charges per molecule for larger proteins and polymers.
The observation of mostly singly charged ions in MALDI reduces mass spectral
complexity, which is especially useful for mixtures such as those found in polymer
distributions, but they limit structural characterization because of the difficulty of
producing fragment ions and requires a mass analyzer with a m/z range at least equal to
the molecular weight of the compounds being analyzed.
Here, we report the ability to selectively produce either ESI-like multiply charged
or MALDI-like singly charged ions using a MALDI process at atmospheric pressure
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(AP). Thus, multiply charged molecular ions dominate the mass spectrum when the
analyte along with the common MALDI matrix, 2,5-dihydroxybenzoic acid (2,5-DHB),
is applied to a glass MALDI target plate using the standard dried droplet sample
preparation method [3] and ablated using a nitrogen laser (337 nm). Under the same
instrumental conditions, except that the sample preparation is by the solvent-free method
[72,73] where analyte and matrix are ground together and placed on the MALDI target
plate without the use of any solvent, MH+ singly charged molecular ions are dominant.
The ability to produce, at will, multiply charged ions in a MALDI process is potentially
analytically important as it extends the mass range of common atmospheric pressure
ionization

(API)

mass

spectrometers

and

provides

enhanced user initiated

fragmentation, similar to ESI.
AP-MALDI offers advantages over vacuum MALDI, including time and
volatility constraints as well as the ability to analyze materials under more
physiologically relevant conditions, which is especially important in the developing area
of compound-specific tissue imaging. Vacuum MALDI which is more sensitive than APMALDI, and often more sensitive than ESI,[23] imposes analysis limitations with
materials that are not compatible with vacuum and solvent conditions.[10] Thus, methods
that offer improved sensitivity for AP-MALDI are needed. Some sensitivity improvement for AP-MALDI is achieved by the implementation of pulse dynamic focusing
(PDF),[76] but part of the sensitivity gain is due to sampling a larger area. Thus, PDF
only provides minimal sensitivity gain for imaging where spatial resolution (small
sampled area) is important. A new AP-MALDI configuration based on theoretical studies
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by Sheehan and Willoughby [24] and by laser ablation studies by Willis and Grosu [25]
is reported here. Sheehan and Willoughby modeled AP ionization and reported that ~90%
of the ions entering the AP to vacuum orifice are lost to the walls (so-called rim losses) if
a high electric field is present in the AP region.[24] Forward momentum caused by the
explosive expansion of materials irradiated in a transmission geometry (TG) laser
ablation experiment in which the laser beam passes through the holder (glass or quartz)
before striking the sample was demonstrated by Willis and Grosu.[25] Thus, combining
these ideas into the configuration shown in Scheme 1.1IA with field-free (FF) conditions
to minimize rim loses and placement of the sample in close proximity to the ion entrance
orifice to enhance momentum transfer of material in the expanding gas jet is expected to
ensure high transmission of ions into the mass analyzer. TG using glass microscope
slides as the MALDI target plate is also ideal for such a source configuration as well as
for tissue imaging microscopy.[77] The initial results from this ion source, with minimal
optimization, demonstrate the FF-TG AP-MALDI concept by successfully obtaining
mass spectra of lipids, carbohydrates, peptides, proteins, and polymers. The potential
analytical utility of this new MALDI approach is discussed and representative examples
presented.
Experimental Section
Materials and sample preparation are included in Chapter 2.1, and the LSI set-up
using the Orbitrap Exactive mass spectrometer is described in Chapter 2.2. For solventbased matrix/analyte preparation, lipids in 70:30 or peptides/proteins in 50:50 ACN/water
was mixed with 2,5-DHB using dried droplet method.[3] One µL of the matrix/analyet
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mixture (200/1 or 5000/1) was placed on the microscope slide and dried using a heat gun
(low heat). Alternatively, the solvent-free sample preparation method was used as
described elsewhere.[72,73] The ion transfer capillary was heated to 350 C. Resolution
could be set from 10,000 to 100,000 (m/z 200, full width at half height definition) and the
maximum ion inject time was set to 50 ms.
Results and Discussion
The mass spectra obtained from laser ablation of the solution based matrix/analyte
preparation dried on a glass microscope slide using FF-TG AP-MALDI are nearly
identical to ESI mass spectra. Thus, singly charged ions are produced from compounds
that do not have basic sites for attachment of more than one proton. Therefore, only
singly charged ions are observed with FF-TG AP-MALDI using solvent-based sample
preparation with 2,5- DHB, as well as with ESI using 50:50 acetonitrile/water, for lipids
such as N-arachidonoylethanolamine (molecular weight [MW] 347.3), N-arachidonoyl
glycine (MW 361.3), phospatidyl glycerol (MW 770.5), sphingomyelin (MW 812.7), and
phospatidyl inositol (MW 886.6) as well as small peptides such as leucine enkephalin
(MW 555.3) and -amyloid 33-42 (MW 914.5) (Appendix A Figures S1, S2 , S3).
However, for bradykinin antagonist (MW 1109.6), angiotensin I (MW 1295.7),
angiotensin II (MW 1045.5), and adrenocorticotropic hormone (ACTH 18-39 human;
MW 2464.2) using the same solvent-based sample preparation conditions with APMALDI or ESI, multiply charged ions dominated the mass spectrum while singly
charged ions were either not observed or in very low abundance. Under these FF-TG APMALDI conditions, higher mass peptides, proteins, and synthetic polymers produce
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higher charge states: insulin B chain oxidized, (MW 3536.7) < β-amyloid (1-42), (MW
4511.5) < porcine insulin (pancreas, MW 5772.6) < polyethylene glycol, (PEG) 6590 <
ubiquitin, (bovine red blood cells, MW 8561) (Figure 3.1A-F).

Figure 3.1. LSII inset mass spectra showing multiply charged molecular ions for (A)
bovine insulin oxidized B chain (MW 3536.7, +3), (B) amyloid (1-42) (MW 4511.5, +4),
(C) bovine pancreas insulin (MW 5772.6, +5), (D) PEG 6690 (+6), (E) ubiquitin (MW
8561, +7), and (F) cytochrome c (MW 12 224, +12).
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Ubiquitin for example displayed ions from charge state +5 to +13. The mass spectrum
of cytochrome c (MW 12,224) obtained from a single 1 s acquisition of 4 pmol applied
to a microscope slide shows multiply charged ions from +8 to +15 in Figure 3.2A.

Figure 3.2. Full-range LSII-MS: (A) 4 pmol of cytochrome c applied to the microscope
slide with 1- s acquisition at 100,000 resolution (MW 12,224) and (B) PEG 6690 in 2,5DHB and NaCl prepared solvent-free and then dissolved in 70:30 ACN/water and 1 μL
placed on the microscope slide using the dried droplet method.
As with ESI, the higher charge states allow MALDI mass spectra to be obtained for
compounds beyond the mass limitation (m/z 4000) of the mass spectrometer. Mass
spectra can be obtained from complex mixtures such a protein digests or polymers.
Multiply or singly charged mass spectra were obtained from narrow polydisperse PEG
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samples with MWs below the 4000 m/z limit of the mass spectrometer using 2,5-DHB
and a trace of NaCl employing solvent-based or solvent-free preparation, respectively.
However, molecular ions of PEG 6590 were only observed with the solvent-based sample
preparation as multiply charged ions that fall within the m/z range of the mass
spectrometer (Figure 3.2B). Ionization with the singly or multiply charged mechanism
was by Na+ adduction, showing that metal adduction is favored for this polymer when
sodium salt is present.
The ability to produce multiply charged ions in a MALDI process has important
advantages. It potentially enables production of enhanced fragmentation from processes
such as collision induced dissociation (CID),[78] electron transfer dissociation
(ETD),[58,79] and electron capture dissociation (ECD).[80,81] It also extends the mass
range of mass spectrometers with limited m/z range, typically found with AP ionization
instruments. Additionally, just as with nanospray ESI, the amount of sample necessary
for an analysis can be reduced by minimizing the amount of matrix/analyte solution
placed on the glass slide. Sufficient signal was obtained in a single laser shot to produce
the isotope distribution of the doubly charged ions from 0.1 µL of a 400 amol solution
(80 amol) of angiotensin II in 2,5-DHB placed on a glass slide (Appendix A Figure S4).
Singly charged molecular ions can be produced for the compounds discussed
above that are within the m/z limit of the Orbitrap Exactive simply using the solvent-free
sample preparation method with 2,5-DHB. The advantage of producing only singly
charged ions is the simplified mass spectra obtained from complex mixtures such as
found in plasma or even synthetic polymers (Appendix A Figure S5). The mechanism
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for producing singly charged ions is distinct from that for producing multiply charged
ions and is shown to originate in the matrix choice or matrix/analyte preparation method.
This is shown in Figure 3.3 for angiotensin I prepared using 2,5-DHB employing the
solvent-based (Figure 3.3A) and solvent-free (Figure 3.3B) methods. The mass spectra
obtained with the singly charged mechanism often displayed matrix or Na+ adduction,
especially for peptides (Appendix A Figure S6). These adductions were rarely observed
and then in low abundance with the multiply charged ionization mechanism.

Figure 3.3. LSII mass spectrum of angiotensin I (MW 1295): (A) solvent-based dried
droplet sample preparation using 2,5-DHB in 50:50 ACN/water and (B) solvent-free
sample preparation using 2,5-DHB.
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It was even possible with 2,5-DHB to produce a mixed mode of ionization with
observation of singly and multiply charged ions by, for example, adding a drop of solvent
onto the solvent-free prepared matrix analyte mixture on the glass plate. After solvent
evaporation, the matrix/analyte mixture is only partially dissolved and the mixed mode
ionization can be observed. The activation of the singly charged ion mechanism was also
achieved using a thin layer experiment and increasingly non-incorporating conditions.
Laser ablation of an aqueous solution of 2,5-DHB placed on angiotensin II which had
been dried on the glass slide produced, after drying, exclusively doubly charged ions
whereas an acetone solution of 2,5-DHB placed over the dried peptide produced mixed
ionization and a dichloromethane 2,5-DHB solution produced only singly charged ions
(Appendix A Figure S7).
With α-cyano-4-hydroxycinnamic acid (CHCA), even under solvent-based
conditions, only singly charged ions are observed for angiotensin II (Appendix A Figure
S8) and substance P. This observation is in line with previously described fieldconstrained TG AP-MALDI experiments.[26] Other compounds such as dithranol, orthochlorobenzoic acid, and benzoic acid were examined as matrixes for AP-MALDI. With
angiotensin II, benzoic acid produced singly and no doubly charged ions while odichlorobenzoic acid produced low abundance doubly charged ions (Appendix A Figure
S9). Dithranol, besides producing singly charged ions with angiotensin II, also produced
notable matrix-adducted analyte molecular ions.
Previous studies have shown a moderate increase in multiple charging in MALDI
using different sample preparations, high laser fluence, a metal-free sample stage, and
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atmospheric pressure.[56,57] From the work presented here, it is clear that the MALDI
process can generate analytically useful ion currents from mechanisms that produce
multiply charged ions as well as singly charged ions. The ease and speed of the FF-TG
AP-MALDI method for producing either singly or multiply charged ions from a wide
variety of compound types with high sensitivity using a focused laser beam demonstrates
analytical utility.
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CHAPTER 4
LASERSPRAY

IONIZATION

–

A

NEW

AP-MALDI

METHOD

FOR

PRODUCING HIGHLY CHARGED GAS-PHASE IONS OF PEPTIDES AND
PROTEINS DIRECTLY FROM SOLID SOLUTIONS “This research was originally
published in Molecular and Cellular Proteomics (Trimpin, S.; Inutan, E.D.; Herath, T.N.;
McEwen, C.N. Mol. Cell. Proteomics 2010; 9:362-367) © the American Society for
Biochemistry and Molecular Biology.”

Introduction
Two primary differences between ESI and MALDI methods are the sample
environment (solution vs. solid) and the observable charge state(s) (multiply vs. singly
charged). The multiply charged ions observed in ESI mass spectrometry (MS) enhance
the yields of fragment ions, a key benefit in structure characterization, and allow analysis
of high molecular weight compounds on mass spectrometers with a limited m/z range. In
contrast, MALDI-MS is ideal for the analysis of heterogeneous samples because it often
requires less sample, and spectra of singly charged ions are easier to interpret. We report
here the astonishing observation of highly charged molecular ions by laser ablation of a
solid matrix/analyte mixture typically used in MALDI-MS analyses. The distribution and
abundances of the observed ions are similar to those obtained by ESI. Importantly, the
MALDI mechanism that produces singly charged ions can be “turned on” at the
operator’s will by changing only the matrix or matrix preparation conditions; this
capability is not available with any other ionization method. These findings show for the
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first time that singly charged ions as well as multiply charged ions are available in
MALDI. Besides having important mechanistic implications relating to MALDI and ESI,
our findings have enormous practical analytical utility.
ESI and MALDI combined with MS revolutionized the study of biological
materials and earned the Nobel Prize in Chemistry for their ability to ionize proteins for
analysis using MS. However, after two decades of extensive studies, the mechanism for
ion formation in MALDI remains controversial [35,54,55,82-87]. At the heart of these
debates lies the predominance of singly charged ions in MALDI mass spectra; the
exception being very high mass compounds. A mechanism for the formation of multiply
charged ions in MALDI has previously been proposed [54] based on molecular modeling
studies [36,38] and glimpses of multiply charged ions have been observed in lower
molecular weight compounds [56,57,88,89]. The formation of these multiply charged
ions has been attributed to sample preparation, high laser fluence, a metal-free sample
stage, use of an IR laser, and atmospheric pressure (AP) conditions. Multiply charged
ions were also recently observed by laser ablation of a liquid surface in the presence of a
high electric field [90]. The inability in that experiment to observe ions from a solid
MALDI matrix/analyte sample or in the absence of an electric field suggests an
ionization process involving liquid droplets in a high field similar to ESI [ 1] or other
liquid based, field-induced ionization methods [91,92].
Here, we show analytically useful ESI-like MALDI mass spectra obtained using
standard MALDI conditions but using a non-traditional source [27] mounted in place of
the standard atmospheric pressure ionization source on a mass spectrometer most

39

commonly used with ESI. The utility of this MALDI-MS method for extending the mass
range of mass spectrometers as well as the capability of peptide/protein sequencing using
electron transfer dissociation (ETD) [58] is demonstrated. Because highly charged ions
have not previously been observed with any MALDI ion source configuration, we briefly
discuss the fundamental concepts that lead to their production. Key aspects of laserspray
ionization (LSI) are laser ablation using a UV laser aligned in transmission geometry
(TG) [26], field-free (FF) at AP [21], using a heated AP to vacuum ion transfer capillary.
In order to emphasize the MALDI sample preparation but distinguish laserspray from
conventional AP-MALDI, the new ionization method will here- after be referred to as
FF-TG AP-MALDI.
Experimental Procedure
Materials and sample preparation are included in Chapter 2.1. An Orbitrap
Exactive mass spectrometer was used for LSI experiments (see Chapter 2.2). Peptides
and proteins were further diluted in 30:70 ACN/water solution and premixed with 2,5DHB, prepared as a concentrated solution in a room temperature 50:50 ACN/water
solution using a standard solvent- based MALDI preparation method [3]. The premixed
matrix/analyte solution was deposited on a glass microscope slide followed by
evaporation of the solvent. The temperature of the ion transfer capillary was used to
control the desolvation conditions for the temperature study with angiotensin I. For ESI,
1 µL of a 1 pmol µL-1 solution of lysozyme was injected into a 50:50 ACN/water solution
infused at a flow rate of 2 µL min-1. LSI-ETD experiments were obtained on a Thermo
Fisher Scientific LTQ with ETD capabilities using the same LSI source configuration

40

described in Chapter 2.2 as well as the ETD conditions as described elsewhere [58]. For
intact sequencing of ubiquitin, ETD mass spectrum was obtained in single scan
acquisition. Proton transfer reaction was applied to simplify the fragment ions.[93]
Results and Discussion
Lysozyme was chosen as a well-studied protein for initial experiments. A typical
FF-TG AP-MALDI mass spectrum for lysozyme is shown in Figure 4.1A and can be
compared with the ESI spectrum shown in Figure 4.1B, also acquired on the Orbitrap
Exactive from the same 1 µM solution at 100,000 resolution and using 1-s acquisition.
Observation of efficient production of such highly charged ions (up to 13+) in MALDI is
unprecedented. As with ESI, the higher charge states allow AP-MALDI mass spectra to
be obtained for compounds with molecular weights beyond the m/z limit of the
instrument (4000). The capability to produce highly charged ions in high abundance in
AP-MALDI and ESI strongly suggests that these ions are formed via related mechanisms.
Process for Producing Highly Charged Molecular Ions by MALDI - Here, we
provide a brief description of mechanistic implications as well as the conditions that are
necessary to observe highly charged ESI-like ions in MALDI-MS. In ESI, the ionization
mechanism is thought to involve highly charged solvent/analyte droplets [51-53]. In
MALDI, the most accepted model is a two-step ionization process that occurs in the
expanding plume that is created by absorption of the laser energy by the MALDI matrix
[82,86]. Primary photochemical ionization is followed by ion-molecule reactions similar
to chemical ionization, leading primarily to singly charged analyte ions.
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Figure 4.1. (A) LSII (1 pmol in 2,5-DHB loaded on a glass microscope slide) and (B)
ESI mass spectra (1 pmol injected into 1:1 ACN/water infused at 2 µL min-1) of a 1 pmol
µL-1 solution of lysozyme (1-s acquisitions, 100,000 resolution (m/m, full-width halfheight at m/z 200)). Insets show the isotope distributions for the most abundant peaks and
charge 10 in each spectrum.
Alternatively, a cluster model has been proposed in which charged clusters
produce multiply charged ions in a MALDI process by a mechanism similar to ESI
[54,56,57]. To explain the dominant observation of singly charged ions, a “lucky
survivor” mechanism was postulated in which highly charged positive ions, of e.g.
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proteins, were reduced to singly charged ions, presumably by ion-electron
recombination.[54] This mechanism was later modified to formation of singly charged
ions directly from clusters.[55] Others have also suggested that clusters are a source of
ions in MALDI, including background ions [85,87,94]. However, the validity of a cluster
mechanism as a significant source of ions in MALDI MS has been questioned [35,82].
Given our observation of abundant, highly charged ions in FF-TG AP-MALDI, the
potential mechanistic commonalities between ESI and MALDI must be reassessed.
In analogy to ESI [1,51-53] and the cluster (liquid droplet) model for MALDI
[54,56,57], we propose a mechanism in which the laser-induced gas-phase clusters are
highly charged. Similar to ESI, evaporation of solvent, but not charge, produces an
unstable surface charge density, resulting in formation of smaller particles and eventually
ion emission (Scheme 1.1IA). Unlike ESI in which an electric field induces excess
positive or negative charges on solvent droplets, in the AP-MALDI experiments
discussed here, cluster charging occurs in the absence of an electric field. Field-free
production of charged clusters can occur at cluster birth by a statistical charge separation
mechanism [53], photoionization, or electron loss from the cluster surface [35,55].
Provided a threshold laser fluence is achieved [56,57], cluster formation in
MALDI is expected [36,38,54,82-87,94], and mechanisms exist for at least some of the
clusters to become charged [35,53-55]. However, detection of higher charge state ions
has remained elusive in MALDI until now. We propose that the highly charged clusters
are initially produced during the explosive deposition of energy into the MALDI matrix
in either AP- or vacuum MALDI at least with solvent-based matrix preparation using 2,5-
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DHB. However, for field emission of multiply charged ions, it is necessary to evaporate
sufficient matrix, but not charge, from the clusters to achieve a surface charge density >
~109 V m-1 [95]. One possibility for the absence of observable highly charged ions under
vacuum conditions is that evaporative cooling quenches the initial rapid cluster
evaporation process prior to achieving the necessary charge density.
In support of a requirement of desolvation for observation of multiply charged but
not singly charged ions, the AP to vacuum ion transfer capillary (Scheme 1.1IA)
temperature was varied for angiotensin I (molecular weight, 1295.7) using solvent-based
and solvent-free 2,5-DHB sample preparation. Barely detectable 2+ and 3+ molecular
ions were observed with the transfer capillary temperature set as low as 150 °C (no 1+
ions were observed). The 2+ and 3+ ion abundances increase rapidly above 275 °C, and
at 350 °C they dominate the mass spectrum (Figure 4.2).

Figure 4.2. Ion count vs. ion transfer tube temperature plot for the 1 through 3 charge
states of angiotensin I. The 2 and 3 ions are produced by the solvent-based and the 1 ions
are produced by the solvent-free MALDI sample preparation methods. The plot suggests
two distinctly different ionization mechanisms, one of which (multiply charged ion
formation) is highly dependent on the ion transfer tube temperature.
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Using the same matrix and analyte but prepared under solvent-free conditions
[96,97], 1+ molecular ions are exclusively produced, and little change in ion abundance
is observed over the same temperature range, strongly implying that an entirely different
ion formation mechanism is being sampled. This and other evidence suggest that the
singly charged ions produced using the solvent-free sample preparation method are
formed near the sample surface by the two-step chemical ionization mechanism normally
observed in MALDI but that the multiply charged ions are produced from clusters far
downstream from the initial laser/matrix interaction (Scheme 1.1IA) and are enhanced by
improved desolvation conditions (higher ion transfer tube temperature). Interestingly,
Figure 4.2 suggests that higher sensitivity will be achieved by increasing the ion transfer
tube temperature beyond 350 °C.
The unique configuration of the FF-TG AP-MALDI arrangement (Scheme 1.1IA)
may also provide improved ion sampling by the combination of the forward momentum
of the laser-generated plume and the flow-dominated entrapment by gas diffusing from
AP to vacuum through the instrument orifice. The absence of an electric field is expected
to minimize loss of ions at the entrance to the ion transfer tube [24] and favor sampling of
higher mass and thus higher momentum species such as clusters relative to free analyte
ions created in the expanding plume region near the sample surface. Thus, the high
efficiency of producing multiply charged ions may partially be the result of preferential
sampling at the capillary inlet orifice.
As noted, either singly or multiply charged ions can be selected in FF-TG APMALDI by choice of matrix or matrix/analyte preparation conditions. Thus, using 2,5-
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DHB and dried droplet solvent-based sample preparation, multiply charged mass
spectra of peptides and proteins nearly identical to those in ESI are produced, whereas
solvent-free sample preparation [96,97] produces MALDI-like singly charged mass
spectra for peptides. One difference in these distinct MALDI sample preparation methods
is that analyte incorporation in the matrix (solid solution) is believed to occur for solventbased preparations [98] but not in the solvent-free case [72,99]. Consistent with this
concept, the addition of a drop of ACN/water solution to the solvent-free prepared sample
on the glass slide and evaporation of the solvent resulted in the mass spectrum changing
from all singly charged with solvent-free preparation to dominantly multiply charged
peptide ions after addition of solvent.
Further support for the importance of analyte incorporation into the matrix is
derived from solvent-based experiments using Cyt. c and various DHB positional
isomers. Highly charged ions of Cyt. c were observed only for the 2,5-DHB isomer.
Previous work [98] reported quantitative incorporation of Cyt. c only into the 2,5-DHB
isomer. Importantly, changes only in the matrix/analyte conditions alter the selected
charge state population, thus assuring that the observed multiply charged ions are related
only to the matrix and not instrument parameters. The ability to select different ionization
pathways provides a unique opportunity to study fundamental processes related to
formation of gas-phase ions from nonvolatile compounds as well as entire new
applications.
Finally, it is unlikely that the multiply charged ions are a result of the ion source
geometry because FF-TG MALDI has previously been used without such observations
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[26]. This is demonstrated by changing the angle of the laser beam relative to the
instrument orifice from 180° (Scheme 1.1IA) to 135°, making it possible to use FF
reflective geometry so that the laser beam strikes the matrix/analyte mixture without
passing through the glass plate. Multiply charged (2+) ions of angiotensin II were
observed with FF reflective geometry AP-MALDI, thus demonstrating that TG alignment
is not necessary for laser-generated multiply charged ion formation.
Analytical Applications of Highly Charged MALDI Ions - The ability to produce
multiply charged ions by AP-MALDI has advantages relative to ease and speed of
analysis, mass range enhancement, and fragmentation and potentially in tissue imaging
studies [27]. The speed of the method is shown by the ability to obtain a complete high
resolution mass spectrum of a peptide or protein in 1 s. Because in AP-MALDI ionization
occurs at atmospheric pressure, the time requirement for loading samples is also greatly
reduced relative to vacuum MALDI, making high throughput analyses a reality.
Sensitivity is also an important issue as it is commonly believed that AP-MALDI
is significantly less sensitive than vacuum MALDI. As with any new technology, the
optimum parameters for the FF-TG AP-MALDI method have likely not been achieved,
and sensitivities much greater than reported here can be expected. Nevertheless, the limit
of detection, defined here as the signal necessary to observe the triply charged molecular
ion and its three 13C isotope peaks for angiotensin I (molecular weight, 1295.7) using 2,5DHB as matrix and the solvent-based sample preparation method, was determined to be
~0.3 fmol applied to the glass slide (data not shown). The actual amount of sample
consumed is estimated to be a less than 50 amol. A more meaningful gauge of sensitivity
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for most analyses is the amount of material required to produce a recognizable full-range
mass spectrum. The mass spectrum obtained from 40 fmol of insulin in 2,5-DHB applied
to the glass slide using the solvent-based dried droplet method is shown in Figure 4.3.

Figure 4.3. The FF-TG AP-MALDI mass spectrum obtained at 100,000 mass resolution
from 40 fmol of bovine pancreas insulin loaded on the glass slide MALDI target plate in
2,5-DHB using the solvent-based dried droplet method. The insets show the 13C isotopic
distribution of the 4 and 5 charge state ions. Rel. Abund., relative abundance.
The ability to obtain enhanced fragmentation in a MALDI process is another
advantage of multiply charged ions. Important new fragmentation methods based on
either electron capture [80,81] or ETD [58] have been applied to sequence termination of
peptides and even proteins. Ubiquitin (molecular weight, 8561) was selected because it
had been previously sequenced using ETD fragmentation.[100] Fluoranthene was used as
the electron transfer reagent as described previously.[100] In initial experiments using
FF-TG AP-MALDI, 2,5-DHB, and solvent-based conditions, ~5 pmol of ubiquitin was
placed on the glass slide, and mass selecting the 11+ (m/z 779) charge state ion
produced the single scan mass spectrum shown in Figure 4.4A. The single acquisition
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ETD spectrum is shown in Figure 4.4B and consists of numerous fragment ions of
various charge states. Making use of the proton transfer reaction method [93] simplifies
the fragment ion spectrum as previously demonstrated using ESI, thus allowing easier
sequence interpretation (Figure 4.4C). These results represent the first MALDI-ETD
mass spectra and provide sequence coverage of the protein as previously presented using
ESI-ETD [93]. The capability to observe either multiply or singly charged molecular ions
by a MALDI process allows new experimental information that fills a gap in the long
standing controversy regarding ionization mechanisms in MALDI and additionally
provides a unique opportunity to study such processes as laser-induced cluster formation,
charging, and desolvation as well as charge reduction mechanisms [54]. The
commonality with ESI also provides a means to probe the mechanisms by which analyte
ions are released from highly charged droplets. Finally, these findings have significant
analytical utility in areas such as high throughput analyses at high sensitivity, tissue
imaging

at

AP

using

high

resolution

instrumentation,

and identifying and

characterizing proteins using fragmentation processes such as ETD.
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Figure 4.4. (A) The FF-TG AP-MALDI mass spectrum of a single scan acquisition from
5 pmol of ubiquitin in 2,5-DHB loaded onto the glass slide. (B) The single scan ETD
acquisition from the mass-selected 11 charge state (m/z 779) ions. (C) The summed (40-s
acquisition) proton transfer spectrum of the m/z 779 ion with the sequence coverage
shown.
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CHAPTER 5
LASERSPRAY IONIZATION (LSI) ION MOBILITY SPECTROMETRY (IMS)
MASS SPECTROMETRY (MS) “Springer and the original publisher (J. Am. Soc.
Mass Spectrom., 21, 2010, 1260-1264, Inutan, E.D., Trimpin, S.) is given to the
publication in which the material was originally published with kind permission from
Springer Science and Business Media.”

Introduction
Laserspray ionization (LSI) mass spectrometry (MS) was recently introduced on
a Thermo Fisher Scientific Orbitrap Exactive [27-29]. The principle of this ionization
method is that the matrix/analyte sample is ablated by the use of a laser operating at
atmospheric pressure (AP) and ions are subsequently formed from highly charged
matrix/analyte clusters during a desolvation process. The free choice of charge state
selection demonstrates the utility of LSI for the analysis of complex mixtures. Singly
charged ions similar to those obtained with matrix-assisted laser desorption/ionization
(MALDI) or multiply charged ions similar to those produced by electrospray ionization
(ESI) [28] can be selected using LSI. Multiply charged ions are especially beneficial for
providing the ability to ionize by laser ablation larger molecules such as proteins and
synthetic polymers on high-performance but mass range limited mass spectrometers such
as the Orbitrap Exactive [28,29]. Full range mass spectra of bovine insulin were obtained
on as little as 40 fmol when applying ion transfer capillary temperatures of ~350 °C [29].
The unique feature of LSI to produce highly charged ions using direct laser
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ablation of a solid surface enhances fragmentation as was demonstrated by obtaining
nearly complete protein sequence coverage of ubiquitin using electron-transfer
dissociation (ETD) technology on a LTQ mass spectrometer [29]. Initial laserspray
applications demonstrated the ability to produce singly charged lipid ions from mouse
brain tissue under ambient conditions [27]. Using transmission geometry, the matrix
treated tissue sections were passed free-hand through the focused laser beam in front of
the mass spectrometer orifice (Orbitrap Exactive) obtaining a spatial resolution of < 100
µm [27]. The objective is to observe proteins from tissue.
Ion mobility spectrometry (IMS) MS has many advantages compared with even
high-resolution mass spectrometers because of its ability to extend the dynamic range and
separate isomeric composition [64-67]. This is possible because ions are separated in the
IMS dimension according to charge and cross-section (size and shape) [101-105]. One
key benefit of this solvent-free gas-phase separation by IMS is that when combined with
solvent-free sample preparation [96] achieves total solvent-free analysis by MS entirely
decoupling ionization, separation, and mass analyses from the use of any solvent
[10,27,30].
We rationalized that to produce LSI multiply charged ions from the proposed
highly charged matrix/analyte clusters [29], a device is required that efficiently
desolvates the 2,5-dihydroxybenzoic acid (2,5-DHB) matrix to produce the highly
charged molecular ions. One function of the Waters Company (Manchester, UK) ESI zspray source design used with the IMS-MS SYNAPT G2 is to reduce the background
arising from cluster ions. However, this arrangement is not satisfactory as a means of
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desolvating clusters in which the matrix (serving as solvent) is 2,5-DHB. We, therefore,
fabricated a simple device that is mounted on the z-spray ESI source and provides the
thermal conditions necessary for desolvation and multiply charged ion production using
the LSI method. The benefits of IMS-MS in combination with direct LSI ambient
ionization for the efficient separation and characterization of a protein mixture is
demonstrated.
Experimental
Materials and sample preparation are included in Chapter 2.1 and the LSI set-up
using the SYANPT G2 mass spectrometer with the fabricated desolvation device is
described in Chapter 2.2. Bovine insulin (50 pmol µL-1) was used to test the fabricated
desolvation device. For the protein mixture, ubiquitin and lysozyme were premixed using
the stock solution in a 1:1 volume ratio. One µL was used to prepare the LSI sample
on the microscope slide employing solvent-based sample preparation protocols using
2,5-DHB matrix [3], prepared in 50:50 ACN/water, and then dried to completeness. The
dried LSI sample was placed in front of the desolvation device in a distance of about 1 to
3 mm (Scheme 2.2), similar to studies in which the dried sample was placed directly in
front of the mass spectrometer orifice of the Orbitrap Excative [27-29]. LSI-IMS-MS was
acquired using the Waters SYNAPT G2 as described in details in Chapter 2.
Results and Discussion
A maximum ion source temperature of 150 °C is available on the z-spray ESI
source of the SYNAPT G2. This was insufficient to produce any meaningful ion current
even for low molecular weight peptides such as angiotensin 1 (MW 1296) using 2,5-DHB
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matrix and the identical laser and configuration used in previous work [27,28,29].
Applying the fabricated temperature device (Scheme 2.2), multiply charged ions of
peptides and proteins are produced. A typical example is shown in Figure 5.1 using
bovine insulin (MW 5731). The total ion current (Figure 5.1a) shows the continuous ion
production when moving the sample stage over unablated areas of the sample showing an
increase when heat (1-84 s) and a decrease when no heat (850-115 s) were applied. The
charge state distribution (Figure 5.1b) is similar to that previously observed using the
commercially available heated transfer capillary of the Thermo Fisher Scientific Ion Max
ESI source of the Orbitrap Exactive and the LTQ mass spectrometers [28,29].

Figure 5.1. LSI-IMS-MS of bovine insulin (MW 5731): (a) The total ion current and (b)
mass spectrum obtained using 2,5-DHB matrix incorporating the solvent-based sample
preparation method.
Larger proteins such as ubiquitin (MW 8561) and lysozyme (MW 14,304) also
produced multiply charged ions in good abundance (Figure 5.2.1) using the simple
desolvation chamber. Myoglobin (MW 16,951), however, produced less abundant ions
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ranging from charge state +10 to +16 possibly suggesting a mass range limit for this
particular desolvation device. All experiments incorporated ion mobility separation. In
ion mobility measurements, three-dimensional (3-D) information is acquired; td, m/z, and
signal intensity. Frequently, the intensity of a signal is embedded in a 2-D plot of td vs.
m/z (Figure 5.2.2) and visualized by the use of a color-code. The 2-D IMS-MS plots of
ubiquitin, lysozyme, and a mixture of ubiquitin and lysozyme are shown, respectively, in
Figure 5.2.2. LSI ions of proteins fall into families depending upon their sizes and charge
states as previously reported for biopolymers using ESI-IMS-MS [101]. Further, one can
readily observe the elongated features indicating con- formational differences within each
charge state of each protein. Similar observations have been reported, especially for
ubiquitin, using a homebuilt ESI-IMS-MS instrument [106-109].
Many features become noticeable in a 2-D plot. Without data extraction and
time-intensive analyses, the pictorial snapshot [66] determines readily the presence of
both proteins (Figure 5.2.2c). By selecting the specific part of the 2-D plot using the
DriftScope, it is possible to extract m/z and/or td information for any ion or inset region of
interest. This removes most of the background interference, especially those at lower
m/z. Most importantly, charge state families of different proteins can be extracted,
providing the respective mass spectrum for each protein.
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Figure 5.2. LSI-IMS-MS using 2,5-DHB matrix and the solvent-based sample
preparation method of (a) ubiquitin (MW 8561), (b) lysozyme (MW 14,304), and (c) a
mixture of ubiquitin and lysozyme. (1) Total mass spectra (as if no IMS dimension is
employed) and (2) two-dimensional plots of td vs. m/z ratio.
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An example of extracting easily interpretable data from lower abundant ions is
shown in Figure 5.3. The mass spectrum of a mixture of ubiquitin and lysozyme,
purposely designed to have a high signal to noise ratio and to be difficult to interpret, is
shown. It is not obvious from the mass spectrum that lysozyme is present, and it could
easily be overlooked. Because the mobility dimension provides clean separation of the
multiply charged ions of these proteins (Figure 5.2.2c), mass spectra can be extracted for
both proteins free of the other. The extracted mass spectrum of lysozyme in the protein
mixture is shown in Figure 5.3 and is similar to that of pure lysozyme (Figure 5.2.1b).
The charge state distributions are essentially identical with the most abundant ions having
charged state +9.

Figure 5.3. The LSI-IMS-MS mass spectrum of the extracted lysozyme component
from the two-dimensional IMS-MS plot displayed in Figure 5.2.2c.
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CHAPTER 6
LASERSPRAY

IONIZATION-ION

MOBILITY

SPECTROMETRY-MASS

SPECTROMETRY: BASELINE SEPARATION OF ISOMERIC AMYLOIDS
WITHOUT THE USE OF SOLVENTS DESORBED

AND IONIZED DIRECTLY

FROM A SURFACE “Reprinted (adapted) with permission from (Inutan, E.D.;
Trimpin, S.

J. Proteome Res. 2010, 9, 6077-6081). Copyright (2010) American

Chemical Society.”

Introduction
No analytical method is available for detailed characterization of complex
mixtures of closely related molecules present in tissue material. Challenges are related to
many different factors associated with complexity including solubility, volatility,
hydrophobicity, isobaric, and isomeric compositions. Mass spectrometry (MS), with
benefits that include high sensitivity, specificity, mass resolution and the ability to
simultaneously characterize many constituents of a mixture, is a promising technique.
Unfortunately, MS methods are limited to the separation of ions measured and displayed
by m/z ratios and ion intensities. Molecular structures, especially isomers, are inferred
indirectly, if at all, through a combination of techniques such as liquid separation
methods coupled with MS. Liquid based separation approaches perform poorly with
solubility restricted materials [10,30] and can be inadequate for tissue analysis, especially
if the need is to analyze the materials unadulterated and with a high spatial
resolution.[110-113]

Further issues include the ionization efficiency, especially of

58

compounds with limited solubility, frequently complicating or preventing analysis. [96]
Ion mobility spectrometry (IMS) MS has been noted for the ability to separate ions in the
gas-phase according to the number of charges and cross-section defined by size and
shape.[59-67]
Laserspray ionization (LSI) shows advantages relative to other MS based
methods, especially for tissue imaging, and include improved spatial and volume
resolution, more relevant atmospheric pressure conditions, faster analyses, extended mass
range for analysis of high-mass analytes that are beyond the mass range limitations of
high performance AP ionization mass spectrometers, and improved fragmentation using
electron transfer dissociation.[28-29,31,41] The desolvation conditions to obtain the
highly charged protein ions from the charged matrix/analyte clusters are critical,
especially for protein analysis, and are accomplished using 2,5-dihydroxybenzoic acid
(2,5-DHB) matrix by heating the AP to vacuum ion transfer capillary to >400 C for
good sensitivity.[29] Unfortunately, most AP ionization mass spectrometers do not use a
heated capillary for ion transfer from AP to vacuum.
Recently, LSI has been retrofitted to an IMS-MS instrument (SYNAPT G2) by
constructing a heated desolvation device in front of the ion entrance orifice of the
nanoelectrospray ionization (nano-ESI) source for evaporation of the matrix from the
highly charged matrix/analyte cluster to give the multiply charged LSI ions.[49] This
was, for example, shown for a mixture of ubiquitin and lysozyme.[49] The temperature
capability of this home-built device is >250 C. The necessity for proper desolvation
conditions was exemplified by turning off the heat entirely.

Without external heat
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applied to the copper tube, the ion current was fully lost using 2,5-DHB as matrix even
though the metal tube was connected to the inlet skimmer maintained at 150 C.
Here, we introduce the ability for efficient desolvation of the highly charged
matrix/protein clusters by lowering the thermal requirements of the matrix. This allows
the operation at 150 C cone temperature available with the SYNAPT G2 mass
spectrometer without applying additional heat to the desolvation tube, and more
importantly, under lower temperature conditions that retain the proteins’ structure.
Experimental Procedure
Materials and sample preparation are included in Chapter 2.1, and the LSI set-up
using the SYNAPT G2 mass spectrometer with the fabricated desolvation device is
described in Chapter 2.2. For LSI-MS, 5 pmol µL-1 of ubiquitin, cytochrome C, and
lysozyme were prepared individually in 50:50 ACN/water with 0.1% TFA, and insulin in
50:50 MeOH/water with 1% acetic acid. Solutions of 10 pmol µL-1 each of β-amyloid (142), β-amyloid (42-1), and the mixture of β-amyloid peptides (1-42) and (42-1) were
made in 50:50 ACN/water with 0.1% TFA to obtain the LSI-IMS-MS. One µL sample
solution was placed on top of the microscopy glass slide after which 1 µL of 2,5-DHAP
matrix prepared in 50:50 ACN/water was added on top, and briefly mixed with the tip of
the pipet. Three more times, 1 µL of matrix solution was added but without further
mixing. The matrix/analyte spot was then blow dried with warm air. For ESI-IMS-MS, a
10 pmol µL-1 solution of the isomeric mixture in 50:50 ACN/water with 0.1% TFA was
used and infused at a flow rate of 1 µL min-1. The capillary voltage was set at 3 kV,
sampling cone at 40 V, and extraction cone at 4 V. The ion source temperature was set to
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150 C to mimic conditions with LSI. Desolvation gas flow was set at 500 L h-1 at a
temperature of 150 C.
Results and Discussion
LSI produces mass spectra from proteins that are nearly identical to those
produced by ESI but has the advantages of fast analyses at high spatial resolution directly
from surfaces. Thus, the method is potentially a powerful new approach to imaging.
While the mass spectra seem very similar to ESI in charge state and relative charge state
abundances, the method is considerable different in the approach to ion formation leaving
questions relative to the softness of this ionization method. Concerns relate to possible
destruction of the protein structure by the deposited laser energy and the applied heat for
desolvation of the matrix/analyte cluster [29,31,49] which is necessary to obtain the ESIlike multiply charged ions by laser ablation.[27] A new LSI matrix, 2,5dihydroxyacetophenone (2,5- DHAP), was shown to produce multiply charged ions using
only the 150 C provided by the source heater supplied with the SYNAPT G2 Z-spray
ion source. Typical mass spectra obtained for proteins using 2,5-DHAP and only the
energy from the 150 C ion source temperature are shown in Figure 6.1. As noted above,
the mass spectra appear very similar to ESI mass spectra. Multiply charged ions as high
as +17 for cytochrome C (Figure 6.1C) are produced without the high temperature
applied to the desolvation region that was required when using 2,5-DHB as an LSI
matrix.[28] Further, when the desolvation device is removed entirely and the experiment
performed with only the 150 C skimmer cone temperature, similar results related to ion
abundance and charge state distribution of these proteins are obtained (Appendix A
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Figure S10); however, significant low mass chemical background and contamination of
the source are then observed.

Figure 6.1. LSI-MS mass spectra of (A) insulin (MW 5731) in 50:50 MeOH/water with
1% acetic acid, (B) ubiquitin (MW 8561), (C) cytochrome C (MW 12361), and (D)
lysozyme (MW 14300) prepared in 50:50 ACN/water with 0.1% TFA using 2,5-DHAP
matrix in 50:50 ACN/water with ion source temperature of 150 °C.
The importance of a soft LSI ionization relates to the desire to obtain structural
conformation information directly from the solid state from proteins as in tissue imaging
experiments. An advantage of the lower heat application is that mass spectra obtained
under similar thermal conditions using ESI and LSI can be compared to determine the
relative softness of the ionization methods. LSI using 2,5-DHAP generally produces
lower charge states than ESI of the same proteins. The lower charge states have been
shown to relate to more compact protein structures while higher charge states are
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frequently elongated by Coulombic repulsion of the ions subject to conditions used
for mass spectral acquisition such as sample preparation, the choice of solvent,
skimmer voltage, and trapping times.[106,114,115] The lower thermal conditions used
with 2,5-DHAP are expected to be beneficial in retaining the proteins’ structure. To
examine the validity of intact protein structure and the practical utility by LSI-IMS-MS,
we studied β-amyloid (1-42),[10,96,116-118]

reversed β-amyloid (42-1), and the

isomeric mixture of β-amyloid (1-42) and (42-1). β-Amyloid (1-42) is known to have low
solubility in common ESI solvents.
Figure 6.2 shows the mass spectra (left panel) and the 2-D plots (right panel) of
drift time vs. m/z for isomeric mixture (A) and the pure β-amyloids (B, C) obtained by the
LSI method using 2,5-DHAP matrix prepared in 50:50 ACN/water and spotted on a glass
microscope slide as described above and dried to completeness before laser ablation. The
mass spectrum alone cannot distinguish one isomer from the other because of the same
charge states and similar abundances (Figure 6.2.1), but the IMS-MS pictorial
‘snapshot’14 readily shows separation and identification of the charge states from the
isomeric mixture (Figure 6.2A2). The separation of the two isomers was then verified by
analyzing the individual isomer samples (Figure 6.2B2 and C2). Thus, solvent-free IMSMS gas-phase separation successfully separated and clearly showed both components of
the isomeric mixture. From the drift times shown in Figure 6.2.2, the β-amyloid (1-42)
reveals a much more compact structure than the reversed β-amyloid (42-1) as one would
expect from the aggregation tendency.[119]
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Figure 6.2. LSI-IMS-MS of (A) an isomeric mixture of β–amyloid (1-42) and reversed βamyloid (42-1), (B) β-amyloid (1-42), and (C) β-amyloid (42-1) prepared in 50:50
ACN/water with 0.1% TFA acquired using 2,5-DHAP matrix in 50:50 ACN/water. The
(1) mass spectrum does not distinguish one isomer from the other, but the (2) 2-D plot of
drift time vs. mass-to-charge (m/z) ratio snapshot clearly shows separation of the two
components.
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Using the DriftScope, it is possible to extract m/z and drift time information for
any ion or inset region of interest and give a much better insight to drift time separation.
The extracted drift time distributions for the individual charge states +3 to +5 are shown
in Figure 6.3A. Charge state +3, the lowest charge state and most compact structure of βamyloid (1-42) and (42-1), shows the least difference in shape as can be seen by some
degree of overlapping drift time distributions for ions. Baseline separation without the
use of any solvent is achieved for charge states +4 and +5 of this isomeric, solubility
restricted protein mixture. Using 2,5-DHAP as matrix and the ion source temperature set
to 150 C allows very similar instrumental conditions for LSI- and ESI-IMS-MS of the

Figure 6.3. Extracted drift times of an isomeric mixture of β-amyloid peptides (1-42) and
(42-1) prepared in 50:50 ACN/water with 0.1% TFA acquired with the ion source
temperature set to 150 °C by (A) LSI using 2,5-DHAP matrix in 50:50 ACN/water, and
(B) by ESI obtained at a flow rate of 1 μL min-1. The drift times in (A) and (B) are nearly
identical demonstrating similar or identical gas phase ion structures by the two ionization
methods.
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isomeric β-amyloid mixture. The results of such a comparison between ESI and LSI is
shown in Figure 6.3 where the drift times for each charge states of the protein mixture
were extracted and compared. The drift times of the ions for the isomeric mixture are
essentially identical between LSI (Figure 6.3A) and ESI (Figure 6.3B) with the minor
exception that the LSI drift distributions are frequently sharper and therefore produce
improved baseline separation of the different isomeric structures. This is evidence that
both ESI and LSI are energetically similar and temperature effects observed for ion
structures studied by ESI might occur after the ions are released into the gas phase and
not in the charged droplets.
Although ESI is the MS technique predominately used for amyloid peptide
detection, for investigating cleavage sites for specific amyloid peptide interaction,[117]
and to study mechanisms of initial oligomerization reactions,[118]

the solubility

issues [116] make LSI an alternative method to ESI. Hyphenated with IMS-MS, LSI is a
suitable analytical method for characterizing complex mixtures and possible molecular
conformations present in tissue material. In case of isomeric composition, IMS separation
is reduced from separation according to the number of charges, size, and shape to the sole
separation according to shape. The baseline separation achieved for the isomeric protein
composition by solvent-free gas-phase separation using IMS-MS demonstrates the utility
of soft desorption directly from a surface combined with soft desolvation for ion
production by LSI in retaining the protein structure (shape).
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CHAPTER 7
LASERSPRAY IONIZATION - A NEW METHOD FOR PROTEIN ANALYSIS
DIRECTLY FROM TISSUE AT ATMOSPHERIC PRESSURE AND WITH
ULTRA-HIGH

MASS

RESOLUTION

AND

ELECTRON

TRANSFER

DISSOCIATION SEQUENCING “This research was originally published in Molecular
and Cellular Proteomics (Inutan, E.D.; Richards, A.L.; Wager-Miller, J.; Mackie, K.;
McEwen, C.N.; Trimpin, S. Mol. Cell. Proteomics 2011; 10:1-8) © the American Society
for Biochemistry and Molecular Biology.”

Introduction
Tissue imaging by mass spectrometry (MS) is proving useful in areas such as
detecting tumor margins, determining sites of high drug uptake, and mapping signaling
molecules in brain tissue [111,120-,121,122,123,124,125,126]. Imaging using secondary
ion mass spectrometry is well established but is only marginally useful with intact
molecular mass measurements from biological tissue [127-129]. Matrix-assisted laser
desorption/ionization (MALDI)-MS operating under vacuum conditions has been used
for tissue imaging with success, especially for abundant components such as membrane
lipids, drug metabolites, and proteins [113,130,131]. Spatial resolution of ~20 µm has
been achieved [132], and the MALDI-MS method has been applied in an attempt to shed
light on Parkinson disease [13,15], muscular dystrophy [133], obesity, and cancer
[130,134].
Unfortunately, there are disadvantages in using vacuum-based MS for tissue
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imaging in relation to analysis of unadulterated tissue. Also, the mass spectrometers used
in these studies frequently have much lower mass resolution and mass accuracy than are
available with atmospheric pressure ionization (API) instruments and are not as widely
available. Because the vacuum ionization methods produce singly charged ions, massselected fragmentation methods provide only limited information, especially for proteins.
In addition, no advanced fragmentation such as electron transfer dissociation (ETD)
[58,100,135] is available for confident protein confirmation or identification.
Atmospheric pressure (AP) MALDI can be coupled to high performance mass
spectrometers but suffers from sensitivity issues for tissue imaging where high spatial
resolution is desired [136]. AP MALDI also primarily produces singly charged ions [2,3].
Thus, mass and cross-section analysis of intact proteins has yet to be accomplished using
AP MALDI because of intrinsic mass range limitations of API instruments, which
frequently have a m/z limit of < 4000. Thus, new improved methods of mass-specific
tissue imaging, especially at AP, are needed.
The

potential

of

laserspray

ionization

(LSI)

(Scheme

1.1.IA)

[27-

31,41,49,50,137,138] for protein tissue analysis is reported here. LSI has advantages
relative to other MS-based methods, including speed of analysis, laser ablation of small
volumes, more relevant AP conditions, extended mass range and improved fragmentation
through multiple charging, and the ability to obtain cross-section data for proteins on
appropriate instrumentation. The applicability of LSI for high mass compounds on high
performance API mass spectrometers (Orbitrap Exactive and SYNAPT G2) has been
demonstrated producing ESI-like multiply protonated ions [28,29,49]. The first
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experiments showing sequence analysis by ETD using the LSI method were successfully
carried out on a Thermo Fisher Scientific (San Jose, CA) LTQ-ETD mass spectrometer
[29]. Nearly complete sequence coverage was obtained for ubiquitin, an important
regulatory protein. Applying ETD fragmentation to LSI-MS analyses potentially provides
a new method for studying biological processes, including the mapping of
phosphorylation, glycosylation, and ubiquitination sites from intact proteins and directly
from tissue.
Furthermore, unlike ESI and related ESI-based methods such as desorption-ESI
[139], the LSI method has been shown to allow analysis of lipids in tissue from ablated
areas < 80 µm [27]. In comparison with literature reports for AP MALDI at the same
stage of development [140], LSI is more than an order of magnitude more sensitive and is
capable of analyzing proteins on high resolution mass spectrometers as was demonstrated
by obtaining full-acquisition mass spectra at 100,000 mass resolution (FWHH, m/z 200)
after application of only 20 fmol of bovine pancreas insulin in the matrix 2,5dihydroxyacetophenone (2,5-DHAP) onto a glass microscope slide [31]. The analysis
speed of LSI was demonstrated by obtaining mass spectra of five samples in 8 s [137].
Here, we show the utility of LSI for intact peptide and protein analyses directly from
mouse brain tissue. The ability to obtain a protein mass spectrum directly from mouse
brain tissue in a single laser shot at 100,000 mass resolution and with ETD fragmentation
is demonstrated.
Experimental Procedure
Analysis of Aged and Fresh Tissue Samples - The mouse brain tissue sections used in
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this study were shipped in dry ice before being delipified according to published
procedure [74] and then again shipped overnight in dry ice. The aged, delipified tissue
sample was stored for approximately 2 months at -5 °C. The delipification was initially
obtained on the aged tissue sample and verified by MALDI-TOF-MS analysis. The
optimized delipification conditions were used for further study comparing results
obtained from MALDI- and LSI-MS analysis. A second set of mouse brain tissue
samples were cut, frozen, and immediately shipped overnight. Each microscopy glass
slide, plain and gold-coated, was mounted with four to five tissue sections. On receipt of
the frozen samples, delipification of the tissue on glass slides was performed as described
below, and again the samples were immediately frozen and shipped overnight for prompt
LSI-MS analysis on an Orbitrap Exactive mass spectrometer. These samples were again
frozen and shipped overnight for microscopy and subsequent MALDI-MS and LSI LTQ
Velos analysis.
LSI-MS of Mouse Brain Tissue - The glass microscope slide mounted with mouse brain
tissue was prepared with the LSI matrix (5 mg mL-1 of 2,5-DHB or 2,5-DHAP, saturated
solution) dissolved in 50:50 ACN/water by placing a number of 0.2-µL drops on top of
the tissue material and allowing them to air dry. After solvent evaporation, the glass slide
containing LSI matrix applied to mouse brain tissue was placed 2-3 mm in front of the
mass spectrometer ion transfer tube entrance, moved manually through the laser beam,
and aligned 180° relative to the ion entrance orifice (transmission geometry) (Scheme
1.1IA). The AP to vacuum ion transfer capillary was heated to 375 °C for 2,5-DHB and
300 °C for 2,5-DHAP, and the laser fluence per pulse was about 0.5-1 J cm-2. Multiply
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charged ions were observed in the absence of an electric field in the ion source region.
Both plain and gold-coated glass slides were used.
LSI-ETD – An LTQ Velos mass spectrometer with ETD capabilities was used as
described in Chapter 2. The reaction time was set at 120 ms using an isolation width of 3
amu. The activation time ranged from 25 to 50 ms for the precursor ions’ 917.5 (2+),
1491 (12+), and 1789 (10+). A supplemental activation of 20 V was used for the 2+
precursor ion. A single 0.33-s acquisition was selected to obtain the ETD fragment ion
mass spectra for peptide identification; the total ETD acquisition time was set for 1 min.
LSI Tissue Imaging - Mouse brain tissue mounted on a glass microscope slide and
coated with a saturated solution of 2,5-DHAP in 50:50 ACN/water using 0.2-µL drops
was controllably moved through the laser beam with ablation in transmission geometry
(Scheme 1.1IA) using an eTrack series xy-stage (Newmark Systems, Mission Viejo,
CA). Lanes were at 100-µm intervals, and each lane was 10 mm long from which 22 s of
data were acquired. For these studies, three mass spectral acquisitions were obtained per
second with the laser operating at ~12 Hz. The ablated diameter for each laser shot after
microscopy was ~15 µm (neglecting the stray beam commonly observed), which
converts to an area of about 4(15) x 15 µm2 ablated per MS acquisition.
MALDI-MS of Mouse Brain Tissue - A MALDI-TOF Bruker Ultraflex mass
spectrometer (Bruker, Bremen, Germany) equipped with a nitrogen laser (337 nm) was
used to monitor the success of the tissue delipification and for comparison with LSI
results. The MALDI sample preparation was performed according to published work
[74]. After washing the tissue and drying in the desiccator, the tissue was spotted with
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0.2-µL of either sinapinic acid matrix dissolved in 50:50 ACN/water in 0.1% TFA or 2,5DHAP in 50:50 ACN/water. The mass spectrum was acquired using the linear positive
ion mode with an accelerating voltage of 20.16 kV, extraction voltage of 18.48 kV, lens
voltage of 7.06 kV, and pulsed ion extraction of 360 ns. Delayed extraction parameters
were optimized to have the optimal resolution and sensitivity for the MALDI range was
12-kDa. An increment of 30 laser shots was used, and shots were positioned and moved
within a single matrix spot to obtain a mass spectrum having a total of 120 laser shots.
The mass spectrum was processed and base line-corrected using the Flex Analysis
software. Both plain and gold-coated microscopy slides were used; only gold-coated
microscopy slides are expected to provide the correct mass calibration.
Data Analysis - MASCOT Distiller version 2.3.2.0 (Matrix Science, London, UK) [141]
was used to interpret ETD mass spectra for peptide and protein identification obtained
from the LTQ-ETD Velos. The Mass Spectrometry protein sequence DataBase (MSDB)
was searched using the no enzyme setting to obtain the sequence analyses directly from
mouse tissue. Parameters were set to include acetylation, deamination, oxidation,
methylation, and phosphorylation. The peptide and protein masses had to be within the
mass tolerance characteristic of the mass spectrometer used for data acquisition. Searches
within 1-Da mass error were performed, but to consider a peptide as well matched, it had
to be within < 5 ppm of the mass obtained from the Orbitrap Exactive.
Results and Discussion
Evaluation of Experimental Conditions on Aged Tissue Sample - Tissue fixation
or washing with solvents to extract lipids enhances the signal quality of peptides and
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proteins and slows enzymatic processes, thus extending the useful life prior to analysis
[142]. The washing solvent was selected based on previously reported studies [74,143] as
well as from results we obtained from MALDI-MS analyses of tissue extracted with
recommended solvents, ethanol and isopropanol. Here, the ethanol wash was selected
because it gave higher intensity protein MALDI-MS signals using SA as the matrix. The
guidelines developed by Schwartz et al. [144] for the proper handling of tissue sections
(tissue storage, sectioning, and mounting) for peptide and protein analyses were applied.
The choice of matrix and its deposition onto the tissue have been shown to be important
in determining the subset of proteins extracted from the tissue and detected using MALDI
[143]. For the MALDI analysis of the delipified mouse brain tissue, peptide and protein
signals were detected using SA as matrix from m/z 5000 to 19,000 (Appendix A Figure
S11) which is within the range that Seeley et al. [74] presented; the mass calibration is
expected to be somewhat off for results in which plain microscopy glass slides without
conductive coating were used. Only a few of the proteins detected give significant signal
intensity similar to previous studies [130].
Once a satisfactory procedure for handling and delipifying mouse brain tissue was
established for MALDI analysis, that method was applied for LSI-MS. Using 2,5-DHB as
matrix, only lipids were observed even with the delipified tissue, similar to a previous
report [27]. However, for the delipified tissue using 2,5-DHAP, lipids were observed in
low abundance if at all, and signals for multiply charged ions having masses as high as 5–
19 kDa (at ZS1) were detected. A mass spectrum obtained from the Orbitrap Exactive at
100,000 (FWHH, m/z 200) mass resolution by summing 15 1-s acquisitions is shown in
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Figure 7.1 and represents ablation of most of the tissue covered by a 0.2-µL solution of
2,5-DHAP. Because the mass resolution of the Orbitrap Exactive provides
separation even for proteins, a single

13

13

C isotope

C isotope distribution is all that is necessary to

determine the monoisotopic protein molecular weight with high mass accuracy (Figure
7.1, insets). Ions observed just above noise, for which the monoisotopic peak cannot be
reliably identified, provide a more accurate average mass than obtained with linear
MALDI-TOF instruments. Figure 7.1B is the inset region from Figure 7.1A with the
mass range displayed between m/z 650 and 1000. The multiply charged ions range from
3+ to 8+, representing ions having molecular masses from approximately 650 to 5000 Da.
For this data set, most ions were from compounds below 10 kDa. Because of the long
storage time for the aged sample, it is possible that some of the observed multiply
charged ions are from post-mortem enzymatic digestion of proteins [74,130]. The use of
gold-coated and plain microscopy glass slides provides comparable abundance LSI mass
spectra of the delipified tissue. As expected, no mass shift was observed in the AP LSI
results using conductive or non- conductive glass slides; matrix placed below the tissue
increased the ion abundance at the expense of a larger ablated area. Experiments without
the addition of the LSI matrix did not provide any useful analytical results. Microscopy
images of the aged mouse brain tissue after LSI analysis showed a variety of ablated
areas, including numerous areas where the laser beam did not appear to penetrate the
tissue (Appendix A Figure S12).

74

Figure 7.1. LSI mass spectra from aged mouse brain tissue washed with ethanol and
spotted with 2,5-DHAP matrix in 50:50 ACN/ water using an Orbitrap Exactive mass
spectrometer. A, full mass spectrum with insets showing multiple charged protein and
peptide ions. B, limited mass range between m/z 650 and 1000 is displayed with
monoisotopic molecular weights of the various multiply charged ions presented. Rel.
Abund., relative abundance.
The areas in which the tissue was completely ablated ranged in dimensions from ~3 to 9
µm x ~5 to 25 µm. Because the laser was fired at several hertz as the tissue was

75

constantly moved through the laser beam, each 1-s acquisition was the sum of several
laser shots. The elongated features observed in the microscopy image may be the result of
multiple laser shots producing continuous ablation as the tissue was moved slowly
through the beam. Holes in the tissue that appear to be from a single laser shot were
typically < 30 µm2 (Appendix A Figure S13). For the 10-µm tissue thickness used in
this study, these microscopy data suggest that the tissue volume below the ablated area
represents ~300 µm3 for a single laser shot. However, to achieve this spatial resolution
will minimally require matrix preparation methods that result in no diffusion of
compounds outside the boundary area and improved mass spectral sensitivity.
Comparison of LSI-MS and MALDI-MS Analysis on Fresh Tissue Samples Successful results with the aged tissue samples prompted us to examine fresh tissue
sections that were maintained at or below -20 °C except for short times required for
mounting the tissue to the glass slide, delipification, mass spectral analysis, and
microscopy. The fresh delipified samples using 2,5-DHAP matrix and acquired on the
Orbitrap Exactive showed an abundant doubly charged LSI ion at m/z 917.50 (molecular
weight 1833.0) and numerous other multiply charged ions at higher m/z values (Figure
7.2). The highest mass protein with at least two observed charge state distributions had a
molecular mass (monoisotopic) of 17,882 Da, although a single low abundance isotope
distribution was observed for an ion having an average molecular mass of ~19,665 Da.
Some of the lower molecular weight proteins observed in the aged tissue sample (Figure
7.1) were also observed in the fresh sample but in lower abundance, whereas the higher
mass proteins were significantly more abundant in the fresh tissue sample. Appendix A
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Figure S14 shows that in a single laser shot the most abundant proteins were observed
from the fresh tissue using the 100,000 mass resolution set- ting of the Orbitrap Exactive.
The mass spectra for the single laser shot, the sum of seven laser shots, and the sum of
the full acquisition for a 0.2-µL matrix deposition are shown in Appendix A Figure
S14B. Notable differences between gold-coated (Appendix A Figure S15) and plain
glass slides (Figure 7.2) were again not observed. Appendix A Figure S15 shows three
isotope distributions each for multiply charge ions representing proteins having molecular
masses of 9908, 11,788, and 12,369 Da (monoisotopic mass).

Figure 7.2. LSI-MS summed full and inset mass spectra of delipified fresh tissue on
plain glass slide spotted with 2,5-DHAP matrix in 50:50 ACN/water showing multiple
charged protein ions using Orbitrap Exactive mass spectrometer. Rel. Abund., relative
abundance.
A fresh tissue section from the same mouse was delipified and immediately massmeasured on an LTQ Velos instrument. The multiply charged ions described above for
fresh tissue were observed. The mass spectrum from summing multiple acquisitions on
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the tissue slice is provided in Figure 7.3A. The distribution of multiple charged ions of
the protein having molecular weight 11,788, however, could be observed in a single
acquisition representing one laser shot (Figure 7.3B1). Single laser shots in different
areas of the mouse brain tissue gave different results. For example, Figure 7.3B2, also
from a single laser shot, shows the protein at molecular weight 17,882 in lower
abundance than the first protein of molecular weight 11,788, and a peptide having a
molecular weight of 1833 was observed more in the center than the edges of the tissue.
The ability to acquire a mass spectrum from a single laser shot using a relatively
inexpensive nitrogen laser suggests the potential for high speed tissue imaging.
Potential of Tissue Imaging Using LSI - To evaluate the potential for tissue
imaging using LSI, a crude experiment was performed using a glass slide with mounted
mouse brain tissue that was coated with the matrix 2,5-DHAP by depositing 0.2-µL
droplets of a saturated solution of 50:50 ACN/water over the tissue surface and allowed
to air dry. This matrix deposition method is not suitable for tissue imaging because
delocalization of compounds in the tissue and uneven matrix deposition are expected with
this approach. An attempt at spray applying the matrix from solution, which is a more
appropriate matrix deposition method, resulted in very low abundances of peptide and
protein

ions

(Appendix A Figure S16). Clearly, improved matrix preparation

conditions for LSI imaging are needed. Nevertheless, attaching the glass microscope slide
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Figure 7.3. LSI-MS spectra of delipified fresh tissue on plain glass slide spotted with
2,5-DHAP matrix in 50:50 ACN/water using LTQ Velos. A, sum of the full acquisition.
B1 and B2, single acquisitions at different tissue locations showing different protein
abundances. The ions observed around m/z 760 are from lipids.
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to a computer controlled xy-stage allowed a crude image of mouse brain tissue to be
obtained. Mass-specific imaging for two charge states of the protein with MW 11,788
and one charge state of the protein with MW 12,369 is shown in Appendix A Figure
S17. Several other peptides and proteins gave sufficient signal intensities in single
acquisitions to produce crude images. Obtaining higher shot-to-shot reproducibility and
increased analyte ion abundances are areas that require further research.
Microscopy images of the laser-ablated tissue after the imaging analysis are
shown in Figure 7.4. Rows spaced at 100-µm intervals of single laser shots are readily
seen. The individual laser-ablated areas in this experiment, as determined by optical
microscopy, are ~15 µm in diameter.

Figure 7.4. Optical images of laser-ablated areas obtained in im- aging experiment. A,
20x magnification. B, 100x magnification. Arrow denotes 15 µm.
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The mass spectrum shown in Appendix A Figure S18 is of a single MS acquisition
during which time four laser shots impacted the tissue in adjacent positions. Thus, each
mass spectral acquisition was of a visibly ablated area of approximately 15 x 4 x 15 µm2.
It is clear from these images that the laser beam frequently completely ablates the tissue
and matrix producing sufficient ions to be detected. The 10-µm-thick tissue slices likely
absorb a fraction of the laser energy before it is absorbed by the matrix.
The LSI method introduces remarkable speed and simplicity of analysis compared
with reflective geometry MALDI where frequently >100 laser shots are summed to
provide each data point in the image [145,146]. For tissue imaging experiments, high
repetition and therefore expensive lasers are required to keep the analysis time reasonable
(hours vs. days). The ability to obtain mass spectra of proteins directly from tissue in a
single or even a few summed laser shots using the LSI approach suggests the potential for
using less expensive lasers to achieve comparable analysis speed relative to high
repetition laser MALDI. For the crude imaging experiment reported here, the laser
repetition rate was ~12 Hz, and each lane received 89 laser shots in 22 s. With 100-µm
spacing between rows, 80 rows were required to image the mouse brain tissue. Thus,
actual acquisition time was only about 30 min. This work demonstrates the potential
speed of this method for tissue analysis or imaging.
The ability to obtain mass spectra of proteins directly from tissue using LSI offers
considerable potential in tissue analysis. However, difficulties that need to be addressed
before tissue imaging becomes a reality using LSI are increased ion abundances from
single acquisitions and higher shot-to-shot reproducibility. We expect reproducibility is
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related to uneven tissue thickness, the condition of the tissue, matrix application, and the
laser flux per unit area. Just as in MALDI imaging, matrix application in LSI is a crucial
step. The dried droplet method of spotting matrix that was used in the present study is
inappropriate for tissue imaging studies. We are currently beginning research aimed at
improving solvent-based and solvent-free matrix preparation methods for tissue imaging
using LSI. Future advances also need to incorporate solvent-free gas-phase separation for
efficient simplification of complexity of the produced gas-phase ions [10,30,49].
For comparison purposes, sequential tissue sections from the same mouse brain
used for the fresh tissue studies mounted on gold-coated and plain glass slides were used
for vacuum MALDI-MS analysis. One-half of each delipified tissue section was coated
with 2,5-DHAP, and the other half was coated with SA applying several 0.2-µL matrix
solutions. Interestingly, none of the observed molecular weights are common between
LSI using 2,5-DHAP and MALDI using either 2,5-DHAP or SA. MALDI with the 2,5DHAP matrix gave poor results, which may help explain the different proteins observed
between vacuum MALDI and LSI.
ETD Fragmentation of Peptides Directly from Tissue - Because LSI produces ESI-like
multiply charged mass spectra directly from tissue, it becomes possible to achieve ETD
fragmentation of these ions. This is demonstrated for the doubly charged peptide ion
that was observed at m/z 917.5 (molecular weight 1833) for a single ETD acquisition
representing four single laser shots, each on fresh spots of the tissue obtained on the
LTQ-ETD Velos mass spectrometer (Figure 7.5). Table I shows the result of the
MASCOT search obtained from the single acquisition data. A MASCOT score of 73 (67
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is considered to be significant) was achieved for the peptide having the sequence AcASQKRPSQRSKYLATA that also is well within the 5-ppm mass tolerance for this
peptide acquired on the Orbitrap Exactive.

Figure 7.5. LSI-ETD single scan acquisition mass spectrum at precursor ion 917.5 (+2)
of delipified fresh mouse brain tissue on plain glass slide spotted with 2,5-DHAP matrix
in 50:50 ACN/water using LTQ Velos.
This sequence encodes for the myelin basic protein N-terminal fragment that is
known to occur in mouse brain. The labeled masses in Figure 7.5 are the predicted “c”
and “z” fragments expected from ETD fragmentation of this peptide. The only missing
sequence ions are related to the proline residue. It is clear that synergy exists between
accurate mass measurement and ETD for reducing the number of hits obtained by
database searching. ETD fragment ions and accurate mass measurement were also
obtained for m/z 1491 and m/z 1789, which are the 12+ and 10+ charge states,
respectively, for the protein of molecular weight 17,889 (Appendix A Figure S19). We
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are in the process of attempting to identify this protein. These first results demonstrate the
potential of LSI for protein identification directly from tissue and are a significant
advance over current methods in which the identity of the ions observed are made only
from an approximate average mass value of the proteins known to be in the tissue.
Table 7.1 LSI-ETD MASCOT scores for m/z 917.5. The Delta value is the difference
between the calculated mass for the sequence shown and the accurate mass measurement
obtained from the Orbitrap at 100,000 mass resolution. Only sequences with a Delta
0.005 were within the mass tolerance of the mass.
Table 7.1 LSI-ETD MASCOT scores for m/z 917.5.
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CHAPTER 8
COMMERCIAL

INTERMEDIATE

PRESSURE

MALDI ION MOBILITY

SPECTROMETRY MASS SPECTROMETER CAPABLE OF PRODUCING
HIGHLY CHARGED LASERSPRAY IONIZATION IONS “Reprinted (adapted)
with permission from (Inutan, E.D.; Wang, B.; Trimpin, S. Anal. Chem. 2011, 83, 678684). Copyright (2011) American Chemical Society.”

Introduction
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS),
for over 20 years, has been an important analytical method for a variety of ﬁelds,
especially those related to analysis of synthetic and biopolymers.[2,3,10,147-150] The
method has been extended from a vacuum technique in which time-of-ﬂight (TOF) mass
analyzers provided nearly unlimited mass range to intermediate pressure (IP; ~0.2 Torr)
and atmospheric pressure (AP) techniques interfaced to mass analyzers having limited
mass-to-charge (m/z) range.[21,75,136] Production of singly charged ions on these m/z
limited instruments eliminates the ability to mass analyze the singly charged ions of highmass compounds. Further, the most accepted ionization mechanism for MALDI involves
ion molecule reactions occurring in the laser plume similar to atmospheric pressure
chemical ionization (APCI).[82] An undeﬁned fraction of the analyte is available for
ionization by this mechanism because a substantial fraction is ablated as matrix/analyte
droplets or clusters.[31,36,37,94,151] Some reports have speculated that the singly
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charged ions produced by MALDI originate from these clusters.[54,85,152] Several
mechanisms by which the clusters become charged have been suggested.[35,54,55,82]
Laserspray ionization (LSI) was the ﬁrst example of laser ablated matrix/analyte
producing electrospray ionization (ESI)-like multiply charged ions.[27-31,41,4850,137,138] Deﬁning features of LSI are AP conditions, the absence of applied ionizing
voltage, the necessity of a heated region in the AP to vacuum interface, and the use of
lasers and matrix compounds commonly employed in ultraviolet (UV)-MALDI (e.g., 2,5dihydroxyacetophenone,

2,5-DHAP

and

2,5-dihydroxybenzoic

acid,

2,5-DHB)

[153,154]. Thus, LSI has the attributes of MALDI related to analysis of compounds
directly from surfaces with high spatial resolution and the attributes of extended mass
range and improved fragmentation associated with multiply charged ions in ESI. LSI is
most commonly applied using transmission geometry (TG) where the laser beam strikes
the matrix/analyte from the backside relative to the ion entrance oriﬁce of the mass
analyzer. While TG is not a requirement for LSI,[41] it is of practical importance for
simplicity of alignment, reproducibility, speed of acquisition, and especially the potential
of high spatial resolution imaging.[27,48] MALDI, especially in vacuum, uses a laser
ﬂuence near the ionization threshold to achieve ions with a low energy spread and, thus,
improved mass resolution. Therefore, numerous laser shots are typically acquired and
summed to produce a mass spectrum, while LSI can achieve ultrahigh resolution even at
high laser ﬂuence, often providing good results from a single laser shot.[48,138]
Nevertheless, vacuum MALDI has been shown to be more sensitive than either APMALDI or AP-LSI.

86

Here, we report the ﬁrst example of producing highly charged LSI ions using
vacuum conditions (ca. 0.16 Torr). The results were achieved on a commercial
intermediate pressure (IP)-MALDI ion source interfaced to a Waters SYNAPT G2 ion
mobility spectrometry (IMS) MS instrument using conditions common with AP-LSI.
Multiply charged ions are also produced in MALDI under vacuum conditions, but the
average mass-to-charge ratio is much higher than reported here. To our knowledge, the
only similar charge state distribution achieved under vacuum conditions two orders of
magnitude higher (~30 Torr) than here was with ESI operated under special conditions
for the purpose of the use of ion funnel technology for ion focusing.[94] Besides the
fundamental implications of this work, an important potential analytical advantage of IPLSI, other than use of a commercial instrument, is the potential for high sensitivity
equivalent or better than AP-LSI and vacuum MALDI. We demonstrate that analysis of
peptides directly from tissue produces nearly identical mass spectra and drift time
distribution appearance observed with AP-LSI and from solution using ESI.
Experimental Section
Analyte solutions were prepared individually in 50:50 ACN/water with 0.1% TFA
(ACTH), 50:50 ACN/water with 0.1% FA (N-acyl MBP fragment), 50:50 MeOH/water
with 1% acetic acid (Ang I, GFP, BI), and 49:49:2 ACN/water/acetic acid (ubiquitin).
The matrix solutions were prepared saturated (20 mg of 2,5-DHB in 100 μL of 50:50
ACN/water with 0.1% TFA, 10 mg of CHCA in 2 mL of MeOH/ACN, and 5 mg of 2,5DHAP in 150 μL ACN, vortexed for a few minutes, then 150 μL water was added and
vortexed again until a darker yellow solution is obtained). The matrix/analyte mixture
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was prepared in 1:1 volume ratio to make the final concentration of the analyte 1 pmol
μL-1 before deposition on the target plates. One microliter of the matrix/analtyte mixture
was used and deposited on metal and glass plates using the dried droplet method.[3] The
model mixture composed of 1 pmol Ang I, 2 pmol GFP, 2 pmol BI, and 2 pmol SM was
prepared in 50:50 MeOH/water with 1% acetic acid. For the tissue sample, an aged
delipified tissue slice prepared as described in a previous study,[48] was spotted with 0.2
μL of the 2,5- DHAP matrix solution and allowed to air-dry prior to analysis.
LSI at IP using the MALDI source of SYNAPT G2 - An IMS-MS SYNAPT G2 (Waters
Corporation) with an IP-MALDI source operating using a Nd:YAG laser (355 nm) was
employed in this study. Instrument parameters and acquisition conditions are included in
Chapter 2.3.
LSI at AP using the NanoESI source of SYNAPT G2 – The description of the set-up is
included in Chapter 2.2. The LSI sample holder was slowly moved through the focused
laser beam using the xy-direction of the stage.
ESI-IMS-MS - The Waters SYNAPT G2 instrument was operated in mobility-TOF using
positive ion sensitivity mode. A 1 pmol μL-1 solution of MBP in 50:50 ACN/water with
0.1% TFA was infused at a flow rate of 1 μL min-1. The capillary voltage was set at 3 kV,
sampling cone at 50 V, and extraction cone at 4.4 V. Desolvation gas flow was at 800 L
h-1 and at a temperature of 150 °C.
MALDI-TOF-MS - A MALDI-TOF Bruker Ultraflex mass spectrometer (Bruker,
Bremen, Germany) equipped with a nitrogen laser (337 nm) was used to acquire the mass
spectrum of the same mixture/analyte used in IP studies on the IMS-MS SYNAPT G2
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mass spectrometer. The mass spectra were acquired using the reflectron positive-ion
mode with a reflectron voltage of 20.30 kV and an ion source lens voltage of 8.85 kV.
Laser repetition rate was set at 20 Hz and increments of 20 laser shots were used to
acquire the mass spectrum with a total of 100 shots. The laser attenuation was set at 45%,
55%, and 70% (highest laser fluence) for CHCA, 2,5-DHB, and 2,5-DHAP, respectively.
Flex Analysis software was used to process the data and obtain the mass spectrum.
Results
The mass spectra obtained at IP on a commercial MALDI-IMS-MS (SYNAPT
G2) are nearly identical in charge state to mass spectra obtained using ESI and LSI on the
same instrument at AP. A number of parameters were explored for their inﬂuence to
provide multiply charged peptide and protein ions with high abundance and good
reproducibility. These include the sample support (glass and metal), matrixes (2,5-DHAP,
2,5-DHB, CHCA), solvent (MeOH, water, ACN, and combinations thereof),

laser

ﬂuence (relative values, with settings: low “50” to highest “500”), and pressure (IP
and high vacuum MALDI instruments). Typical IP results are shown in Figure 8.1 for
Ang I, BI, and ubiquitin, though with increasing molecular weight, the ion abundance
decreases notably. As is the case in LSI at AP using laser alignment in reﬂective
geometry,[41] both glass and metal plates can be used at IP (Appendix B Figure S1).
The glass plate provided higher abundance than a metal target plate for multiply charged
ions and less chemical background, a well-known issue in MALDI.[94]
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Figure 8.1. IP-LSI-IMS-MS mass spectra using a glass plate, 2,5-DHAP matrix
(50:50ACN/water), “200” laser power: (A) angiotensin I (methanol/water with 1% acetic
acid), (B) BI (methanol/water with 1% acetic acid), (C) ubiquitin (49:49:2% acetic acid).
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As with AP-LSI, the best results were obtained with 2,5-DHAP (vs. CHCA and
2,5-DHB, Appendix B Figure S2). Also similar to previous studies [41] on a commercial
AP-MALDI source on an Orbitrap XL using 2,5-DHAP and reﬂection geometry,
irreproducibility is encountered at relative low threshold laser ﬂuence by the inability to
observe ions after a couple of laser shots at the same location. Moving to the next spot
and increasing the laser ﬂuence improved the reproducibility. We relate this issue to the
laser aligned in reﬂection geometry and not to IP conditions; in transmission geometry,
this is not observed because the sample in the path of the laser beam is completely
ablated in a single shot. [48,138] In MALDI, ﬁrst shot phenomena have been reported
for the analysis of molecular complexes.[155,156]
Another interesting phenomena affecting the relative abundances of singly and
multiply charged ions produced by IP is the sample preparation and morphology as
determined for 2,5-DHAP using microscopy. The crystallized LSI matrix/analyte sample
showed a ﬂat ﬁlm-like appearance around the edge and a center with a ﬂuffy crystalline
appearance (Appendix B Figure S3). Mass spectral results showed that the center
provided more abundant multiply charged ions (Appendix B Figure S4) while the outer
ﬁlm produced more singly charged ions. The similarity to results obtained using AP-LSI,
suggests that a similar ionization mechanism is active at IP, and thus, we refer to this new
method as IP-LSI.
The commercial MALDI source at IP allows for the ﬁrst time a precise
assessment of the laser ﬂuence on the production of highly charged LSI ions. The effect
of laser ﬂuence on the formation of multiply charged ions is notable for any of the
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matrixes. Results are summarized in Appendix B Figure S5 for Ang I and Appendix B
Figure S6 for MBP, a neuropeptide, using in both cases 2,5-DHAP matrix. At very low
laser ﬂuence of “50” and “100” low abundant MBP ions are detected barely above the
baseline. At “150”, highly charged ions are observed but in relative low abundance and
with essentially no chemical background. At “200”, the ion abundances of the highly
charged ions increase by a factor of 3 vs. “150”, also with essentially no chemical
background signals. With increasing laser ﬂuence up to “500”, matrix signals start to
show up and the relative intensity of the multiply charged ions increases for the lower
charge states and formation of singly charged ions become much more evident. At the
highest laser ﬂuence of “500”, the doubly charged ions are the base peak for both
compounds but the triply charged ions are signiﬁcantly reduced in abundance. Further,
the ion abundance of the background increases to the point of overwhelming the ion
intensity of both the multiply and the singly charged ions present in the mass spectra.
Increasing the laser ﬂuence to “500” provided only highly charged but no singly charged
ions of BI (Appendix B Figure S7).
Only singly charged ions (Ang I, GFP, ACTH, BI) are observed using the same
matrix/analyte samples on a high vacuum commercial MALDI instrument (Appendix B
Figure S8) with glass or metal sample plates using 55% and 70% laser ﬂuence for CHCA
and 2,5-DHAP matrixes, respectively. Higher laser ﬂuence was necessary for 2,5-DHAP
in comparison to CHCA and 2,5-DHB for the detection of singly charged analyte ions.
2,5-DHAP produced low abundant doubly charged ions for ACTH and BI at high laser
ﬂuence under vacuum MALDI conditions, whereas the other matrixes only produced
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singly charged ions. These results suggest that matrix/analyte clusters are formed under
vacuum conditions, similar to suggestions by Karas, Tabet, and others,[54,85,152] but
multiply charged ions are only observed with proper desolvation conditions, which in this
case are produced primarily by the choice of matrix and laser ﬂuence.
The evaluation of parameters under our control on the SYNAPT G2 allowed
extension of the mass range at IP to proteins as large as ubiquitin with charge states to
+12 (Figure 1C, laser “200”, and Appendix B Figure S9, laser “500”). There are no
provisions to provide heat in the pressure drop region between the IP source and the high
vacuum of the mass analyzer. Previous AP-LSI studies on a LTQ Velos (Thermo
Fisher Scientiﬁc) with the capability of heating the ion inlet capillary to 450 °C
produced highly charged ions of carbonic anhydrase (~29 kDa) with charge states up to
+27.[138] Interestingly, with the SYNAPT G2, it appears that the helium gas associated
with the IMS region is of critical importance. Only singly charged ions are observed, as
expected from a MALDI process without added helium gas, but the addition helium gas
results in observation of multiply charged ions (Appendix B Figure S10). We assume
this is a result of desolvation of charged clusters and are currently developing methods to
apply heat within the IP region with the expectation that similar sensitivity [29] and mass
range [138] enhancements observed with AP-LSI will be observed at IP-LSI.
The practical utility of this novel ionization method is shown for analysis of a
mixture composed of a lipid (SM), peptides (Ang I, GFP), and a small protein (BI) using
the common LSI matrix 2,5-DHAP, a glass plate sample holder, and the maximum laser
ﬂuence provided by the manufacturer settings (Figures 2 and S11, Appendix B) metal
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plate of mixture; Figures S12 and S13 (Appendix B) pure samples with low and high
laser ﬂuence). Interestingly, the lipid and small peptide showed metal adducted singly
charged ions especially with high laser ﬂuence. Collision-induced dissociation can be
used to characterize lipid compositions directly from tissue (Appendix B Figure S14).

Figure 8.2. IP-LSI-IMS-MS of a model mixture of angiotensin I (Ang I), sphingomyolin
(SM), [Glu1]-fibrinopeptide B (GFP), and bovine insulin (BI) using a glass plate, 2,5DHAP matrix (50:50 ACN/water), and “500” relative laser power: (A) 2-D plot of drift
time vs. m/z and extracted drift time for +4 BI, +2 and +1 Ang I ions; (B) total mass
spectrum and inset spectrum of +4 BI ion.
Figure 2A shows the 2D data set of drift time vs. m/z separations of the IP-LSIIMS-MS measurement of this model mixture at a laser ﬂuence of “500”. In the total mass
spectrum (Figure 2B), the most abundant signal is from Ang I observed with charge
states +1 and +2. The other components of the model mixture, especially the higher
charge states of the protein, are not very noticeable because of the low signal intensity as
compared to the higher abundant Ang I. Because of the exquisite sensitivity for the entire
sample composition, the IMS-MS 2-D display allows these ions to be readily visualized
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(Figure 2A).
Singly charged ions of lipids and peptides fall nearly on the same diagonal
indicating little separation in the IMS dimension. However, the charge states +1, +2, and
+3 are well separated from each other and readily observed individually. The highly
charged bovine insulin ions +4, +5, and +6 fall on a diagonal line that is well separated
from lower charge states +3, +2, and +1. The relative drift times of the diagonal lines
drawn through the different components in the sample are highly charged protein ions +6,
+5, and +4 < multiply charged peptide and protein ions +3 and +2 < singly charged
matrix ions < singly charged peptide and lipid ions. The separation trend is in accord with
previous studies using vacuum MALDI-IMS-MS.[157-162] Here, the extent of
separation between the highly charged and the singly charged ions is of notable analytical
utility.
Comparison of the results obtained with IP-LSI to those obtained with AP-LSI
(Appendix B Figure S15) shows that, at IP using low laser ﬂuence of “200”, the results
closely resemble those obtained with unattenuated laser ﬂuence at AP. Increasing the
laser ﬂuence at IP to “300” increases the abundance of the singly charged lipid and
peptide ions at the expense of a notable increase in matrix background and decrease of
the abundance of higher charged ions.
A second set of comparison experiments was applied to obtain data directly from
mouse brain tissue using IP-LSI-IMS-MS (Figure 3). This same tissue section was
previously analyzed using AP-LSI-MS in combination with ultrahigh mass resolution and
electron transfer dissociation (ETD) enabling identiﬁcation of an endogenous
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neuropeptide directly from its native and complex environment.[48] At IP, charge state
families similar to the model mixture in Figure 2 were observed ranging from charge
state +1 to +3. Extracting diagonal slices through the 2D data set in Figure 3 provide
mass spectra that deconvolute the different charges states, as is exempliﬁed by the
extracted mass spectrum and inset mass spectra for charge state +2 shown in Figure
8.4A.

Figure 8.3. IP-LSI-IMS-MS of a delipified mouse brain tissue (analyzed previously,[31])
using a glass plate, 2,5-DHAP matrix (50:50 ACN/water), and “500” relative laser
power: (A) 2-D plot of drift time vs. m/z and extracted drift time for +3 peptide and +1
lipid ions; (B) total mass spectrum and inset spectrum of +3 ion and the ion (+2) with the
largest MW 3216.
The highest molecular weight peptide observed is 3216 Da. Previous studies of
the same tissue using AP-LSI-MS on LTQ Velos and Orbitrap mass spectrometers
showed low abundant protein ions up to MW ca. 19,665 Da.[48] The extracted slices
from the 2-D data set permit examining in detail the different charge-state distributions
(+2, Figure 8.4A) and drift time distributions (Figure 8.4B; Figures S16 and S17,
Appendix B, for lipids and peptides) even of low-abundant ions that would otherwise be
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diffcult to extract (e.g., charge state +2 vs. charge states +1 or +3).

Figure 8.4. Extracted data from Figure 3: (A) mass spectrum of chargestate family +2
and respective inset mass spectra; (B) drift time distributions of charge states +1 to +3:
(1) N-acetylated fragment of myelin basic protein (characterized previously by ETD,[8])
and (2) from the synthesized neuropeptide (+1, +2, and +3, MW 1833).
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Drift time distributions can be extracted for speciﬁc m/z values from which cross
sections can be determined using a calibration approach.[163] These values can give
insight into structures when combined with computer modeling approaches [164-176]
or aid identification when standards are available.[50,66] For example, Figure 8.4B
shows the drift time distributions obtained for +1, +2, and +3 charge states for the Nacetylated fragment of myelin basic protein with a MW of 1833 Da. Narrower drift time
distributions are observed with increasing charge state. The drift time distributions of the
singly charged ions are, however, unexpectedly broad, as is the case for any of the
peptides that showed singly and doubly charged ions (Appendix B Figure S16). The
singly charged ions obtained from the deﬁned lipid, peptides, and protein mixture
analysis (Appendix B Figure S17) also showed notably broader drift time distributions
relative to the multiply charged ions. The width of the drift time distributions may
indicate more than one ionization mechanism for singly charged ion production.
For further insight, we obtained the custom synthesized neuropeptide that was
previously identiﬁed directly from tissue by a MASCOT search of LSI data from a LTQETD and Orbitrap Exactive.[48] The extraction of the drift times of the IP-LSI-IMS-MS
measurements of singly charged ions (Figure 8.4B) again showed the unusual broad drift
time distributions as compared to the multiply charged ions. Importantly, the endogenous
neuropeptide and the standard sample provide identical drift time distributions for charge
states +1 to +3 obtained by IP-LSI-IMS giving further conﬁrmation of the structure
present in the tissue. We noted earlier that the charge state and drift time distribution
appearance is nearly identical for the synthetic neuropeptide sample to that observed in
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AP-LSI or ESI IMS-MS (Appendix B Figures S18-S19) but with the important
difference that singly charged ions are not present under AP conditions even though APLSI uses signiﬁcantly higher laser ﬂuence than those used with IP-LSI. Previous
investigations of isomeric beta amyloid peptide mixtures showed baseline separation
using a LSI-IMS-MS (SYNAPT G2) approach,[50] strongly suggesting that even rather
small differences in the structures of the peptides would be observed using the IMS-MS
approach.
Discussion
The production of highly charged ions using a commercial IP-MALDI source has
important analytical implications but is also of fundamental interest. As noted previously,
a number of authors have suggested ion formation in MALDI occurs from charged
matrix/analyte clusters or droplets.[54,55,85,94,152]

Garrison and co-workers ﬁrst

modeled formation of matrix droplets by vacuum laser

ablation

of

a

solid

matrix.[36,38] Tabet and co-workers postulated on the basis of Karas's lucky survivor
model [152] that two energy-dependent processes exist for ion formation from
matrix/analyte clusters: hard desolvation leading to low charge states (+1) by emission of
charged matrix molecules and soft desolvation leading to multiply charged ions (+2) by
emission of neutral matrix molecules in a process similar to the mechanism proposed for
ESI. This study was based primarily on relative abundances of +1 and +2 ions produced
at different laser ﬂuences. If, in fact, MALDI ions are produced from charged clusters,
then the results presented here are the logical extension of this process as would be the
case with AP-LSI. However, both AP-LSI and the work presented here have almost
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identical outcomes for various matrix compounds tested and, thus, we refer to the
methods as AP-LSI and IP-LSI rather than MALDI methods. Not only do these methods
produce highly charged ions not previously observed with MALDI but also the out- come
of all experiments to date is nearly identical to matrix assisted ionization inlet (MAII)
results.[39] MAII requires no laser and, thus, is outside the deﬁnition of MALDI.
However, it is not clear yet if ions can be produced at IP with MAII, at least without a
source of thermal energy. The laser ﬂuence in IP-LSI may provide the energy that the
heated inlet provides in AP-LSI and MAII for the initial ionization. The ability to extend
the LSI/MAII methods to vacuum conditions also poses new questions relating to the
MALDI mechanism and has the potential to even shed new light on the ionization
mechanism in ESI.
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CHAPTER 9
LASERSPRAY IONIZATION IMAGING OF MULTIPLY CHARGED IONS
USING A COMMERCIAL VACUUM MALDI ION SOURCE “Reprinted (adapted)
with permission from (Inutan, E. D.; Wager-Miller, J.; Mackie, K.; Trimpin, S. Anal.
Chem. 2012, 84, 9079–9084). Copyright (2012) American Chemical Society.”

Introduction
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS)
produces abundant singly charged ions of peptides from the solid state under low
pressure, intermediate pressure, and atmospheric pressure conditions.[3,21,75] Time-ofﬂight (TOF) is the common mass analyzer used with low-pressure MALDI and in
principle provides unlimited mass range for detection of large molecules.[177] A
limitation of the production of primarily singly charged ions is that high-mass compounds
cannot be analyzed using high-performance instruments with only a limited mass
range such as Fourier transform ion cyclotron resonance, Orbitrap, or ion mobility
spectrometry (IMS) (SYNAPT G2) mass spectrometers. MALDI imaging mass
spectrometry has provided information on spatial distributions of lipids,[162,178]
peptides,[179] and proteins [180] directly from biological tissue sections, and MALDIIMS-MS imaging has been applied for lipids [113,162] and peptides [162] as well as
studying protein changes related to several diseases such as Alzheimer’s
Parkinson’s [13,15,16] as

well

as

and

cancer.[124,181,182] Secondary ion mass

spectrometry (SIMS) has also been used to map the distribution of cancer
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chemotherapeutic agents in tissues and cells,[183,184] lipids,[185-187] and later, matrixenhanced SIMS to enhanced subcellular imaging of tissue samples.[188-190] Desorption
electrospray ionization is promising for imaging living tissue without sample
preparation.[191-193]
Laserspray ionization inlet (LSII) [27-31,41,48-50,137,138] and matrix assisted
ionization inlet (MAII) [39,194] are two new ionization methods in MS operating
from atmospheric pressure to produce highly charged ions similar to electrospray
ionization (ESI). Both LSII and MAII have attributes in common with MALDI allowing
analysis of compounds directly from the solid state by using a solid matrix material
composed of a small organic compound.[40] The application of heat and the presence of
an atmospheric pressure to vacuum pressure drop region are two important factors in
producing abundant highly charged ions in the inlet of the mass spectrometer.[29,31,45]
In LSII, the laser alignment is not important because multiply charged ions are
formed without the use of a laser,[39,40,44] as well as with the use of a laser aligned in
transmission [27-31,48-50,138] or reﬂection geometry.[41] For example, a commercial
atmospheric pressure MALDI source with the laser aligned in reﬂection geometry
produced abundant highly charged protein (e.g., lysozyme) ions on a Thermo Orbitrap
mass spectrometer.[41] Critical is that sufficient heat is provided to the inlet of the mass
spectrometer which directly depends on the matrix used.[29,40] Multiply charged ions
produced by LSII and MAII using 2-nitrophologlucinol (2- NPG) matrix extend the mass
range of detection to at least bovine serum albumin (~66 kDa).[194] LSII was also shown
to produce sufficient ion abundance directly from tissue to identify an endogenous
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peptide, a fragment of N-acetylated myelin basic protein (MBP) (amino acid (aa) 1−16),
using electron transfer dissociation (ETD) and high-accuracy mass measurement [48]
and has been successfully introduced on a mass spectrometer with a heated inlet to
perform imaging of lipids.[50,138] The laser aligned in transmission geometry provides
ease of operation [27-31,48-50,138] and offers the potential for high spatial resolution
imaging. [48,195,196].
Initial studies on matrixes [138] enabled us to introduce LSI technology operating
from vacuum, LSIV, using a commercial intermediate pressure MALDI ion source
interfaced to a Waters IMS-MS SYNAPT G2 mass spectrometer.[42] In the absence of a
heated inlet region, abundant multiply charged analyte ions are formed by laser ablation
using a matrix that efficiently evaporates.[40] 2-NPG matrix is the ﬁrst matrix to
produce highly charged ions at atmospheric pressure, intermediate pressure, and low
pressure.[44,45,194] The mechanism proposed [45] for the LSI inlet and vacuum
ionization process is laser ablation producing highly charged matrix/analyte droplets
which upon matrix evaporation releases ions by a similar process to that proposed for
ESI.[51,52] The impact of a laser has been experimentally and theoretically shown to
form molten droplets of matrix/analyte, and the existence of clusters was veriﬁed
recently

for

LSII.[31,36,197] 2,5-Dihydroxyacetophenone

(2,5-DHAP),[48,50] a

matrix that requires a lower inlet temperature than, for example, 2,5-dihydroxybenzoic
acid (2,5-DHB), produces abundant multiply charged ions at intermediate pressure under
LSI tuning conditions.[39,42] However, the use of higher laser power [42] and voltages
[45] increase the abundance of singly charged ions. Using a higher laser power makes
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only minor contribution to the production of singly charged ions. It is primarily the
higher voltages of the MALDI settings that allow switching from multiply charged using
ESI-like settings to singly charged ions either at atmospheric pressure [41] or
intermediate pressure.[45] The practical utility of LSIV on a commercial vacuum
MALDI source in combination with IMS-MS was demonstrated using 2,5-DHAP as
matrix for the mixture analysis of lipids, peptides, and proteins.[42] Various families of
compounds are well-separated from each other. Imaging applications are an extension to
these tissue analysis developments. Here, we show the applicability of LSIV using a
commercially available vacuum MALDI source operating at intermediate pressure
(~0.16 Torr) for tissue imaging of multiply charged peptide ions achieved without any
physical instrument modiﬁcations.
Experimental Section
2,5-DHAP and 2-NPG matrix solutions were prepared by dissolving 5 mg in 150
μL of 50:50 ACN/water (warmed), and 100 and 300 μL of 50:50 ACN/water (with and
without 0.1% FA), respectively. The matrix:analyte mixture was prepared in 1:1 volume
ratio before depositing 1 μL of the analyte/matrix mixture on a glass plate using the dried
droplet method.[42] Mouse brain tissue sections were obtained as previously described
[48,113,195,196] and included in Chapter 2.1. The tissue sections were mounted on
plain and precoated glass plates with CHCA matrix using a tissue box [195] and
delipiﬁed with ethanol as previously described.[48] The delipiﬁed tissue slices were
spotted separately with several 0.5 μL of 100% 2,5-DHAP and 100% 2-NPG matrix in
50:50 ACN/water for direct analysis and spray-coated with 2-NPG for imaging. A binary
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mixture of 10%

2-NPG

and

90%

2,5-DHAP

by

volume

composition matrix

solutions was also used for tissue imaging.
Laserspray Ionization Vacuum (LSIV) – A commercial IP-MALDI source of SYNAPT
G2 mass spectrometer was employed in this study as described in Chapter 2.3. In the
analysis of standards (MBP, galanin, bovine insulin), the laser power used ranged from
4.2 to 7.3 J cm-2 as previously reported,[45] at a ﬁring rate of 200 Hz and a scan rate of 1
scan s-1 acquiring a sum mass spectrum of 1-2 min. For tissue imaging, the instrument’s
MALDI imaging pattern creator software was used as one would use for MALDI
imaging. The sampling resolution was set at 100 μm × 100 μm x,y laser step size, similar
to MALDI imaging. Acquisition was set at a scan time of 2 s, laser power of 12.5 J cm -2
at a ﬁring rate of 200 Hz, and 1 scan time per pixel. The total imaging acquisition time
was ~5 h to image the entire tissue section. Laserspray Ionization Inlet (LSII) - A
Nanolockspray source of the SYNAPT G2 was used LSII comparison as described in
Chapter 2.2 using a home-built skimmer cone with a fabricated copper inlet tube
attached, and the laser was aligned at 180° to the inlet tube, focused onto the
matrix/analyte sample on a glass plate, and ablated in transmission geometry
(Scheme 2.1) relative to the inlet of the mass spectrometer. The source temperature
was set at 150 °C, and acquisition was obtained in resolution mode using 100 and 4 V
sample cone and extraction cone voltages, respectively, with a scan time of 1 s for 2 min.
Data Processing - MassLynx version 4.1 was used to process the mass spectra,
DriftScope version 2.2 was used to extract the two-dimensional (2-D) plot of drift time
vs. mass-to-charge (m/z) ratio, and mobility extractor was used to obtain the drift time vs.
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m/z selected data set and convert into an MSI ﬁle using the MALDI imaging converter.
BioMAP 3.8.0.1 was used from Novartis Institutes for Biomedical Research, Basel,
Switzerland, to extract from the MSI ﬁle the images of the peptides.
Results and Discussion
The endogenous N-acetylated MBP peptide (Ac-ASQKRPSQRSKYLATA),
previously

sequenced

by

LSII

(Scheme

1.1IA)

using

high-performance

fragmentation,[48] was the initial focus for obtaining MS images of multiply charged
ions using LSIV (Scheme 1.1IIA) on a commercial IP-MALDI source of the SYNAPT
G2 mass spectrometer. The use of a suitable matrix material and appropriate settings and
acquisition conditions such as laser power and voltages for ion acceleration and
transmission are important factors inﬂuencing the formation of the highly charge ions at
intermediate pressure.[40,42,45] The direct analysis of MBP peptide from delipiﬁed
mouse brain tissue was ﬁrst achieved by spotting 2,5-DHAP matrix onto the tissue.
Multiply charged peptide ions up to charge state +3 were detected with the largest MW of
~3.2 kDa (Appendix B Figure S20). Exceptional ion abundance is obtained for the MBP
peptide with m/z 917.39 using 2,5-DHAP, but only when the matrix is directly spotted on
the tissue (Appendix B Figure S20A). With LSII, spotting 2,5-DHAP matrix on
nondelipiﬁed mouse brain tissue allowed detection of lipids as well as multiply charged
ions of the N-acetylated MBP fragment peptide (Appendix B Figure S21). However,
spray-coating of the matrix, necessary for good spatial resolution in tissue imaging,
provided poor ion abundance using 2,5-DHAP operated from atmospheric pressure or
vacuum.
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2-NPG, a more volatile matrix than 2,5-DHAP, produced abundant multiply
charged ions of up to charge state +4 from a synthesized MBP peptide standard (Figure
9.1I.A) at low laser power applying “LSI settings” [42,45] on the commercial IPMALDI

source

without

any physical instrument modiﬁcations. The analyte ion

intensity increased as did the chemical noise background with increasing laser power
(Figure 9.1I.B). The chemical background could be removed using the IMS dimension,
especially because

the

different charge state ions are well-separated in the IMS

dimension, identical to ESI-IMS-MS.[59-63,67] Only singly charged ions are produced
when the default “MALDI settings” [45] are applied (Figure 9.1II). The ion abundances
observed are similar for the multiply charged ions (“LSI settings”) (Figure 9.1I) and the
singly charged ion (“MALDI settings”).[45] For a number of peptide and small-protein
standards using “LSI settings” [42,45] (Appendix B Figure S22): (A) MBP, MW 1833
Da; (B) galanin, MW 3150 Da; and (C) bovine insulin, MW 5731 Da), 2-NPG matrix
allows detection of higher charge states than 2,5-DHAP matrix. 2-NPG requires less laser
power (ca. 4.2 J cm-2) than 2,5-DHAP (ca. 7.3 J cm-2) to obtain good ion abundance
while maintaining higher charge states (Appendix B Figure S23). However, the ion
abundance near the respective threshold for ion formation is then slightly lower with 2NPG relative to 2,5-DHAP (Appendix B Figure S22). The laser power dependence is in
agreement with a previous study that found a higher laser power induces lower charge
states using 2,5-DHAP matrix.[42]
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Figure 9.1. LSIV-IMS-MS (1) total mass spectra and (2) two dimensional plot of drift
time vs m/z of N-acetylated MBP peptide (MW ∼1833 Da) with 2-NPG matrix acquired
using (I) “LSI settings” [42,45] at (A) low “4.2 J cm−2” and (B) higher “7.3 J cm−2” laser
power with an inset of the isotopic distribution of +4 ion and (II) commercial “MALDI
settings” [45] on a Waters SYNAPT G2 MALDI source. Insets in parts 1 and 2 show
isotopic distributions and drift times of MBP ion.
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Figure 9.2 shows the LSIV analysis of delipiﬁed mouse brain tissue using “LSI
settings” with 2-NPG matrix applied to the tissue by different deposition methods. By
directly spotting 100% 2-NPG matrix on the tissue and the use of a relatively high laser
power (12.5 J cm-2), abundant multiply charged ions from peptides and proteins are
obtained (Figure 9.2I.A) and are well-separated by IMS from the singly charged lipid
ions (Figure 9.2I.B). Ions are observed from proteins that are present in the tissue having
molecular weights up to ~8.6 kDa (Appendix B Figure S24) on a high-performance
mass spectrometer with a mass range of 8000. As noted above, spotting the tissue with
100% 2,5-DHAP matrix only detected up to ~3.2 kDa (Appendix B Figure S20).
Unfortunately, 100% 2-NPG matrix spray-coated on a mouse brain tissue section
required the application of a laser power of 12.5 J cm-2 to obtain sufficient ion abundance
(Figure 9.2II) for good images. Using “LSI settings”, as described above, under these
higher laser ﬂuence conditions, only +2 and +1 ions are detected (Figure 9.2II.A) from
mouse brain tissue. However, the IMS dimension separating +2 from the +1 charge state
allows extraction of the +2 peptide ions with good ion abundance (Figure 9.2II.B).
Just as in MALDI imaging, sample preparation is important with LSI imaging.
Thus, a number of sample preparation protocols were explored. For example, mouse
brain tissue sections mounted on a CHCA precoated glass slide, similar to previous
protein studies,[31] and spray-coated with a binary mixture of 90% 2,5-DHAP and 10%
2-NPG allowed observation of higher molecular weight peptides and proteins ions
(Appendix B Figure S25) but with notably less ion abundance relative to 100% 2NPG (Figure 9.2I). Thus, in the absence of the heated inlet,[27−40] the volatility of the
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matrix composition in vacuum deﬁnes the outcome of the tissue analysis and is
especially restrictive to imaging for which direct matrix spotting cannot be employed
because of delocalization of the tissue composition, as is also the case with
MALDI. Clearly, further developments in sample preparation will be necessary to
advance LSIV imaging just as it was for MALDI.

Figure 9.2. LSIV-IMS-MS (A) total mass spectra and (B) two-dimensional plot of drift
time vs. m/z of delipified mouse brain tissue (I) spotted and (II) spray-coated with 100%
2-NPG matrix. Insets show (A) isotopic distributions of +2 charge state ion of the
identified peptide N-acetylated MBP fragment, (I.B) drift times of charge state +4 and +1
ions, and (II.B) isotopic distribution of the +2 ions. Insets of higher charge states in part I
are included in Supporting Information Figure S24.
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The drift time and m/z values of an area of choice can be selected in the 2-D IMS-MS
plot, which becomes possible because of the two dimensionality of the data set,[66,67]
allowing investigation of any ion of interest, while disregarding others. Here, using the
ion mobility embedded mass spectral data set from the 100% 2-NPG spray-coating
approach in Figure 9.2II.B, images were created for three peptides. This ion at m/z
917.40 had previously been sequenced using ETD fragmentation of the doubly charged
N-acetylated MBP peptide (1−16) ion.[48] The image (Figure 9.3A) relates well with the
known location of the myelin basic protein (Figure 9.3D),[54] validating our tissue
imaging MS approach of multiply charged ions at vacuum. Using similar procedures,
images of two additional doubly charged peptide ions are obtained, m/z 831.35 and
795.81 (Figure 9.3, parts B and C), respectively. All three peptide images have the
same location as the myelin basic protein in the mouse brain tissue (Figure 9.3D).[198]
Using the amino acid sequence information obtained from the identiﬁed peptide
MBP fragment with a MW of 1832.8 Da [48] (aa residues (1−16), Figure 9.3A), images
of MWs 1660.7 Da (aa residues (1−14), Figure 9.3B), and 1589.6 Da (aa residues
(1−13), Figure 9.3C), then correspond to MBP peptides with two and three amino acid
truncations (Figure 9.3, parts B and C) of the C-terminal end.
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Figure 9.3. LSIV at intermediate pressure images of endogenous peptides from delipified
mouse brain tissue spray-coated with 100% 2-NPG matrix: (A) m/z 917.40 (+2) MW
1832.8, (B) m/z 831.35 (+2) MW 1660.7, and (C) m/z 795.81 (+2) MW 1589.6. (D)
Coronal section of the mouse brain [198] at a level similar to those analyzed in panels
A−C. Arrowheads in panel D indicate heavily myelinated fiber tracts. Insets show
molecular weight and amino acid sequence of the images relative to the identified peptide
N-acetylated MBP fragment. The highest ion intensities are m/z 917 = 1.02 e4, m/z 831
=1.27 e4, and m/z 795 = 1.06 e4, respectively.
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CHAPTER 10
MATRIX ASSISTED IONIZATION VACUUM, A NEW IONIZATION METHOD
FOR BIOLOGICAL MATERIALS ANALYSIS USING MASS SPECTROMETRY
“This research was originally published in Molecular and Cellular Proteomics (Inutan,
E.D.; Trimpin, S. Mol. Cell. Proteomics 2013; 12:792-796) © the American Society for
Biochemistry and Molecular Biology.”

Introduction
The conversion of large and nonvolatile compounds such as proteins into gasphase ions is of immense fundamental and practical importance. The 2002 Nobel Prize in
Chemistry was awarded for the accomplishment of this conversion via electrospray
ionization (ESI) [1] and matrix-assisted laser desorption/ionization (MALDI) [2]
interfaced with mass spectrometry (MS) to obtain the molecular weights of proteins with
high accuracy. These methods employ high voltage or a laser to form gaseous analyte
ions from a wide variety

of

compounds

in

solution

or

a

solid

matrix,

respectively.
MALDI interfaced with a time-of-flight (TOF) mass spectrometer produces gasphase analyte ions in vacuum and is the method of choice for the molecular imaging of
biological surfaces. Ionization in vacuum provides excellent ion transmission [23], as
well as good spatial resolution achieved using a focused laser beam. However, the
analysis of protein complexes is very challenging with MALDI, requiring strategies such
as first-shot phenomena [199] and chemical crosslinking [200]. The necessity of a laser
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also makes MALDI less soft than ESI and produces background ions, which can hinder
the analysis of small molecules [94,201]. MALDI is also of limited utility on high
performance mass-to-charge (m/z) analyzers because of mass range issues related to the
formation of singly charged ions, which also produce few fragment ions for structural
characterization [202].
Multiple charged ions produced directly from solution in ESI bring the m/z ratio
within the range of high performance mass spectrometers, allowing the analysis of highmass

compounds.

These

instruments

have

advanced

features

for

structural

characterization, such as ion mobility spectrometry (IMS) for gas-phase separations
[42,45,50], ultra-high mass resolution and mass accuracy [27-29,48], and advanced
fragmentation such as electron transfer dissociation (ETD) [29,48]. However, ESI is
limited for surface characterization, requiring approaches such as desorption-ESI [139]
and laser ablation ESI [203], ionization methods that produce multiply charged ions but
are not compatible with analyses of larger proteins or fragile complexes.
A softer ionization approach is needed in order to observe fragile molecules and
molecular complexes in living organisms at low levels directly from tissue and cell
cultures, without extensive sample preparation, while retaining spatial information.
Ideally, this approach would be compatible with mass spectrometers having advanced
capabilities to aid structural characterization directly from surfaces. The new ionization
method described here, in which molecules are transferred from solid-phase to gas-phase
ions through the simple exposure of a material of interest in a suitable matrix to vacuum,
is an advance toward this goal and is of fundamental interest.
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Experimental Procedures
Analyte solutions were diluted with water to make concentrations ranging from 1
to 5 pmol uL-1, 20 pmol uL-1 for BSA, and 50 fmol uL-1 for ubiquitin. For the
noncovalent complex, stock solutions of lysozyme and penta-N-acetylchitopentaose were
individually diluted in 25 mMol ammonium acetate buffer with 10% methanol according
to published procedures [204]. The molar ratio of the protein-ligand mixture was
optimized, and a premixed noncovalent complex mixture of 1:285 protein:ligand molar
ratio was used. The blood sample was diluted in water at a 1:10 volume ratio. 3-NBN was
dissolved in 50 uL of 100% ACN with 0.1% formic acid and 150 uL of 50:50 ACN/water
with 0.1% formic acid (positive mode measurements), and 150 uL of 50:50 ACN/water
was mixed with 0.1% NH4OH for peptides and 1% NH4OH for proteins (negative mode
measurements). The matrix/analyte solution was prepared at 1:3 and 1:1 volume ratios
for positive and negative mode measurements, respectively, and 1 uL was spotted on the
target plate. Mouse brain tissue, obtained using a protocol described elsewhere
[48,195,196], was donated by Professor Ken Mackie (Indiana University). The delipified
mouse brain tissue [48] was coated with several 0.5-uL spots of 3-NBN matrix in 50:50
ACN/water with 0.1% formic acid. The matrix deposition on brain tissue sections from
mouse brain tissue was miniaturized by spotting, on the same area, a total of 1 uL in five
increments of 0.2 uL, covering a ~400 µm x 150 µm area on the tissue. Blood was
extracted from Band-Aid using water. After solvent evaporation of the matrix/analyte
spot, the target plate was introduced into the vacuum of the mass spectrometer.
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Matrix Assisted Ionization Vacuum (MAIV) on a Commercial Vacuum MALDI Source
– IMS-MS SYNAPT G2 (Waters Co., Milford, MA) with a commercial intermediatepressure MALDI source conventionally operated with an Nd:YAG laser (355 nm) was
employed with the laser off as described in Chapter 2.4. Analyte ions were observed
with as little as 1 V applied between the sample plate and the extraction lens. Some
voltage is necessary to accelerate ions into the hexapole ion guides and to the mass
analyzer.
MAIV on Commercial Atmospheric Pressure ESI Source of Waters Co. SYNAPT G2 –
The skimmer cone of the z-spray was modified as described in Chapter 2.4 using a wider
outer (~4.5 mm) and inner (~3 mm) cones.
MAIV on Commercial Atmospheric Pressure ESI Source of Thermo Scientific LTQ
Velos – The transfer capillary was modified by inserting a ferrule on the outer opening of
the inlet tube to hold the glass plate as described in Chapter 2.4.
Results and Discussion
The MAIV method described here, using 3-NBN as matrix, produces ions when
placed in vacuum. Similar to ESI [204], multiple charging, even of protein complexes, is
observed, but it occurs directly from the solid state. For example, the MAIV mass
spectrum of the 14.3 kDa lysozyme protein using the vacuum MALDI source of the
SYNAPT G2 is shown in Figure 10.1A, and its complex with penta-Nacetylchitopentaose, separated from both the lysozyme and the peptide ions via IMS, is
shown in Figure 10.1B. A challenge in analyzing molecular complexes via any MS
approach is that the sample preparation must keep the complex intact under conditions
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suitable for ionization. These mass spectra are obtained simply by placing the
matrix/analyte sample in vacuum. Ions are continuously formed until the matrix
completely sublimes, which, depending on the applied conditions, can take a few seconds
to tens of minutes (Figure 10.1C). No laser, voltage, or heat is used to initiate the
ionization process. The “hot spot phenomenon” [205-207], an intrinsic limitation for
quantitation in MALDI, is not an issue because the entire matrix/analyte sample is
analyzed by simply summing mass spectra acquired during complete matrix sublimation.

Figure 10.1. MAIV mass spectra of (A) lysozyme, 14.3 kDa, (B) noncovalent complex
of lysozyme/penta-N-acetylchitopentaose (PNAP) extracted from the IMS-MS twodimensional dataset, (C) total ion current of A, (D) bovine serum albumin, 66 kDa. Red
numbers indicate the charge states, and blue numbers in the upper right corner of each
spectrum provide relative ion abundances.
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3-NBN has no acidic protons needed for ionization, so the protons must be
supplied by the solvent, analyte, or acid during sample preparation. Typically, the matrix
is dissolved in organic or water-organic solvents, with or without 0.1% formic acid, and
the analyte in water/organic solvent or, for complexes, water buffered with ammonium
acetate. The matrix and analyte solutions are mixed in the same way as the sample
preparation used in MALDI, dried, and placed in vacuum or, for labile compounds,
immediately placed in vacuum without drying. Astonishingly, MAIV produces ions from
proteins at least as large as BSA (~66 kDa) (Figure 10.1D).
As with ESI, small molecules are detected as singly charged with little matrixrelated chemical background (e.g. leucine enkaphelin; Figure 10.2IA), and larger
peptides (e.g. acetylated N-terminal fragment peptide of myelin basic protein; Figure
10.2IB) as multiply charged ions. Mass spectra are obtained using the SYNAPT G2 mass
spectrometer vacuum MALDI source, consuming low femtomoles of small proteins such
as ubiquitin (50 fmol) (Figure 10.2IC). Good negative ion abundances of, for example,
ubiquitin (Figure 10.2IIA), the hirudin (55– 65) peptide (Figure 10.2IIB), and the
phosphorylated peptide cholecystokinin (10 –20) (Figure 10.2IIC) are also observed
with MAIV.
Peptides and proteins are detected by applying 3-NBN in an appropriate solvent
onto the surface of a mouse brain tissue section (Figure 10.3A) and subjecting the
sample to the vacuum of the mass spectrometer (Figure 10.3B). Selected areas of interest
of a tissue can be exposed to matrix, and even if the entire tissue section is placed in
vacuum, only molecular ions from compounds in those specific areas are observed
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(Figure 10.3C). Miniaturizing the matrix deposition area to ca. 150 µm x 400 µm using a
micropipette enables enhanced spatial resolution analyses without the need for a laser, as
is required with MALDI [208]. The high signal-to-noise obtained for this analysis
suggests that much smaller spot sizes can be analyzed with appropriate matrix deposition
methods and faster introduction of the sample into vacuum. The multiple charging in

Figure 10.2. MAIV mass spectra acquired in (I) Positive ion mode: (A) 1 pmol leucine
enkephalin (molecular weight (MW) 555 Da), (B) 1 pmol MBP peptide (MW 1833 Da),
and (C) 50 fmol ubiquitin (MW 8559 Da) and (II) Negative ion mode: (A) ubiquitin, (B)
phosphorylated peptide cholecystokinin (10 –20) (MW 1332 Da), and (C) hirudin (55–
65) peptide (MW 1411 Da).
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MAIV aids the separation of the compound classes (proteins, peptides, and lipids) by
size, shape, number of charges, and m/z using IMS-MS.

Figure 10.3. MAIV-IMS-MS of a mouse brain tissue section using a commercial vacuum
MALDI source with the laser off: (A) photograph of application of matrix solution to a
section of mouse brain on a glass microscope slide, (B) two-dimensional IMS-MS plot of
drift time vs. m/z of ions showing separation of compound classes by charge, size, and
shape of lipids, peptides, and proteins. Insets show isotopic distributions of lipid and
protein ions, and (C) microscopy photograph of the mouse brain tissue before and after
ionization. Circled area shows the area on the tissue analyzed in B, and small arrows are
included to guide the eye for a better relative comparison of the photographs.
Mass spectrometers with vacuum MALDI sources are not a requirement for
MAIV, as ESI sources can be reversibly modified for MAIV operation. Figure 10.4A
shows a glass microscope slide (Appendix C Figure S1) onto which a microliter of
blood, diluted 1 part in 10 of water, mixed with 3-NBN matrix in ACN:water, and dried,
is held against the inlet of a modified ESI source of the SYNAPT G2 mass spectrometer
by the atmospheric-pressure-to-vacuum differential. Unlike with ESI, which detects
predominantly the α-subunit of hemoglobin [209], both the α- and β-subunits are detected
in good ion abundance from the blood spot using MAIV. Figure 10.4B shows the IMSMS plot of the gas-phase drift-time separated α- and β-subunit multiply charged
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molecular ions. The extracted mass spectrum of the β-subunit is shown in Figure 10.4C.
These results correlate well with blood spot results obtained with MAIV using the
SYNAPT G2 vacuum MALDI source, indicating the universal utility of this ionization
method with vacuum and atmospheric pressure ion sources.

Figure 10.4. MAIV-IMS-MS of a solvent-extracted blood spot from a Band-Aid using a
commercial atmospheric pressure ESI source with a modified skimmer cone to provide a
larger inlet aperture. (A) photograph of the device showing the isolation valve in the open
position with a glass microscope slide held by the pressure differential against the
skimmer opening, with the matrix– blood spot sample exposed to the vacuum initiating
ionization; more details on source modifications are provided in supplemental Appendix
C Figure S1. (B) two-dimensional IMS-MS plot of drift time vs. m/z of ions showing
separation of compound classes by charge, size, and shape: α-globin (MW 15,126 Da)
and β-globin (MW 15,866 Da) chains of hemoglobin. Both and chains of hemoglobin are
detected with MAIV in good ion abundance (mass spectral details in supplemental
Appendix C Figure S2), something that has been reported [209] to be problematic with
ESI (1). Extraction of the mass spectral information from the two-dimensional display in
B provides the individual mass spectra of the proteins, and (C) extracted full range mass
spectrum of the β-globin chain.
Using MAIV, sufficient ion abundance is obtained with the modified ESI source
to perform sequence characterization. ETD fragmentation of the quadruply charged
molecular ions of the acetylated N-terminal peptide fragment of myelin basic protein
provides complete sequence coverage (Figure 10.5) using the modified ESI source,
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identical to the principle shown in Figure 10.4A, of a linear ion trap LTQ Velos. An
expansion of the region between m/z 450 and 900 is shown in the inset, graphically
demonstrating the degree of fragmentation obtained with this method. ETD is more
applicable to the fragmentation of peptides and proteins than collision-induced
dissociation, but only with ionization methods that produce abundant multiply charged
ions [13, 14].
The similarity of the charge states of ions produced via MAIV and ESI suggests
similar mechanisms for their formation. A requirement for producing bare ions in ESI is
solvent evaporation from highly charged droplets, and MAIV may require matrix
sublimation from highly charged particles. A special property of 3-NBN, beside its ability
to sublime at ambient temperature when placed in vacuum [68], is triboluminescence
[69,70] producing unusually strong dinitrogen discharge emission under conditions in
which crystal fracturing occurs. This discharge is believed to result from a high electric
field created between fractured crystal surfaces having opposite charge [26]. In vacuum,
the fracturing would be driven by sublimation of the matrix or residual solvent, producing
charged particles that, upon sublimation of matrix, release analyte ions. 3-NBN matrix
particles are observed leaving the surface in vacuum. Other matrices have been found to
produce ions via MAIV, but none as well as 3-NBN.
This contribution represents the first example of a new ionization phenomenon
demonstrating that small and large molecules are transferred as ions from the solid phase
to the gas phase under vacuum conditions, without the application of external energy or
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Figure 10.5. MAIV using the LTQ Velos ESI source to perform ETD fragmentation of
the MBP peptide +4 charge state ion (m/z 459). Top, total fragment spectrum; bottom,
inset m/z 400–900. Sequence coverage is increased relative to previous ETD studies of
this peptide [48]. Red numbers indicate the charge state, and blue numbers the ion
abundance. Sequence coverage is provided (top).
fields, apparently via a sublimation-driven process. Multiply charged ions are produced
from the solid state with high sensitivity, giving MAIV advantages of both ESI and
MALDI. Analyses of surfaces of biological tissue, thin layer chromatography plates, and
one- and two-dimensional gels are logical applications. MAIV, requiring only the
vacuum necessary for the proper functioning of the mass spectrometer, might be
applicable with common electron/chemical ionization mass spectrometers, with the
filament used for ionization turned off. The simplicity and wide applicability of MAIV
also might prove useful in clinical settings and in field portable instruments.
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CHAPTER 11
MATRIX ASSISTED IONIZATION IN VACUUM, A SENSITIVE AND WIDELY
APPLICABLE IONIZATION METHOD FOR MASS SPECTROMETRY “Springer
and the original publisher (J. Am. Soc. Mass Spectrom., 24, 2013, 722-732, Trimpin, S.,
Inutan, E.D.) is given to the publication in which the material was originally published
with kind permission from Springer Science and Business Media.”

Introduction
Vacuum ionization coupled to mass spectrometry (MS) is highly sensitive and has
enormous potential [23], but relative to ambient ionization methods, progress in this area
has

been

relatively

slow

since

the

introduction

of

matrix-assisted

laser

desorption/ionization (MALDI) [2,3]. Important developments include intermediate
pressure vacuum MALDI [75,136], solvent-free MALDI [30,72], surface enhanced LDI
[210], the application of MALDI in imaging [111,146], soft laser desorption [211-213],
and cluster beam methods [214-217], all of which produce singly or low charge state
ions. However, the ability to produce high charge state ions under vacuum conditions
would expand analytical capabilities to high performance mass spectrometers that have
limited mass ranges, would enable advanced fragmentation technology for improved
characterization, and would have the potential to maximize signal-to-noise in complex
samples [23,202]. Vacuum ionization approaches are promising in terms of applications
because ion transmission losses inherent with atmospheric pressure ion sources are
eliminated [24], thus, potentially enhancing sensitivity [23].
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Highly charged quasi-molecular ions have been observed under sub-ambient
pressure using electrospray ionization (ESI) [218], and in low abundance, using an
explosive matrix with plasma desorption MS [219,220]. Inlet ionization was described, in
which multiply charged ions were produced under sub-ambient conditions inside a heated
inlet tube connecting the atmospheric pressure ionization region and the first vacuum
region of a mass spectrometer. Mass spectra nearly identical to those produced in ESI
were obtained by laser ablation of matrices common to MALDI [28,29], or by using
physical forces to dislodge the matrix/analyte into the inlet from a surface [39,194].
Introduction of solubilized analyte into the heated inlet also produced multiply charged
ions [221,222]. Concepts learned from these inlet ionization methods enabled discovery
of methods for producing highly charged ions of peptides, proteins, and polymers at
intermediate [42] and low pressure [44] using laser ablation of certain matrix compounds.
Here, we report the rather astonishing discovery [46] of matrix compounds that
produce positive or negative analyte ions simply by placing the matrix/analyte sample
directly in vacuum in the absence of a laser, high voltage, or even added heat. We have
termed this method matrix assisted ionization vacuum (MAIV). MAIV has been shown
to operate in the positive and negative ion modes and to produce ions from a variety of
compound classes including drugs, lipids, peptides, and proteins with high sensitivity.
Besides the analytical utility of MAIV, this work demonstrates that a laser is not a
requirement for ion formation in vacuum, just as it was not required for inlet ionization
using matrices common with MALDI [40,45].
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Experimental Procedure
Analyte solutions were diluted with water, with the following exceptions:
lysozyme was diluted using 25 mM ammonium acetate in 10 % MeOH, 50:50
ACN/water with 0.1 % TFA was used with β-amyloid (1-42) for positive mode
measurements and 50:50 MeOH/water was used for negative mode measurements. Final
concentrations of all analyte solutions ranged from 1 to 10 pmol μL-1. PEG-DME 2000
was doped with LiCl (10 % by volume from a 1 M LiCl solution). The small molecule
model

mixture

composed

of

5 pmol μL-1 each

of

clozapine,

Leu-enkephalin,

sphingomyelin, angiotensin II, ACTH, and bovine insulin was prepared in water. The
large molecule model mixture in addition contained Leu-enkephalin, sphingomyelin,
galanin, bovine insulin, and ubiquitin. The higher mass protein mixture contained
5 pmol μL-1 each of lysozyme (added from 25 mM ammonium acetate in 10 % MeOH)
and ubiquitin, and 10 pmol μL-1 of myoglobin.
For testing the different compounds for use as MAIV matrix, solutions were
prepared by dissolving 5 mg of the matrix compound in 100 μL of 50:50 ACN/water. The
3-nitrobenzonitrile (3-NBN) matrix was also dissolved in 150 μL of 50:50 ACN/water
with 0.1 % formic acid and 50 μL 100 % ACN with 0.1 % formic acid. For positive mode
measurements, the matrix/analyte mixture was prepared (1:3 v:v) using 3-NBN in 100 %
ACN with 0.1 % formic acid; for negative mode, the ratio was 1:1 v:v using 3-NBN in
50:50 ACN/water with 1 % ammonium hydroxide. Coumarin was also prepared by
dissolving 5 mg in 50 μL of 50:50 ACN/water with 0.1 % formic acid and 2,5-DHAP in
150 μL of 50:50 ACN/water with 0.1 % formic acid (warmed).
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From a given matrix/analyte mixture, 1 μL was typically spotted on the target
plate using the dried droplet method. For matrix assisted ionization inlet (MAII) and
MAIV using a custom modified ESI source, 1 μL of the analyte was spotted on a glass
plate and 2 μL of 3-NBN matrix was added and air-dried, as previously described [40]. A
similar procedure was used with 2,5-DHAP and coumarin. For the glass capillary
experiments, the capillaries were partially filled with acidified 3-NBN matrix containing
an equal volume of analyte solution. The sample was allowed to dry before taping the
capillary to a modified MALDI sample plate.
A number of surfaces were analyzed by taping different materials (e.g., currency,
filter paper, KimWipe (Kimberly-Clark Professional, Roswell, GA USA) tissue, plastic,
aluminum foil, and thin layer chromatography (TLC) plates) onto a MALDI modified
plate; each surface was spotted with 1 μL of matrix/analyte. Solvent-free sample
preparation was employed as previously described using angiotensin I [223]. In brief,
metal beads (1.3 mm, BioSpec Products, Inc., Bartlesville, OK, USA) and matrix powder
were combined in a vial in which analyte had been added in solution and completely
dried. Homogenization/transfer of the matrix/analyte to the glass plate was accomplished
using a TissueLyser II (Qiagen Inc., Valencia, CA, USA) with a 30 Hz frequency and a
duration of 10 minutes. Binary matrices were prepared according to published procedures
[40,44] using 3-NBN and α-cyanohydroxycinnamic acid (CHCA). Partially dry and wet
samples were introduced to the vacuum of the mass spectrometer in a glass capillary and
on a metal plate. Some 3-NBN/analyte samples were frozen in the wet state on the
MALDI plate at -80 °C and immediately placed in vacuum for analysis.
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Matrix Assisted Ionization Vacuum (MAIV) - MAIV-MS was performed on IMS-MS
SYNAPT G2 mass spectrometer (Waters Co.) operated in the positive, negative and
sensitivity (V) modes. For MAIV using the commercial vacuum MALDI source, the
source was operated without firing the laser (Scheme 1.1.IIB and 2.3) as described in
details in Chapter 2.4. The dried and in some cases slightly wet matrix/analyte mixtures
were individually loaded into the source vacuum (0.226 mbar) requiring ∼2 min to load.
Glass tubes and other surfaces, such as a currency bill, were introduced to the vacuum
source using the commercial MALDI plate holder and moving stage. Ionization from the
cold (from -80 °C) and glass tube experiments lasted for 10 and 30 min, respectively. For
MAIV using the commercial ESI source, the skimmer cone of the z-spray was first
modified by inserting a small ferrule to the normal outer cone of the skimmer. The glass
plate with the matrix/analyte spot was placed tight to the ferrule facing the source
entrance. The matrix/analyte crystals were drawn by the pressure differential between the
atmospheric pressure and the instrument vacuum. Ions were observed once the
matrix/analyte crystals were drawn by the vacuum of the mass spectrometer. The ESI
source block temperature was set to 80 °C and was operated with default ESI settings. In
the second version as described in Chapter 2.4, the inner cone opening was widened to
about ~3 mm and the outer cone was widened to about ~4.5 mm with a ferrule inserted
forming vacuum seal between the glass plate and the inner cone; in this case, the vacuum
was protected by keeping the isolation valve closed until the sample was loaded (Scheme
2.4). For sensitivity comparison between MAIV and ESI, 5 fmol clozapine in 50:50
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MeOH/water was used depositing 1 μL in 3-NBN for MAIV and for ESI using an
infusion flow rate of 1 μL min-1 for 1 min.
Matrix Assisted Ionization Inlet (MAII) - MAII-MS was performed on a LTQ Velos
mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) with commercially
available inlet temperature control using inlet temperatures of 50 to 450 °C as previously
reported (Scheme 1.1.IB).[40]
Results and Discussion
Introduction of analyte, incorporated in the matrix 3-NBN into the vacuum of the
mass spectrometer produces ions from small molecules as well as proteins without the
need of a laser voltage, other than that necessary for ion transmission, or heating the
sample. A typical example using the SYNAPT G2 vacuum MALDI source is shown in
Figure 11.1a where multiply and singly charged ions, similar to ESI, are observed with
good resolution and abundance from a mixture containing the lipid sphingomyelin,
peptides Leu-enkaphelin, and galanin, and small proteins insulin and ubiquitin. This
example demonstrates the breadth of the MAIV method to ionize differing compound
classes over a wide mass range. Ions were produced until the matrix was no longer
observed on the commercial sample plate. The MAIV mass spectrum of lysozyme is
shown in Figure 11.1b, but using a binary matrix mixture containing only 20% 3-NBN in
CHCA matrix solution, corresponding to a molar ratio of 1.6:1 molar ratio of 3NBN:CHCA. By incorporating a less volatile matrix with the more volatile 3-NBN, the
time over which ions are observed was increased. Snapshots of the plate taken about 2
and 3 min after introduction to vacuum shows loss of matrix from the surface with
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increasing time (Appendix C Figure S4). A video of the ionization process is provided
online as Supplemental (‘MAIV on MALDI source video I’).

Figure 11.1. MAIV mass spectra using the vacuum MALDI source of: (a) a mixture of
sphingomyelin (molecular weight, MW 703 Da), leu-enkephalin (MW 555 Da), galanin
(MW 3156 Da), bovine insulin (MW 5731 Da), and ubiquitin (MW 8561 Da), (b)
lysozyme (MW 14.3 kDa) using binary matrix mixture of 3-NBN and CHCA in 1.6:1
molar ratio using the SYNAPT G2 intermediate pressure MALDI source, and (c) is the
same sample obtained on the SYNAPT G2 modified ESI source. Isotopic distributions
are shown in Appendix C Figure S3. Blue numbers in upper right corner of each
spectrum provide relative ion abundance and red numbers the charge states.
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The MAIV matrix, 3-NBN, was discovered while testing compounds having
characteristics similar to 2-nitrophloroglucinol (2-NPG), the best matrix found to
produce multiply charged analyte ions using MAII [40,194], and one that requires a
relatively low inlet temperature for ion production [45]. Importantly, 2-NPG was also
shown to produce multiply charged ions using laser ablation under vacuum conditions
[44,45]. Of the compounds tested (Table S1.I, Scheme 1.1.IB), 3-NBN was found to
produce highly charged ions of acidified insulin by MAII at an inlet temperature of 50 °C
and with maximum abundance at ca. 100 °C (Appendix C Figure S5). This is contrary to
other matrix compounds (>100) useful for inlet ionization for which good ion abundance
is only obtained at much higher inlet temperature [40] using the same mass spectrometer.
Thus, the thermal requirement for 3-NBN matrix to produce abundant analyte ions from
atmospheric pressure is low.
This matrix was therefore deemed to be a potential matrix for producing highly
charged ions on atmospheric pressure ionization mass spectrometers lacking a heated
inlet as well as with vacuum MALDI ion sources which are postulated to need matrix
volatility to produce multiply charged ions through desolvation of charged matrix
droplets/clusters that are produced by laser ablation [45]. 3-NBN was therefore employed
with a homebuilt modification to the SYNAPT G2 skimmer cone inlet, which allowed
rapid testing of matrices using laser ablation of the sample under vacuum conditions. In
this approach, a connecting ferrule was constructed at the inlet skimmer cone of the ESI
source (Scheme 2.4), which made a sufficient vacuum seal to hold a glass microscope
slide. Matrix/analyte was placed on the vacuum side of the glass slide with the intention
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of ablating the sample using a focused beam from a nitrogen laser fired in transmission
geometry.
Surprisingly, a mass spectrum of insulin was obtained without the laser. A larger
inner and outer cone opening was subsequently shown to provide improved vacuum
when sealed using the glass slide, as judged by the force with which the slide is held to
the modified mass spectrometer entrance (Appendix C Figure S6). The larger opening
also achieves substantially improved ion abundance (Figure 11.1c) and more rapidly (a
few seconds, Appendix C Figure S6) than the smaller opening. A video of the process is
provided online in the Supplemental (‘MAIV on ESI source video II’). Introducing the
same matrix/analyte sample composition into the intermediate pressure vacuum MALDI
source of the SYNAPT G2 produced very similar mass spectra to those observed with the
sealed atmospheric pressure inlet but requires longer introduction time and
sublimation/evaporation of the matrix/analyte sample is slower. This, to our knowledge,
is the first example of matrix assisted ionization requiring only vacuum conditions, which
are available with any mass spectrometer.
A number of compounds similar to 3-NBN were also examined for their potential
as MAIV matrices to ionize insulin and ubiquitin. Using the same acquisition settings and
insertion of the matrix/analyte into a vacuum MALDI source without the use of a laser, 3NBN performed exceptionally well, 2-NBN showed reasonable analyte ion abundance,
and 4-NBN produced no ions (Appendix C Figure S7). A visually apparent difference is
that 3-NBN sublimes quickly in the SYNAPT G2 MALDI source and is completely
removed from the sample plate after roughly 5 min followed by 2-NBN, and then 4-
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NBN, which could still be observed on the plate with no visual differences after 1 h. Even
with laser ablation, 4-NBN does not produce the desired analyte ions. Of the isomers of
NBN and nitrobenzaldehyde, 3-NBN and 4-nitrobenzaldehyde are reported to sublime
under vacuum conditions [68]. Of the nitrobenzaldehyde isomers (Appendix C Figure
S8), only 1,3-nitrobenzaldehyde produces ions of angiotensin I under the conditions
employed, but with low ion abundance. The best results with this matrix were obtained
when the matrix:analyte was prepared solvent-free. Morphology changes during the
prolonged grinding of matrix/analyte in the solvent-free preparation [223] may be related
to matrix melting aiding incorporation of analyte.
With 3-NBN matrix containing insulin on the MALDI sample plate, multiply
charged quasi-molecular analyte ions are detected with the mass spectrometer while
simultaneously observing the matrix through the optical microscope camera display
available with the SYNAPT G2 MALDI source. The footprint of the matrix decreases
with time due to sublimation and the detected ion abundance similarly decreases. No ions
are observed once there is no visible matrix. The ability of the matrix to sublime or
evaporate is apparently critical for producing ions of nonvolatile analyte molecules, but
can also be a hindrance because the matrix must not sublime/evaporate too rapidly or it
will not survive the ca. 2 min introduction period from atmospheric pressure to vacuum
of the commercial MALDI source. There are a number of ways to partially circumvent
the rapid sublimation besides use of binary matrix mixtures (Figure 11.1b), including
cooling the sample plate to -80 °C before insertion to vacuum (main ion abundance
postponed to ~2.5 min, Appendix C Figure S9b), and placing the sample in capillaries
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which restricts the rate of sublimation by reducing the matrix surface exposed to vacuum
(ion abundance extended to ~30 min, Appendix C Figure S10). A problem with current
vacuum MALDI sources is that, because of sublimation, only one sample can be placed
into vacuum at a time. However, a modified atmospheric pressure ionization source
(Scheme 2.4) allows rapid analysis of samples by MAIV (Figure 11.1c).
Mechanistic Considerations
Under vacuum conditions, the matrix, as noted above, appears to sublime from
the surface until it is no longer observed. However, placing a glass plate near 3-NBN
under low pressure conditions does not result in a thin even layer of matrix collecting on
the surface as would be expected for sublimation, but in numerous small particles, which
can be observed using an optical microscope at 50× magnification. One possibility for the
observed ejection of particles is the cooling of the surface in vacuum due to the latent
heat of sublimation causing surface splintering, and may be similar to charged ice
particles observed to be ejected from freezing water droplets [224]. Alternatively,
sublimation/evaporation of the matrix, or trapped solvent, under vacuum conditions may
contribute to ejection of matrix particles from the surface.
Charged solvent droplets in ESI and solvent assisted ionization inlet (SAII)
[221,222] and charged matrix droplets/particles in MAII are proposed to be responsible
for producing similar charge state distributions to those observed with MAIV. Producing
charged droplets or particles is common in nature. For water droplets and ice crystals, it
has been shown that a cold subliming/evaporating surface has an excess of positive
charge and a warm condensing surface an excess negative charge [224]. The dislodging
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of the surface of ice crystals [225] carrying excess surface charge is believed to be the
source of electrification of thunderclouds [224]. Thus, the observed 3-NBN particles, by
a similar mechanism may be ejected having an excess of the surface charge. Such a
charging mechanism occurring from the surface rather than individual particle is
problematic for explaining continuous ionization and observation of both positive and
negative ions.
Another characteristic of 3-NBN that could lead to charging of the ejected
particles is dinitrogen discharge emission (triboluminescence) during crystal fracturing
[69,70]. Triboluminescence [226,227] is known to occur when 3-NBN undergoes a
fracturing process [69,70]. The emitted light, referred to as lightening, is caused by
electric charge of opposite sign being produced on opposing surfaces of a crack in the
crystal. The electric field caused by these charges is sufficiently high to initiate a
discharge at atmospheric pressure, and thus it seems reasonable that the process of
splintering matrix particles from the 3-NBN surface could create charges. The particles
ejected from the matrix surface could also splinter, creating smaller charged particles. In
the case of 3-NBN, once the charged particles are formed, matrix sublimation, similar to
solvent evaporation in ESI, would also be required to release the bare analyte ions.
Sublimation/evaporation of the charged solid particles could release analyte ions by the
charge residue mechanism [51], or possibly a modified ion evaporation mechanism [52].
However, without addition of thermal energy, it seems unlikely that the matrix could
convert to molten droplets [31] or molten clusters [197] as previously observed for LSII
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and modeled for vacuum MALDI [36,37]. Thus, multiply charged ions must be produced
directly from the solid state.
Sublimation/evaporation of the charged particles appears to be rapid based on
similar ion abundances with and without the use of the IMS TriWave Technology of the
SYNAPT G2 mass spectrometer (Appendix C Figure S11). Thus, with 3-NBN, the bare
ions are already formed before they reach the TriWave device. This was not the case for
laser ablation of 2,5-DHAP matrix, where desolvation appears to occur as late as the IMS
region [42].
According to the above scenario, a successful MAIV matrix requires both a
fracturing mechanism that produces charged particles and either sublimation or
evaporation to release bare ions. Conditions of pressure and temperature will affect both
charge generation and ion release. Therefore, the number of successful MAIV matrices
may be restricted in the absence of heat and proper vacuum conditions. A means of
supplying thermal energy under vacuum conditions may increase analyte ion abundance
and expand the compounds that act as MAIV matrices. This hypothesis is based on the
fact that heating the mass spectrometer inlet tube in MAII to 450 °C produced multiply
charged ions for peptides and proteins with well over 100 small molecules tested as
matrices [40].
A number of compounds tested show sublimation (Table S1.I) but no analyte
ions are formed using MAIV conditions. Several compounds that triboluminescence were
also examined, but did not sublime visually from the surface of the sample holder and
produce no ions by MAIV (Table S1.II). However, like 3-NBN, coumarin is a
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triboluminescence compound [228] that sublimes [229] in vacuum and produces multiply
charged analyte ions in the SYNAPT G2 MALDI source and ESI source (Appendix C
Figure S12) similar to 3-NBN. On the other hand, 2,5-dihydroxyacetophenone (2,5DHAP) matrix does not produce ions in the intermediate pressure vacuum MALDI
source without laser ablation and requires added heat to produce analyte ions using the
modified ESI source (Appendix C Figure S13). Based on these results, we hypothesize
that MAIV is a sublimation/evaporation-driven triboluminescence process leading to
analyte ionization.
Fundamentally interesting is that larger proteins are efficiently ionized with
MAIV, with and without acidifying the matrix or analyte solutions, and, because of
multiple charging, can be analyzed on a mass range limited mass spectrometer having a
commercial MALDI source. Higher charge state ions are obtained when the
matrix:analyte sample is introduced to the vacuum source with some solvent still present.
Myoglobin (Figure 11.2a) is found to produce up to +22 charges and carbonic anhydrase
(Figure 11.2b) up to +31 charges. Observation of multiply charged ions of proteins using
matrix assisted laser ablation in a vacuum MALDI source (Scheme 1.1.IIA) was limited
at high mass to ionization of ubiquitin using 2,5-DHAP as matrix [42]. However, the
MAIV results for carbonic anhydrase are similar to those obtained with MAII [194] or
LSII [138] (Scheme 1.1.I). This seems to indicate a similar ionization mechanism, but in
MAII and LSII ionization occurs in a heated inlet to the mass spectrometer, whereas in
MAIV ions are produced under cold vacuum sublimation conditions. ESI and SAII also
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produce similar mass spectra of proteins [221] demonstrating that ion formation from
charged droplets and charged particles produce similar results.

Figure 11.2. MAIV-IMS-MS of (a) myoglobin (MW ∼17 kDa) and (b) carbonic
anhydrase (MW ∼29 kDa) with 3-NBN matrix using the intermediate pressure vacuum
SYNAPT G2 MALDI source. Blue numbers in upper right corner of each spectrum
provide an indication of ion abundance and red numbers the charge states.
Applications
The sensitivity of MAIV is demonstrated by a comparison using ESI and MAIV
of 5 fmol consumed of clozapine, a schizophrenia drug (Figure 11.3). The isotopic
distribution is readily discerned for MAIV but not ESI because of the chemical
background observed with ESI. Cooling the plate slows matrix loss during the ca. 2 min
sample plate introduction period allowing observation of sub-fmol of clozapine using
MAIV on the vacuum MALDI source (Appendix C Figure S14).
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Figure 11.3. Mass spectra of 5 fmol clozapine (MW 326 Da) using: (a) MAIV on an
intermediate pressure vacuum MALDI source with 3-NBN matrix and (b) an ESI source
in 50:50 MeOH:water. Insets show isotopic distribution of clozapine and its chemical
structure. Numbers in red are clozapine ions reflecting the expected chlorine isotopic
distribution. Blue numbers in upper right corner of each spectrum provide an indication
of ion abundance and red numbers indicate the isotopic distribution.
MAIV is also broadly applicable to a wide range of compounds. Because of
multiply charging, MAIV works well with advanced methods such as IMS. The twodimensional dataset of drift time vs. mass-to-charge (m/z) separations for the MAIV-IMSMS measurement of a mixture of compounds is shown in Figure 11.4Ia.
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Figure 11.4. MAIV-IMS-MS of a mixture of (I) clozapine (MW 326 Da), sphingomyelin
(MW 702 Da), leu-enkephalin (MW 555 Da), angiotensin II (MW 1040 DA), ACTH
(MW 2465 Da), and bovine insulin (MW 5731 Da), and (II) ubiquitin (MW 8561 Da),
lysozyme (MW ∼14.3 kDa), and myoglobin (MW ∼17 kDa) in 3-NBN matrix using the
SYNAPT G2 intermediate pressure vacuum MALDI source: (a) two-dimensional plot (2D) of drift time vs. m/z, (b) total mass spectrum, and (c) extracted mass spectrum from
the 2-D plot of the least abundant component from (b). Other extracted mass spectra are
displayed in Appendix C Figure S15. Blue numbers of each spectrum provide an
indication of ion abundance; other colors indicate the charge states.
The charge states +1 (clozapine MW 326, sphingomyelin MW 702, Leu-enkephalin MW
555), +2 (ACTH MW 2465, angiotensin II MW 1040), and +3 (ACTH, insulin MW
5731) are well separated from each other and from the higher charge states (+4 and +5)
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from bovine insulin. The mass spectrum of this mixture (Figure 11.4Ib) show
exceptional quality both in terms of ion intensity across the mass range for all mixture
components and low chemical background. Making use of the two-dimensionality of the
dataset allows clean mass spectra to be extracted for any of the component of the mixture
(e.g., ACTH, Figure 11.4Ic). IMS-MS can also be used to separate proteins that are
beyond the m/z range of the instrument. Figure 11.4II demonstrates this capability with a
mixture containing the proteins ubiquitin (~8.5 kDa), lysozyme (~14.3 kDa), and
myoglobin (~17 kDa). The cleanly extracted mass spectrum for the least abundant
component, lysozyme, is shown in Figure 11.4IIc.
A variety of other compounds have been analyzed using the MAIV method on the
commercial vacuum MALDI source of the SYNAPT G2 without the use of the laser. For
example, the low solubility β-amyloid (1-42) peptide produces abundant multiply
charged ions using MAIV in the positive (most abundant charge state +4, Figure 11.5a)
and negative (most abundant charge state -3) modes (Figure 11.5b). Arachidonic acid
produces abundant negative singly charged ions (Figure 11.5c). PEG-DME 2000 doped
with LiCl produces multiply cationized molecular ions (Figure 11.5d). Similar to ESI,
small molecules such as the illicit drug cocaine (Appendix C Figure S16a), the pesticide
foramsulfuran (Appendix C Figure S16b), and the D-mannopyranose derivative
(Appendix C Figure S16c), produce singly charged ions with MAIV from the solid state
in vacuum and with relative little chemical background ions. The background ions
observed in MALDI-MS at every mass has been shown to be related to charged matrix
clusters [94]. The low background in MAIV-MS may be related to the absence of laser
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ablation. Ions related to the matrix and, possibly, matrix and solution impurities are
observed in MAIV, but only at a relatively few masses (e.g, m/z 328 and 415).

Figure 11.5. MAIV-IMS-MS of beta-amyloid (1-42) (MW 4511 Da) (a) positive and (b)
negative mode measurements, (c) arachidonic acid (MW 304 Da) in negative mode, and
(d) PEG DME 2000 doped with 10 % 1 M LiCl in positive mode using the intermediate
pressure vacuum SYNAPT G2 MALDI source. Insets show isotopic distributions. Red
numbers indicate the charge states of the negatively and positively charged analyte ions.
Other applications show MAIV to be useful for the analysis of molecules from
native surfaces such as mouse brain tissue [46]. Synthetic surfaces can also be sampled in
this manner (e.g., TLC plate, tissue, and filter paper, Appendix C Figure S17).
Characterization of cocaine from paper currency using MS (Figure 11.6a), IMS
(Figure 11.6b), and MS/MS (Figure 11.6c) was achieved by application of 2 μL of
matrix solution on the eye of President Jackson and introducing the $20 bill folded and
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attached to the sample plate into the intermediate pressure vacuum MALDI source of a
SYNAPT G2 mass spectrometer.

Figure 11.6. Surface analysis by MAIV (a) MAIV mass spectrum from a $20 bill spotted
with 3-NBN matrix and acquired using the intermediate pressure vacuum SYNAPT G2
MALDI source, (b) extracted drift time, and (c) collision-induced dissociation mass
spectra of illicit drug cocaine (MW 303 Da) detected from (1) $20 bill and (2) standard
cocaine. MS/MS fragmentation pattern is essentially identical to [298]. The other major
component detected from the surface of the bill with a repeat unit of 58 indicates
polypropylene glycol. Blue numbers of each spectrum provide an indication of ion
abundance and red numbers the charge state.
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The results were compared with those obtained from a cocaine standard prepared on a
glass slide and with MS/MS results described in the literature [230]. Cocaine has been
analyzed directly from currency by a number of ambient ionization methods [231,232],
but with MAIV, the location sampled is readily defined by the matrix application.
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Introduction
Identifying clinically relevant health and disease biomarkers is often like
searching for the proverbial needle in a haystack. Mass spectrometric approaches are well
suited for such a search because they can interrogate complex biological matrices at the
molecular level with superb sensitivity, mass resolution, and mass accuracy. However,
improved sensitivity and dynamic range, as well as reproducibility from sample to
sample, are required for many clinically relevant applications. The extreme complexity
that comes with clinical samples combined with the pressure of accuracy, time and cost
constraints requires that operator involvement be limited as much as possible. While
tandem mass spectrometry (MS) targeted screening has been very successful, it requires
expertise in operation, data interpretation, and is time consuming because it is usually
preceded by liquid chromatography (LC) or gas chromatography (GC), methods that can
be prone to column fouling, and additionally the targeted approach does not detect non-
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targeted molecules. LC-MS has significantly impacted analyses of complex biological
materials such as tissue, plasma, and urine [233-246]. However, this technology has had
only limited success in clinical applications. It is generally accepted that clinical MS
analysis needs more efficient and simple ionization, and ideally, real time separation
orthogonal to MS for additional specificity. Ion mobility spectrometry (IMS), especially
combined with MS, has emerged as a powerful method for separating ions, without the
use of a solvent, according to number of charge, size, and shape. Near real time
separation is achieved and molecular shape information is available using cross-section
analysis [61,64,67,247-262]. Additional characterization technologies can be applied
such as MS/MS using collision induced dissociation (CID) or electron transfer
dissociation (ETD) [58,100,263,264].
MS ionization methods are powerful, but problematic for many clinical
applications for reasons including cost, robustness, degree of difficulty, and interference
from the generation of high background ions. In the past decade, numerous ‘ambient
ionization’ sampling strategies have been implemented using established ionization
methods to circumvent some of these issues [139,232,265-267]. Heretofore unknown
ionization methods for MS have recently been discovered and fundamental studies are
starting to define physical underlying processes [29,31,40,45,197]. These new ionization
methods encompass inlet ionization with a laser, laserspray ionization inlet (LSII)
[28,49], and without a laser, matrix assisted ionization inlet (MAII) [39,194], or with a
solvent, solvent assisted ionization inlet (SAII) [221,222,268,269], as well as
the vacuum ionization methods of laserspray ionization vacuum (LSIV) [42-44], and
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matrix assisted ionization vacuum (MAIV) [46,47,]. These methods are sensitive, operate
from atmospheric pressure or vacuum, and are applicable for low and high mass analytes
in the solid phase or in solution. Charge states similar to electrospray ionization (ESI) are
produced, and on high performance mass spectrometers yield high resolution, accurate
mass measurement, charge state resolved IMS-MS, and/or advanced fragmentation for
structural characterization. Of these new ionization methods, MAIV stands out as being
exceptionally simple, requiring no high voltage or laser, and operates at room
temperature or with heat, ionizing a variety of different compounds from fatty acids to a
protein complex [46,47]. We previously hypothesized that the underlying mechanism of
MAIV may be a sublimation driven triboluminescence like process [46,47]. Four
different MAIV matrix compounds have been discovered, 3-nitrobenzonitrile (3-NBN),
2-nitrobenzonitrile, 3-nitrobenzaldehyde, and coumarin [47], but none work nearly as
well as 3-NBN. Here we show initial results to analytical utility using MAIV in
conjunction with real-time separation by IMS, MS, and MS/MS, which suggests a future
of this methodology in clinical applications.
Experimental Methods
Materials and sample preparation are included in Chapter 2.1. Nicotine and its
metabolite standards and the smoker’s urine were provided by DMC (Detroit, MI).
Cetirizine, an allergy medication, was purchased as tablets from a pharmacy and taken
orally (human) and subsequently used for urine analysis. Dilutions from stock solutions
were made in water for most of the analytes, in 50:50 methanol/water for clozapine, and
in 25 mM ammonium acetate in 10 % methanol for lysozyme to make 1 to 5 pmol μL-1
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concentrations. The analyte concentrations in the model mixture of lipids, peptide, and
proteins ranged from 1 pmol μL-1 (sphingomyelin, leucine enkephalin, angiotensin II) to
5 pmol μL-1 (galanin, bovine insulin, ubiquitin) and the small molecule mixture ranged
from 1 to 8 pmol μL-1. The protein mixture contained 5 pmol μL-1 lysozyme and
10 pmol μL-1 myoglobin. The mixture for negative mode measurements contained bovine
insulin (2 pmol μL-1), beta amyloid (1–42) (5 pmol μL-1) and ubiquitin (10 pmol μL-1).
Clozapine, angiotensin I, and ubiquitin were diluted in 1 M NaCl for the salt studies.
Clozapine was diluted in water and 50:50 methanol/water for solvent and pH studies of
small and large molecules with 3-NBN added with and without formic acid. 3-NBN
matrix was prepared by dissolving 5 mg in 50 μL 100 % ACN with and without 0.1 %
formic acid, 150 μL 50:50 ACN/water with 0.1 % formic acid (mixing and deposition on
tissue), and 50 μL 50:50 ACN/methanol with 0.1 % formic acid (small molecule mixture)
for positive mode measurements, and 150 μL 50:50 ACN/water with 1 % NH4OH
(MAIV and ESI comparison) and 50:50 ACN/methanol with 1 % NH4OH for negative
mode measurements.
The dried droplet method was used to prepare 1 μL spots of analyte:matrix
mixture in 3:1 and 2:1 volume ratio for positive and negative measurements, respectively.
For tissue analysis, sections of a non-drug and drug treated mouse brain tissue were
collected and mounted on a glass microscope slide as previously described in Chapter
2.1 and in previous studies.[48,195] The mouse received clozapine (50 mg kg−1,
intraperitoneal) 90 min before it was sacrificed. Clozapine plasma was obtained by
centrifugation of heparinized blood collected by cardiac puncture from treated mouse
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after euthanasia. A 25 μL volume of the plasma was concentrated by evaporation in the
biodryer without heat and redissolved in 10 μL water. A total of 1 μL of 3-NBN matrix in
50:50 ACN:water with 0.1 % formic acid was spotted in 0.2 μL increments. Small
sections of tissue removed from the glass plate were also dipped in 3-NBN matrix
solution and spotted directly on the sample target plate. For the human body fluids
analysis, separately 10 μL of the drug dosed urine and blood (extracted with water from
an adhesive bandage) was diluted to 100 μL with water. The smoker’s urine (5 μL) was
directly combined with the 3-NBN solution. Isomeric mixture of 5 pmol μL-1 betaamyloid (1–42) and 2 pmol μL-1 (42–1) was prepared in 50:50 ACN/water with 0.1 %
TFA. For the matrix assisted laser/desorption ionization (MALDI) comparison, 5 mg of
CHCA was dissolved in 1 mL of 50:50 ACN/water with 0.1 % formic acid and mixed
with the analyte in 1:1 volume ratio. For ESI comparison, 10 pmol μL-1 of beta-amyloid
(1–42) in 50:50 MeOH/water was used at an infusion flow rate of 4 μL min-1 for 30 s.
Ion mobility spectrometry (IMS)-MS - An IMS-MS (SYNAPT G2) mass
spectrometer (Waters Co., Manchester, UK) was used in this study. The mass
spectrometer was operated in the positive, negative and sensitivity (‘V’ optics of the
time-of-flight mass analyzer) modes. The IMS drift cell pressure was set at ~3.7 mbar.
Argon was used as the collision gas for MS/MS in the transfer region. MassLynx 4.1
software was used to extract the mass spectrum and DriftScope version 2.2 for the IMS 2dimensional (2-D) display of drift time (td ) vs. mass-to-charge (m/z) using a color
background of hot metal or emerald forest and square root display. Nested datasets of
drift(flight)time in units of td(m/z) were used as previously defined [67,270]. BayesSpray

149

from MaxEnt methods [271] was used to deconvolute the multiply charged ions to mass
values.
Matrix assisted ionization vacuum (MAIV) MALDI source SYNAPT G2 - The IP-MALDI source of SYNAPT G2 was used
to perform MAIV using a vacuum source as described in Chapter 2.4. Unless otherwise
noted, the data were acquired using ‘LSI settings’ as previously reported [42,45] similar
to those used with ESI with the extraction lens at a lower voltage than used with the
default ‘MALDI settings’. The default ‘MALDI settings’ [45] of the vacuum MALDI
source were used to obtain comparison mass spectra and proteins from tissue. In both
operation modes, no laser was used and acquisition times were set at a scan time of one
second for a period of 1 to 2 min. ESI source SYNAPT G2 - The interlocks of the ESI
source of SYNAPT G2 were overridden using the connecting flange available with the
MALDI source of the instrument to allow open access to the Z-spray skimmer cone;
however, MAIV acquisition can also be obtained using the nano-ESI source as previously
described for LSI [49,50]. The Z-spray skimmer cone was modified as described in
Chapter 2.4 to perform MAIV on an ESI source. The source temperature was set at
50 °C with a sample cone voltage of 40 V and extraction cone voltage of 4 V, similar to
ESI source settings.
Conventional ionization methods
MALDI - The intermediate pressure MALDI source of SYNAPT G2 was
operated using a Nd:YAG laser (355 nm, 200 Hz). Default ‘MALDI settings’ [45] were
used in sensitivity mode with 20 V on sample plate holder and a laser power of setting of
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‘225’ or ca. ~12.5 J cm-2. ESI - Acquisition conditions were set similar to MAIV using
the MALDI source but with capillary voltage of 2.5 kV, desolvation gas flow of
500 L hr−1, and 80 °C source temperature.
Results and Discussion
The MAIV method depends only on an appropriate matrix and the vacuum
conditions common to mass analyzers. Thus, this method is applicable on either a
commercial intermediate pressure MALDI source (Appendix C Figure S18.I) or an ESI
source with minor modifications (Appendix C Figure S18.II). MAIV sample
preparation can be the same as MALDI but produces multiply charged ions essentially
identical to ESI. The MAIV procedure to generate a mass spectrum is amazingly simple.
A solution of the MAIV matrix compound, e.g. 3-NBN, is pipetted onto the sample in a
manner that is identical to MALDI sample preparation protocols. The matrix:analyte
sample is then exposed to the vacuum of the mass spectrometer (Appendix C Figure
S18.Ia). The total ion current (TIC) exemplifies the ion production during the time
required for the matix:analyte to be removed from the sample plate surface, which is
approximately 2 min for sample introduction and an additional 1 to 5 min, depending on
the sample preparation, during which time analyte ions are observed (Appendix C
Figure S18.Ib). Matrix apparently sublimes when exposed to vacuum. As long as the
matrix is on the sample plate (Appendix C Figure S18.Ia, Inset), analyte ions are
observed even for proteins (Appendix C Figure S18.Ic). Similarly, the nicotine standard
and its diagnostic metabolite cotinine, which is predictive of recent tobacco smoking, are
readily observed with MAIV using an ESI source (Appendix C Figure S18.IIa). Analyte
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ions are observed in high abundance with little chemical background (Appendix C
Figure S18.IIc). The ion formation in MAIV is continuous until the sample is depleted.
Using the ESI source (Appendix C Figure S18.IIb) the analysis time is considerably
compressed relative to MAIV operated on the intermediate pressure vacuum MALDI
source (Appendix C Figure S18.Ib). From visual observations at atmospheric pressure,
the matrix:analyte sample under favorable conditions is entirely removed within a few
seconds, which accounts for the more rapid ionization process. Samples can be
completely dry or still in solution when presented to the vacuum (Appendix C Figure
S19) because the vacuum assists in drying the sample. The ready sublimation of 3-NBN
under vacuum conditions is expected to eliminate instrument contamination by this
matrix.
The MAIV method is sensitive as is demonstrated by the mass spectra of 50 fmol
of levofloxacin, an antibiotic drug, and bovine insulin shown in Appendix C Figure S20.
MALDI mass spectra (Appendix C Figure S20.I) were acquired with the same
levofloxacin sample (50 fmol applied) using the common matrix CHCA. The abundant
chemical background observed with MALDI dominates the mass spectrum, and is likely
related to photoionization of the matrix [94]. MAIV also fairs better than MALDI
because without the use of a laser, ‘hotspot’ issues are not observed. Only 5 fmol of
clozapine in the presence of 20 pmol of bovine insulin allow identification of clozapine
using the extracted mass spectrum (Appendix C Figure S20.III). This is accomplished
through the use of the IMS real time separation, which increases the dynamic range of the
experiment, allowing minor components to be detected in the presence of abundant
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components. Previous studies on pure clozapine standard showed mass spectra
consuming only 5 fmoles in MS, and in MS/MS only 900 attomoles [47]. The use and
application of IMS are discussed below.
MAIV is also tolerant of salts which often add difficulty when directly analyzing
biological samples using MS. High levels of salt (1 M NaCl, Appendix C Figure S21)
added to samples had minimal deleterious effects as is demonstrated for clozapine,
angiotensin I, and ubiquitin, all of which are detected as protonated ions. Only with
increasing size of the protein is sodium adduction detected. Initial experiments suggest
that pH has little influence on the charge state distribution. The ion abundance is best
near neutral pH conditions for small and large molecules (Appendix C Figure S22),
however, different solvents systems show different degrees of chemical background
(Appendix C Figure S22.I). For smaller molecules, more volatile solvents seem to aid in
ionization; visual observations suggest that crystal formation of matrix:analyte is more
favorable. Although MAIV is a soft ionization method, fragmentation can be induced by,
for example, increasing the extraction voltage in the intermediate pressure MALDI
source. Using the low extraction voltage of LSI settings the drug clozapine is detected
intact or with little fragmentation (m/z 270) (Appendix C Figure S23a), however, using
the higher extraction voltage of the default MALDI settings with the same
matrix:clozapine sample, abundant fragment ions are observed (Appendix C Figure
S23b). Interestingly, the softer MAIV ionization conditions using LSI settings provide
simplicity of data interpretation (Appendix C Figure S24.I) whereas MAIV using
commercial MALDI settings (Appendix C Figure S24.II), but without the use of a laser,
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form gas-phase dimers of lipid aggregates commonly observed in MALDI [272] and ESI
analysis [273], especially when using laser irradiation or increased concentrations. These
aggregates are readily visualized incorporating IMS [67,157,166], as is the case here
(Appendix C Figure S24.IIB). All compounds tested to date have produced less
chemical background, fragmentation, or aggregation, and improved ion abundance of the
multiply charged ions using ‘LSI settings’. In the following examples, LSI settings were
therefore used for analyte ionization with the exception for proteins from tissue. These
ionization trends of high salt and pH tolerance allow direct analysis of small and large
molecules from their native and complex environments by simply exposing the analyte or
just the area of interest to 3-NBN and the vacuum of the mass spectrometer. Small and
large molecule analyses using MAIV in combination with IMS real time separation
technologies are discussed for potential use as a direct analysis platform in clinical
applications using MS.
Small molecules
Drugs such as clozapine (MW 326), and levofloxacin (MW 361) as well as
commonly abused drugs (cocaine MW 303, fentanyl MW 336, benzoylecgonine MW
289) (Figure 12.1.Ia) can rapidly be analyzed using MAIV on an ESI source without the
low-mass matrix background ions common at every mass with MALDI [274,275]. The 2dimensional (2-D) plot of drift time vs. m/z (Figure 12.1.Ib) shows separation in the ion
mobility dimension of the singly charged MAIV ions produced for each of the
compounds in the mixture. Singly charged ions are detected with no fragmentation and
little chemical background (Figure 12.1.I). The extracted drift times (Figure 12.1.Ib,
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Insets) display well-resolved peaks, and the isotopic distributions (Appendix C Figure
S25.I) and accurate mass assignments help in identifying the drugs in the mixture. Nested
td(m/z) data information [67,270] from IMS and MS can be extracted and used for
identification, e.g. levofloxacin 4.28(337). An example of this approach with direct
ionization from a mouse brain tissue sample is provided below. For additional specificity
and confirmation, MS/MS without precursor ion selection (Figure 12.1.Ia) is performed
with IMS similar to MSe but without the alternating low and high collision energy [276],
or LC separations [277-288]. In other words, the entire set of ions, both directly ionized
by MAIV as well as separated by IMS, are fragmented in the transfer region without
precursor selection of the ions. Figure 12.1.Ib shows the 2-D plot display of drift time
vs. m/z of the fragment ions obtained for each of the analyte molecules in the mixture.
With the IMS dataset, each of the MS/MS mass spectra can be extracted based on the
drift time information. This is shown for cocaine in Figure 12.1.Ic and Appendix C
Figure S25.II. The validity of the method is shown by comparison with conventional
IMS-MS/MS using precursor selection in the quadrupole, as demonstrated for cocaine in
Figure 12.1.III. Identical results were obtained for all mixture components without
(Appendix C Figure S25.II) and with (Appendix C Figure S25.III) precursor selection
so that nested data information applies for IMS-MS/MS, e.g., td(m/z→m/z)
3.25(304→182). Obtaining specificity for all mixture components without the precursor
selection has the advantage of potentially being a fast non-targeted approach. The
collective IMS-MS and IMS-MS/MS dataset should be sufficiently specific for
automated data interpretation of large datasets, even if molecular ions are not completely
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baseline separated by IMS or MS, and without LC, which is important for robust, direct,
and surface analyses methods.
The direct characterization of drugs from tissue is illustrated for clozapine using
IMS and MS (Appendix C Figure S26). The first dimension information, the drift time
distribution, is identical to the synthesized standard (Appendix C Figure S16b, Insets
bottom right). The second dimension information, the mass measurement and isotopic
distribution, readily identifies the drug because of the uniqueness of the chlorine pattern
and superimposes over the standard sample (Appendix C Figure S26b, Insets top left).
Therefore the nested dataset, 3.26(327) for clozapine, is sufficiently distinctive for
identifying a small drug molecule directly from complex biological matrix such as tissue,
at least if a standard is available. However, MS/MS can be employed if improved
specificity is desired (Appendix C Figure S27). This may require an additional minute
of data acquisition and perhaps more user expertise to enable interpretation. As long as
the fragmentation patterns are known, the procedures are similar to those employed for
targeted analysis using triple quadrupole technology, but includes a MS profile of the
sample composition.
Ions are only observed from the section of the tissue (Figures 12.2 and S26,
Appendix C) where matrix is applied, which can be substantially smaller than 1 mm2.
Matrix solution added to minute amounts of tissue is shown in Figure 12.2c. Contary to
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Figure 12.1. MAIV-IMS of small molecule mixture of clozapine (MW 326 Da), lavaquin
(MW 361 Da), and common abused drugs cocaine (MW 303 Da), fentanyl (MW 336
Da), and benzoylecgonine (MW 289 Da) with 3-NBN matrix using the custom modified
ESI source of SYNAPT G2 mass spectrometer: (I) MS, (II) MS/MS without precursor
ion selection, and (III) MS/MS with m/z 304 precursor selection (cocaine). a Total mass
spectra, b 2-D plot of drift time (td) vs. m/z. Insets in I.b show extracted drift times
labeled in a nested fashion as td (m/z) as described previously [67,270]. II.c show the
extracted MS/MS mass spectrum of cocaine from II.b
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established technology, location is frozen in time as only the tissue exposed to the 3-NBN
is ionized (Figure 12.2a). A spatial analyses of about 500 μm diamater is readily
obtained without the use of a laser or a (micro) dissecting knife. Using this approach,
mouse brain tissue was readily analyzed only 30 min after receiving 50 mg kg-1 of
clozapine (Figure 12.b). This approach is therefore sensitive enough for low abundance
drug detection. The protocol can be repeated until the tissue has been consumed by the
ionization event. Using a similar approach, a tissue piece dipped into the matrix solution
and subsequently inserted into the mass spectrometer for analysis is shown in Appendix
C Figure S28.I.

Figure 12.2. MAIV-IMS-MS of clozapine treated mouse brain tissue spotted with 3NBN matrix: a total mass spectra, b 2-D plot display of drift time vs. m/z, and c
microscopy photographs of the tissue (1) before and (2) after matrix deposition. Insets
show (a) isotopic distribution fromthe total mass spectrum, (b) isotopic distribution
extracted from the 2-D plot, and extracted drift times labeled in a nested fashion for
clozapine. Data was acquired using LSI settings without the use of a laser on the
intermediate pressure MALDI source of SYNAPT G2 mass spectrometer.
This simple method holds great potential as a rapid means for (e.g.) biopsy assays.
Further, blood taken from a mouse 30 min after receiving 50 mg kg-1 of clozapine was
also analyzed in a straightforward manner (Appendix C Figure S28.II). Despite the
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complexity of the sample composition, clozapine at m/z 327 is readily observed. Because
no laser is used and hot spot issues are avoided, quantitation studies might be possible.
Using MAIV-IMS-MS, diluted urine can be analyzed without sample desalting.
Ample ion abundance to characterize the drug cetirizine hydrochloride (Figure 12.3.I)
from the urine of an individual taking allergy medication is produced by simply diluting
the urine 1:10 in water and mixing it with the 3-NBN matrix before placing in vacuum.
Again, the nested dataset is sufficiently distinctive. Specificity gained through MS/MS
data for the drug cetirizine confirms its presence in the urine sample (Appendix C
Figure S29.I). Similarly, the diagnostic nicotine metabolites, cotinine and nornicotine,
can be observed simultaneously from the urine sample from a smoker using MAIV-IMSMS (Figure 12.3.II). Interestingly, the isobaric compounds (Inset right) of nornicotine
(accurate molecular weight 148.0995 Da), one of the metabolites of nicotine, and 3-NBN
(accurate molecular weight 148.0267 Da) are baseline separated in the IMS dimension
(Inset left). Nornicotinine (Inset top), present in relatively low abundance, is matched
with its nested data against the pure standards discussed above (Appendix C Figure
S18.IIc). Using the notably different drift times and MS/MS fragmentation in the transfer
fragmentation region of the mass spectrometer verified the identities of the two different
isobaric small molecules (Appendix C Figure S29.IIa). Both urine solutions and plasma
samples have been directly analyzed from glass microscope slides requiring only dilution
with water before mixing with the matrix and required no sample clean up. Typically,
such complex mixtures can result in column fouling in LC/MS and GC/MS, but with
MAIV nonvolatile, un-ionized compounds remain on the sample plate, while compounds
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that are volatile under the vacuum, including the matrix, are pumped from the instrument,
potentially reducing or eliminating instrument contamination. IMS-MS and, if need be,
MS/MS provide a instantaneous means for separation, profiling and characterization with
very little operator expertise needed for sample preparation and analyses. Unlike targeted

Figure 12.3. MAIV-IMS-MS using 3-NBN matrix of (I) urine from drug dosed
individual taking cetirizine, an allergy medication and (II) smoker’s urine: (a) total mass
spectra and (b) 2-D plot display of drift time vs. m/z. Insets in b show extracted drift
times labeled in a nested fashion and isotopic distributions. Data was acquired using LSI
settings without the use of a laser on the intermediate pressure MALDI source of
SYNAPT G2 mass spectrometer.
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analysis, the entire material is profiled. An intrinsic limitation of targeted analyses using
traditional clinical assays is that one can only interrogate analytes for which assays are
established and must run many samples, if need be, until the ‘hit’ is determined.
Large molecules
An example of a MAIV mass spectrum of the peptide beta amyloid (1–42)
(molecular weight 4511 Da) using 3-NBN on the intermediate pressure Waters SYNAPT
G2 MALDI source with the laser ‘off’ (Appendix C Figure S18.Ia) is shown for both
positive (Fig. 4.I) and negative (Figure 12.4.II) mode detection. For comparison, the
same sample was analyzed using ESI (Figure 12.4.III) on the same mass spectrometer.
The negative mode mass spectra are nearly identical in charge state and sensitivity to ESI
as shown in Figure 12.4.II and III but the charge states are slightly lower relative to the
positive mode (Figure 12.4.I). The successful ionization in the negative mode is in
support of the triboluminescence particle charging hypothesis [46,47]. With the IMS
dataset, the drift times of the multiply charged ions of beta amyloid (1–42)
(Figure 12.4.b, Insets) can be extracted. The extracted drift time information using the
MALDI source with MAIV in the negative mode measurements (Figure 12.4IIb, Insets)
is essentially identical to the extracted drift time using traditional ESI (Figure 12.4IIIb,
Insets) additionally to the same charge state distributions. This is of fundamental interest
because two different methods and acquisition conditions are used; MAIV operates from
the solid state and ESI from solution. This indicates that cross-section analyses are
applicable for MAIV using conditions and methods established for ESI. Previous studies
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Figure 12.4. IMS-MS (a) mass spectra and (b) 2-D plot display of drift time vs. m/z of
beta-amyloid (1–42) (MW 4511 Da) using MAIV with 3-NBN matrix in (I) positive
mode and (II) negative mode on the intermediate pressure vacuum MALDI source, and
(III) ESI comparison in negative mode of the SYNAPT G2 mass spectrometer. Insets
show extracted drift times.
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using ESI-IMS-MS suggested that negative mode measurements for amyloid β-protein
are more reliable than positive mode measurements relative to cross-section analyses
[118]. The drift time distributions may give additional information to the relative
structures of these analyte ions directly from their native surfaces in the future.
Figure 12.5 shows the MAIV data obtained from a mixture of beta amyloid (1–
42) (molecular weight 4511 Da), bovine insulin (molecular weight 5730 Da), and
ubiquitin (molecular weight 8560 Da) in 2.5:1:5 molar ratio, respectively, using 3-NBN
as matrix in the negative mode on the custom modified ESI source. Good ion abundance
is observed from this mixture. However, ubiquitin ions are observed in lower ion
abundance in the total mass spectrum (Figure 12.5a1 ) compared to bovine insulin,
which is in the lowest concentration in the mixture. Using the drift time dimension
provided by IMS (Figure 12.5b), the mass spectrum of each protein can be extracted
(Appendix C Figure S30). The cleanly separated mass spectrum for ubiquitin is
exemplified in Figure 12.5a2.
The ability of MAIV to analyze a variety of samples is demonstrated for a model
mixture containing a lipid (sphingomyelin molecular weight 702 Da), peptides (leucine
enkephalin molecular weight 555 Da, angiotensin II molecular weight 1045 Da), small
proteins (galanin molecular weight 3156 Da, bovine insulin molecular weight 5730 Da)
and ubiquitin (molecular weight 8560 Da) in the positive detection mode using the
SYNAPT G2 MALDI source (Appendix C Figure S31). MAIV ionizes all the individual
components of the mixture from lipids to proteins with good ion abundance and
essentially no chemical background (Appendix C Figure S31a). The multiply charged
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Figure 12.5. MAIV-IMS-MS a mass spectra: (1) total and (2) extracted from b 2-D plot
display of drift time vs. m/z of model mixture of beta amyloid (1–42) (MW 4511 Da),
bovine insulin (MW 5730 Da), and ubiquitin (MW 8560 Da) in negative mode using the
custom modified ESI source of SYNAPT G2 mass spectrometer.
peptide and protein ions are well separated from the singly charged ions in the IMS
dimension (Appendix C Figure S31b) allowing extraction of the mass spectra for the
individual components (Appendix C Figure S31c).
A mixture of higher mass proteins comprising lysozyme (MW ~14.3 kDa) and
myoglobin (MW ~17 kDa) using MAIV with the MALDI source is shown in Appendix
C Figure S32a. Lysozyme is present in low abundance compared to myoglobin, and
therefore its signal is not readily observed in the total mass spectrum. However, the
multiply charged ions of lysozyme are well separated from myoglobin as can be seen in
the 2-D plot (Appendix C Figure S32b) making it possible to extract the cleanly
separated protein mass spectra (Appendix C Figure S33c). Without the inclusion of
IMS, lysozyme could have been overlooked in the total mass spectrum (Appendix C
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Figure S32a). The multiply charged ions allow this dataset to be observed using a
MALDI source (Appendix C Figure S18.I and II) on an instrument that is limited
to m/z 8000. Thus, the multiply charged ions produced by MAIV have the advantage that
protein analysis can be implemented on mass range limited IMS-MS mass spectrometers.
Programs previously introduced for ESI analyses [271] are available to convert mass
spectra of multiply charged ions to the molecular weight, as demonstrated using MAIVIMS-MS in Appendix C Figure S33 for the total mass spectrum of the mixture
compositions discussed above (Figures S14 and S15). This is also applicable to proteins
directly analyzed from whole blood (Appendix C Figure S33c and S34).
A mixture of beta amyloid (1–42), of biological significance in Alzheimer
Disease [289,290], and the reversed peptide (42–1) is efficiently ionized using the 3-NBN
matrix (Appendix C Figure S35a). The two isoforms are baseline separated as is shown
for charge state +4 (Appendix C Figure S35b); the achieved separation is identical to
LSII-IMS-MS [50]. Using MS/MS in the transfer region, as is shown in Figure 12.6, and
thus after the isomers are cleanly baseline separated according to their apparent shape
difference using IMS, provides good fragmentation yield and sequence information
content as is shown for the m/z selected charge state +5. The fragmentation pattern is
different for the two peptides as might be expected considering that the hydrophobic end
of (1–42) is at the C-terminus and at the N-terminus for (42–1). Although the charge
mostly resides on the hydrophilic amino acids of both peptides, the highest sequence
coverage is from the hydrophobic end.
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Figure 12.6. The 2-D display of an isomeric mixture of beta-amyloid (1–42) (in red) and
(42–1) (in yellow) using MAIV-IMS-MS/MSwith 3-NBN acquired on the intermediate
pressure vacuum MALDI source of SYNAPT G2 mass spectrometer shows the IMS
separated ions fragmented in the transfer region of the IMS TriWave using CID
fragmentation. The charge state 5+ precursor ion was selected in the quadruple. The
fragment ion mass spectra and sequence coverage of both isomers are overlaid on the 2D plot. MAIV-IMS-MS results are provided in Appendix C Figure S35 and, for
comparison, the same characterization approach was obtained using MAIV on the ESI
source (Appendix C Figure S36).
The fragmentation of the (1–42) peptide has previously been reported [291,292]. The
MAIV-MS/MS of beta-amyloid (1–42) relates well with those observed with ESIMS/MS [292]. Another interesting observation is that MAIV on the vacuum MALDI
source provided the better sequence coverage for both isoforms relative to those obtained
with MAIV on the ESI source using the same matrix:analyte sample (Appendix C
Figure S36). The apparent difference is better ion abundance of the parent ion using
MAIV on the vacuum MALDI source. Expectedly, traditional ESI was cumbersome with
the solubility restricted (1–42) relative to capillary clogging and MALDI only provides
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singly charged ions with less resolved IMS separation and poorer fragmentation. MAIV
combines the positive attributes of ESI and MALDI ionization methods for efficient
ionization and characterization using high performance technology such as IMS and
MS/MS.
Application of 3-NBN to tissue is not limited to determining the location of small
molecules. An example is shown in Figure 12.7 in which a specific area of a delipified
mouse brain tissue (~500 × 600 μm) was exposed with 3-NBN matrix and analyzed
(Figure 12.7a,b). The spatially resolved area depends on the matrix deposition; a
delipification procedure is currently needed to observe proteins from tissue similar to
MALDI-MS [74]. Information is obtained more rapidly without the laser by simply
exposing the area of interest to matrix solution and placing the tissue into the vacuum of
the mass spectrometer (Figure 12.7c). Proteins are detected with a molecular weight of
5440 Da [46] and 16788 Da (Figure 12.7b). The deconvoluted masses for the extracted
higher molecular weight are shown (Figure 12.7d). A literature search failed to confirm
the identity of this protein and we found no report of it being observed in mouse brain
tissue using MALDI of the higher abundant proteins such as myelin basic protein (MBP)
[293]. This suggests that this novel ionization method may be complementary with
MALDI as well as LSI [43,48]. Complementary information using laserspray ionization
and MALDI was previously reported [48]. At the current development stage, sufficient
ion abundance from tissue is obtained using MAIV on the vacuum MALDI source, but
not on the ESI source. Therefore, ETD fragmentation, which is currently only available
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on the ESI source, is not available to characterize these proteins directly from tissue as
was achieved for laserspray ionization of peptides from tissue [48].

Figure 12.7. MAIV-IMS-MS of delipified mouse brain tissue spotted with 3-NBN
matrix: (a) total mass spectrum, (b) 2-D plot display of drift time vs. m/z, (c) microscopy
photograph on the tissue after poking, and (d) deconvolved mass spectrum of protein.
Data was acquired using the intermediate pressure vacuum MALDI source of SYNAPT
G2 mass spectrometer.
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CHAPTER 13
CONCLUSIONS AND PROSPECTUS

The novel ionization methods presented at AP and vacuum produces multiply
charged ions similar to ESI in a MALDI-like sample preparation. The production of
multiply charged ions extends the mass range of high performance mass spectrometers
that have limited mass-to-charge (m/z) range and enhances fragmentation. The
incorporation of IMS to these new ionization methods provides separation of ions
according to charge, size and shape or cross section. Further compounds are ionized
directly from surfaces. The laser-based ionization method at AP (LSII) has the speed of
analysis beneficial for tissue imaging, and the TG approach produces smaller ablated
areas to improve spatial resolution provided sufficient ion intensity is obtained. Single
scan acquisition by LSII using a high performance mass spectrometer is sufficient to
obtain good quality mass spectra with sensitivity as low as attomole amounts of the
analyte. The observation of clusters and liquid droplets from the microscopy study of the
collected ablated material and the heated inlet temperature study suggest that the multiply
charged ions are formed by heating the inlet to desolvate the matrix in the clusters in a
field-free environment.

The use of high performance mass spectrometer provides

isotopic resolution and accurate mass measurement even for proteins and allows the
characterization and identification of endogenous peptide directly from mouse brain
tissue using advanced fragmentation such as ETD. The coupling of LSII with IMS-MS
separates mixtures, including isomers directly from surfaces. LSII shows identical drift
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times to ESI suggesting ion structure information occurs after formation of the gas phase
ions.
LSII extended its application using a vacuum MALDI source. In the absence of a
heated inlet, multiply charged ions are formed by using a matrix that has low thermal
requirements for evaporation or sublimation. The multiply charged ions observed are
similar to LSI and is thus termed LSIV. No external energy is supplied except for the
laser energy absorbed by the matrix and the pressure drop from IP to vacuum. The use of
a suitable matrix, laser power, and proper acquisition and instrument settings are
important factors in producing multiply charged ions using LSIV in a vacuum MALDI
source. With IMS, drift time analysis directly from mouse brain tissue is achieved, and
are identical to the drift times from the synthesized standard using LSII and ESI
indicating similar structures are detected from the tissue. LSIV with IMS for tissue
analysis improves the separation of singly charged lipids from multiply charged peptides
and proteins. With the use of a suitable matrix, the proper sample preparation, and
incorporation of IMS for tissue imaging, images of multiply charged endogenous peptide
are obtained from the mouse brain tissue. These compounds were characterized and
identified previously by LSII.
The fundamental understandings gained from LSII, the production of ions by
tapping matrix:analyte into the inlet tube without the use of laser (MAII), and the
observation of multiply charged ions in a vacuum MALDI source (LSIV) emboldened us
to continue the search for matrixes that can produce multiply charged ions with very low
thermal requirements. The aromaticity and/or functionality, as well as absorption of the
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laser wavelength by the matrix, is not a requirement to produce multiply charged ions
either with (LSII) or without the use of a laser (MAII). Astonishingly, one of these
matrixes, 3-NBN has the highest ion abundance of multiply charged ions at very low
temperature and produces ions in an IP-MALDI vacuum source without the use of a laser
and was thus termed MAIV in analogy to MAII. MAIV using 3-NBN produces gas phase
ions directly from the matrix/analyte crystals through a sublimation process, a
characteristic property of 3-NBN. Both positive and negative ions are detected. A
property of 3-NBN that may explain the production of charges is triboluminscence.
MAIV produces ions from small and large molecules with little or no chemical
background. Large molecules are observed as multiply charged ions in a vacuum MALDI
source. Without the use of a laser, MAIV is applicable to fragile molecules and protein
complexes. Biological fluids or tissue are ionized efficiently by just incorporating 3-NBN
matrix into the sample and exposing the sample to the vacuum of the mass spectrometer.
The sublimation process in the formation of ions makes it possible to miniaturize the
matrix deposition on the tissue which is potentially useful for spatial and drug target
analyses. The use of 3-NBN as the matrix and formation of the ions by exposing the
matrix/analyte crystals to the vacuum of the mass spectrometer can be extended to ESI
sources. This ionization process is rapid, robust, sensitive, and fast, making it potentially
useful for clinical applications. The instantaneous ionization by MAIV, and the real time
separation and characterization by IMS enhances the dynamic range, provides rapid
analysis, separation of isomers and isobars, and cross section analysis directly from the
surface important for biological applications. The laser based ionization methods LSII
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improves spatial resolution and the vacuum condition LSIV enhances sensitivity useful
for tissue imaging.
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APPENDIX A
Laserspray Ionization Inlet Supplementary information

Figure S1: Chemical analysis of sphingomyelin (molecular weight [MW] 812.7): A)
Total ion current: Ions are produced in a continuous fashion obtained by moving the
sample holder through the focused laser beam. B) TG AP-MALDI mass spectrum with
Inset region. Additionally, the [M2+H]+ dimers at > m/z 1500 are observed in accordance
with previous studies (Trimpin, S., Tan, B., Bohrer, B.C., O’Dell, D.K., Merenbloom, S.I.,
Pazos, M.X., Clemmer, D.E., Walker, J.M. Profiling of Phospholipids and Related Lipid
Structures usingMultidimensional Ion Mobility Spectrometry-Mass Spectrometry 2009,
287, 58-69.

173

Figure S2: TG AP-MALDI mass spectra using 2,5-DHB: A) anandamide (MW 347.3);
B) NAGly (MW 361.3); C) phosphatidyl glycerol (MW 770.5); D) phosphatidyl inositol
(MW 886.6).
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Figure S3: Solvent-based TG AP-MALDI mass spectrum of Leu-Enkaphelin (MW
555.3) and 2,5-DHB.
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Figure S4: TG AP-MALDI mass spectrum of angiotensin II (MW 1045.5) with a
resolution 100,000 (solvent-based 2,5-DHB). The inset shows the doubly charged ion for
a single laser shot obtained from the application to the glass slide of 0.1 μL of 400
attomoles of angiotensin II solution.
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Figure S5. TG AP-MALDI mass spectrum of a mixture of PEG 970 and PEG DME 2160
in dithranol and NaCl prepared solvent-free.
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Figure S6: TG AP-MALDI mass spectrum of (A) Met-Enkephalin (MW 573.2) and
(B) beta-amyloid (33-42) (MW 914.5) in 2,5-DHB prepared solvent-free.
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Figure S7: TG AP-MALDI mass spectra (with Inset regions) of angiotensin II (MW
1046.2) in a layered experiment by placing the analyte (1 μg) on the glass substrate,
drying to completeness, and adding the 2,5-DHB matrix on top of the analyte using
increasingly non-incorporating analyte/matrix conditions: A) aqueous, B) acetone, C)
dichloromethane solution.
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Figure S8: TG AP-MALDI mass spectrum of angiotensin II with A) 2,5-DHB: full mass:
30 pmol μL-1; 50,000 resolution; 100,000 resolution. B) CHCA: 100,000 resolution with
Inset regions.
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Figure S9: TG AP-MALDI mass spectra (single shot) of angiotensin II (MW 1045.5; 30
pmol μL-1) in (A) benzoic acid matrix and (B) o-chlorobenzoic acid matrix; resolution
100,000; with Inset region.
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Figure S10: LSI-IMS-MS total mass spectra of (A) β-amyloid (1-42), (B) β-amyloid (421), (C) an isomeric mixture of β-amyloid (1-42) and (42-1) prepared in 50:50 ACN:water
with 0.1% TFA and (D) insulin in 50:50 MeOH/water with 1 % acetic acid obtained
without the use of the desolvation device but with the source temperature set at 150 °C
using 2,5-DHAP matrix in 50:50 ACN:water employing the thin layer sample
preparation.
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Figure S11: MALDI mass spectrum of delipified aged tissue on a plain glass slide using
sinapinic acid as the matrix desolved in 50:50 ACN:water in 0.1% TFA.
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Figure S12: Microscopy after laser ablation using LSI-IMS of delipified aged tissue
on a plain glass slide spotted with 2,5-DHAP matrix in 50:50 ACN:water. (A1) and (B1)
20x magnification and (A2), (A3), (B2), (B3) 100x magnification.
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Figure S13: Optical microscopy image from delipified aged mouse brain tissue after
LSI-MS analysis showing two ablated areas. The spatial resolution scale is shown in
the lower right corner.
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Figure S14: LSI mass spectra of delipified fresh tissue on gold coated glass slide spotted
with 2,5- DHAP in 50:50 ACN:water using the Orbitrap Exactive. A) Total ion current;
B1) Sum of 120 acquisitions; B2) single shot acquisition; B3) sum of 7 laser shot
acquisitions.
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Figure S15: Insets of LSI mass spectra: Isotopic distributions of the proteins
detected from delipified fresh tissue on a gold-coated glass slide spotted with 2,5DHAP matrix in 50:50 ACN:water using the Orbitrap Exactive.
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Figure S16: Optical images of laser ablated areas obtained in an imaging experiment
on mouse brain tissue spray-coated with matrix using an airbrush: A) 20 X
magnification and B) 100X magnification
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Figure S17: Mass specific images for the same charge state +8 of two different proteins:
A) MW 11788 and B) MW 12369.
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Figure S18: Single scan acquisition on the LTQ Velos obtained in imaging
experiment. The protein with monoisotopic mass 11788 Da as determined on the Orbitrap
Exactive is labeled with +6 to +10 charges.
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Figure S19: LSI-MS and MS/MS mass spectra using ETD obtained from delipified
tissue spotted with 2,5-DHAP in 50:50 ACN:water. A) Full mass spectrum and ETD
fragment ion mass spectra of B) m/z 1491 (+12) and C) m/z 1789 (+10) with Insets
displaying the m/z range above the selected parent ions of (1) 1491 and (2) 1789.
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APPENDIX B
Laserspray Ionization Vacuum Supplementary information

Figure S1. IP-LSI-MS mass spectra of peptides and proteins: (A) GFP, (B) ACTH, (C)
insulin and (D) ubiquitin acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water
using laser energy of (a) “200” and (b) “500” on different target plates: (I) glass plate and
(II) metal plate.
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Figure S2. IP-LSI-MS mass spectra of angiotensin I (MW 1295) acquired from different
matrixes: (A) 2,5-DHAP in 50:50 ACN:water, (B) CHCA, and (C) 2,5-DHB both in
50:50 ACN:water with 0.1% TFA using laser energy of “500”.
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Figure S3. Photographs of the microscopy of the analyte/matrix mixture spot of
angiotensin 1 (A) before ablation and (B) after ablation using 200 laser energy.
Analyte/matrix mixture prepared in 1:1 volume ratio using 2,5-DHAP matrix in 50:50
ACN:water. The center spot (A) provides preferentially the multiply charged ions
(Figure S4).
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Figure S4. Comparison of the IP-LSI-MS mass spectra of angiotensin 1 (MW 1295)
acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water between (A) large and
(B) needle-like crystals after deposition of analyte/matrix mixture (Figure S3). Laser
energy used was “500”.
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Figure S5. IP-LSI-MS mass spectra of angiotensin I (MW 1295) acquired using 2,5DHAP matrix prepared in 50:50 ACN:water from (I) glass plate and (II) metal plate with
different laser fluence: (1) “200”, (2) “300”, and (3) “500”. (A) Full mass spectra and (B)
insets of +3, +2, and +1.
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Figure S6. IP-LSI-MS mass spectra of N-acetylated fragment of MBP (MW 1833)
acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water at different laser fluence
from A) “50” to H) “500”.
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Figure S7. IP-LSI-MS of bovine insulin using 2,5-DHAP matrix in 50:50 ACN:water
acquired in full mass range. (A) Glass Plate and (B) Metal Plate.
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Figure S8. MALDI-TOF-MS mass spectra of (A) Angiotensin I (MW 1295), (B) [Glu1]-fibrinopeptide B (MW 1569), (C) adrenocorticotropic hormone fragment (MW 2465),
and (D) bovine insulin (MW 5731) acquired under high vacuum conditions using the
same analyte/matrix mixture used to obtain the mass of spectra of IP-LSI-IMS-MS using
2,5-DHAP matrix prepared in 50:50 ACN:water.
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m/z

Figure S9. IP-LSI-MS mass spectrum of ubiquitin (MW 8561) acquired using 2,5-DHAP
matrix prepared in 50:50 ACN:water using laser energy of “500”.

200

Figure S10. IP-LSI mass spectra of synthesized N-acetylated terminal fragment of
myelin basic protein acquired using 2,5-DHAP matrix prepared in 50:50 ACN:water
using low laser fluence: A) TOF (cooling gas 10 mL min-1 and trap gas flow (2.5 mL
min-1) and B) IMS-TOF modes with He cell and IMS gas flow at 24 mL min-1; C) He cell
(180 mL min-1), D) IMS cell (90 mL min-1) and E) both gas flows increased.
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Figure S11. IP-LSI-IMS-MS of the model mixture (SM, Ang I, GFP, and BI) acquired
using 2,5-DHAP matrix prepared in 50:50 ACN:water from (A) glass plate and (B) metal
plate. (1) Total mass spectrum with an inset +4 charged state distribution of BI and (2) 2D plot of drift time vs. m/z and drift time distribution of +4 for BI.
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Figure S12. IP-LSI mass spectra of the pure components in the model mixture using 2,5DHAP matrix prepared in 50:50 ACN:water using low laser energy of “200” from (I)
glass and (II) metal plates.: lipid A) sphingomyelin MW 703, peptides B) angiotensin I
MW 1295 and C) [Glu-1]-fibrinopeptide B MW 1569, and a protein D) bovine insulin
MW 5731.
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Figure S13. IP-LSI mass spectra of the pure components in the model mixture using 2,5DHAP matrix prepared in 50:50 ACN:water using laser energy of “500” from (I) glass
and (II) metal plates: lipid (A) sphinomyelin (MW 703), peptides (B) Angiotensin 1
(MW 1295), (C) [Glu-1]-fibrinopeptide B (1569) and a protein (D) bovine insulin (MW
5731).
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Figure S14. IP-LSI-MS/MS of lipid sphingomyelin (MW 703) using collision induced
dissociation acquired directly from an aged mouse brain tissue section spotted with 2,5DHAP matrix prepared in 50:50 ACN:water. A collision energy of 32 V was applied in
the trap cell to produce the choline fragment peak m/z 183.
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Figure S15. Mass spectra of the model mixture (SM, Ang 1, GFP, and BI) acquired at (1)
AP-LSI using a UV laser (Nitrogen 337 nm), and at IP-LSI (Nd:Yag 355 nm) using (2)
“200” and (3) “300” laser power. (A) Full mass spectra; (B) Inset mass spectra from m/z
400 to 2000.
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Figure S16. Extracted drift times of the lipids detected from aged delipified mouse brain
tissue section spotted with 2,5-DHAP matrix solution in 50:50 ACN:water using IP-LSIIMS-MS with a laser energy of “500”.
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Figure S17. Extracted drift times of the +1, +2 and +3 charged states of peptides detected
from aged delipified mouse brain tissue spotted with 2,5-DHAP matrix solution in 50:50
ACN:water using IP-LSI-IMS-MS with a laser energy of “500”.
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Figure S18. Extracted drift times of the individual component in the model mixture (SM,
Ang I, GFP, and BI) acquired using 2,5-DHAP matrix in 50:50 ACN:water. (A) Glass
plate and (B) Metal plate using a laser of 500.
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Figure S19. Extracted drift times of the neuropeptide with charge states +2, +3, and +4
(when present): (A) from mouse brain tissue section by AP-LSI-IMS-MS, and from the
synthesized N-acetylated fragment of myelin basic protein obtained by (B) AP-LSIIMSMS and (B) ESI-IMS-MS.
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Figure S20: LSIV-IMS-MS (A) total mass spectrum and (B) two-dimensional plot of
drift time vs. m/z of delipified mouse brain tissue spotted with 2,5-DHAP matrix and
acquired using ‘LSI settings’[42,45] on a commercial intermediate pressure MALDI
source of the SYNAPT G2 mass spectrometer. Insets show (A) isotopic distribution of +2
ions of the identified N-acetylated MBP peptide (m/z 917.39) and the highest MW
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Figure S21: LSII-IMS-MS (A) total mass spectrum and (B) two-dimensional plot of drift
time vs. m/z of non delipified mouse brain tissue spotted with 2,5-DHAP matrix and
acquired using the nanoESI source of the SYNAPT G2 mass spectrometer with a
homebuilt skimmer cone to perform LSII in transmission geometry. Insets show in (A)
isotopic distribution and (B) drift times of +3 charge state ion (m/z 612.36) of the
identified N-acetylated MBP peptide and +1 drift time of a lipid (m/z 760.62).
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Figure S22: LSIV-MS using (I) 2-NPG matrix at low laser power (4.2 J cm-2) and (II)
2,5-DHAP matrix at higher laser power (7.3 J cm-2) of (A) N-acetylated MBP peptide
(MW 1833 Da), (B) galanin (MW 3150 Da), and (C) bovine insulin (MW 5731 Da)
acquired using ‘LSI settings [42,45] on a commercial intermediate pressure MALDI
source of the SYNAPT G2 mass spectrometer.
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Figure S23: LSIV-MS of N-acetylated MBP peptide (MW 1833 Da) with 2-NPG matrix
using different laser power: (A) 4.2, (B) 5.7, and (C) 7.3 J cm-2 acquired using ‘LSI
settings [42,45] on a commercial intermediate pressure MALDI source of the SYNAPT
G2 mass spectrometer.
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Figure S24: LSIV-IMS-MS of delipified mouse brain tissue spotted with 2-NPG matrix
shown in Figure 2A. Shown here is the total mass spectrum of the multiply charged
peptide and protein ions with the large molecular weight detected, an ~8.6 kDa protein
(m/z 2855.84) with insets of the isotopic distributions of higher charge states: +3 (m/z
1655.22) and +4 (m/z 1680.87) ions. Data acquired using ‘LSI settings [42,45] on a
commercial intermediate pressure MALDI source of the SYNAPT G2 mass
spectrometer.
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Figure S25: LSIV-IMS-MS two-dimensional plot of drift time vs. m/z of delipified
mouse brain tissue mounted on CHCA precoated glass plate spray coated with binary
matrix mixture of 90% 2,5-DHAP and 10% 2-NPG and acquired using ‘LSI settings
[42,45] on a commercial intermediate pressure MALDI source of SYNAPT G2 mass
spectrometer.
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APPENDIX C
Matrix Assisted Ionization Vacuum Supplementary Information

Figure S1. (I) Photographs of typical operation of MAIV on the ESI source: (A) vacuum
valve closed, (B) glass on, (C) vacuum valve open, (D) matrix:analyte sample enters
readily mass spectrometer by vacuum forces. This custom designed MAVI source
operating from atmospheric pressure conditions is a means of rapid sample introduction
to the vacuum of the mass spectrometer. (II) MAIV-MS of lysozyme (MW ~14.3 kDa) in
25 mM ammonium acetate buffer in 10% MeOH on the ESI source of SYNAPT G2
using (I) a modified skimmer cone with wider outer cone (~4.5 mm ID) and inner cone of
(A) ~0.5 mm, (B) ~1 mm, (C) ~3 mm ID using 3-NBN in 50:50 ACN:water with 0.1%
FA acquired with a source temperature of (II) 50 °C and (II) 80 °C. Red numbers
indicate the charge state and blue numbers indicate the ion abundance.
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Figure S2. MAIV-IMS-MS using ESI source of solvent extracted blood spot from a band
aid (A) Total mass spectra and (B) extracted mass spectra of (1) α-globin ions (MW
15126 Da) and (2) β-globin (MW 15866 Da) chain of hemoglobin. Data acquired on the
SYNAPT G2 using a source temperature of 50 °C.
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Figure S3. MAIV isotopic distributions from Figure 1A: (a) leucine enkephalin (+1), (b)
sphingomyelin (+1), (c) galanin (+2), (d) galanin (+4), (e) bovine insulin (+5), and (f)
ubiquitin (+9) in the model mixture with 3-NBN matrix. Blue numbers of each spectrum
provide an indication of ion abundance and red numbers the charge states.
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Figure S4. Picture snapshots of matrix:analyte spot with 3-NBN matrix using the
MALDI source of SYNAPT G2: (a) 5 seconds after indexing sample plate that requires
ca. 2 min and (b) after additional 70 seconds. Yellow and blue arrows point the areas of
the spot where crystals sublimed after 70 seconds in the vacuum source. See online
‘MAIV on MALDI source video I’ using the intermediate pressure vacuum MALDI
source of SYNAPT G2 mass spectrometer.
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Figure S5. MAII temperature study of 3-NBN in 50:50 ACN:water using acidified
bovine insulin (MW 5731 Da) acquired using the LTQ Velos at (a) 450 °C, (b) 300 °C,
(c) 200 °C, (d) 150 °C, (e) 100 °C, and (f) 50 °C inlet capillary temperature of the
overridden ESI source. Blue numbers of each spectrum provide an indication of ion
abundance and red numbers the charge states.

221

TIC ion chromatogram
I.I. Total
9.23e4

0.41
0.15 0.24

0.65 0.87
0.53
0.77

0.10

0.55

0.95

0

800

1100

1400
+4
1434.35

100

100

4.38e3

+3
1912.09

b

b

+4
1434.58

+6
956.58
+7
825.34

0.94
0

+5
1147.69

100

%

0.36

100

%

Massspectra
spectra
II. Mass
a

a

2.12e6

1700

2000

3.83e5

%

%

+5
1147.47

0

0.10

0.50

0.90

1.30

c
1.31e6

0.25
0

+12
1301.70
+13
1101.91
+14
+15
+16

0.05

0.15
0.25
Time (min)

0

1000

1700

2000

3.83e5

+8
1790.15

%

%

100 0.05

+3
1911.81

+6
956.55
0
800
1100
1400
+10
c
+111432.12
100
1301.96 +9
1591.20

+7
2045.68
+6
1400

1800
m/z

2200

Figure S6. MAIV (I) total ion current (TIC) and (II) mass spectra of bovine insulin
(MW 5731 Da) with 3-NBN matrix using a SYNAPT G2 mass spectrometer (a) on the
commercial ESI source with the custom modified inner and outer cone (Scheme 1II) and
(b) using LSI settings of a commercial SYNAPT G2 intermediate pressure vacuum
MALDI source. (c) Lysozyme (MW 14.3 kDa) with 3-NBN matrix on custom modified
commercial ESI source of SYNAPT G2 with a wider inner and outer cones. Blue
numbers in upper right corner of each spectrum provide an indication of ion abundance
and red numbers the charge states. See online ‘MAIV on ESI source video II’ using the
custom modified ESI source of SYNAPT G2 mass spectrometer.
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Figure S7. Mass spectra of nitrobenzonitrile (NBN) isomers: (a) 2-NBN, (b) 3-NBN, and
(c) 4-NBN with (I) ubiquitin in water (MW 8561 Da) using solvent-based: (1) MAIV and
(2) with laser, and (II) angiotensin I in water (MW 1295 Da) using solvent-free sample
preparations acquired using LSI settings of a commercial SYNAPT G2 intermediate
pressure vacuum MALDI source. Blue numbers in upper right corner of each spectrum
provide an indication of ion abundance and red numbers the charge states.

223

Figure S8. Mass spectra of nitrobenzaldehyde isomers: (a) 2-nitrobenzaldehyde, (b) 3nitrobenzaldehyde, and (c) 4-nitrobenzaldehyde with angiotensin I (MW 1295 Da) using
(I) solvent-based and (II) solvent-free sample preparations acquired using LSI settings of
a commercial SYNAPT G2 intermediate pressure vacuum MALDI source. Blue numbers
of each spectrum provide an indication of ion abundance and red numbers the charge
states.
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Figure S9. MAIV-MS of ubiquitin in water with 3-NBN matrix in 100% ACN with 0.1%
formic acid acquired using LSI settings of a commercial SYNAPT G2 intermediate
pressure vacuum MALDI ion source without the use of a laser with matrix:analyte
crystals (a) wet when loaded in the MALDI source and (b) cooled at -80 C before
loading into the vacuum MALDI source: (I) total ion current (TIC) and (II) mass spectra.
Blue numbers in upper right corner of each spectrum provide an indication of ion
abundance and red numbers the charge states.
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Figure S10. (a) Photograph of the target plate holder with the glass capillary tube
containing 3-NBN matrix:analyte crystals with acidified bovine insulin (MW 5731 Da),
(b) total ion current (TIC) showing the 30 minute continuous ion production using the
glass capillary tube, (c) picture capture of the open end of the glass tube containing the
matrix:analyte crystals after placing the sample holder inside the intermediate pressure
vacuum MALDI source of a commercial SYNAPT G2, and (d) mass spectra of bovine
insulin at a time period of 1 to 30 min using LSI settings. Blue numbers in upper right
corner of each spectrum provide an indication of ion abundance and red numbers the
charge states.
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Figure S11. MAIV mass spectra of ubiquitin in water (MW 8561 Da) with 3-NBN in
100% ACN with 0.1% formic acid acquired using LSI settings of the SYNAPT G2
intermediate pressure vacuum MALDI source: (a) TOF and (b) mobility TOF modes.
Blue numbers in upper right corner of each spectrum provide an indication of ion
abundance and red numbers the charge states.
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Figure S12. MAIV (a) picture snapshots of matrix:analyte spot with coumarin matrix:
(1) after indexing sample plate and (2) after 16 seconds, and mass spectra of 5 pmol
bovine insulin with coumarin using (b) intermediate pressure vacuum MALDI source and
(c) custom modified ESI source of SYNAPT G2 mass spectrometer. Blue numbers in
upper right corner of each spectrum provide an indication of ion abundance and red
numbers the charge states.
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II. LSIV on vacuum MALDI source using a laser for dislodging
the 2,5-DHAP matrix:analyte from the surface
B. Mass spectrum
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Figure S13. MAIV-MS using 2,5-DHAP for the analyses of lysozyme (MW ~14.3 kDa)
in 25 mM ammonium acetate buffer in 10% MeOH; 2,5-DHAP is dissolved in 50:50
ACN:water with 0.1% formic acid. (I) ESI source of SYNAPT G2 using a modified
skimmer cone with the larger outer (~4.5 mm ID) and inner (~3 mm ID) cones acquired
with a source temperature of (a) 80 C and (b) 150 C. (II) Intermediate pressure
vacuum MALDI source of SYNAPT G2 operated to perform laserspray ionization
(LSIV): (a) total ion current (TIC) and (b) mass spectrum. As expected for a MALDI
matrix, the materials are dislodged by the laser based on sufficient absorption of the
matrix at the laser wavelength. A laser power of ‘230’, an arbitrary vendor value (‘200’
relates to a laser fluence of ~7.3 J cm-2 and ‘250’ to ~12.5 J cm-2), was used. Red numbers
indicate the charge state and blue numbers indicate the ion abundance.
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Figure S14. MAIV (a) total ion current and (b) MS/MS mass spectra using collisioninduced fragmentation of 900 attomole clozapine (MW 326 Da) using the ‘normal’
analyte:matrix spot on target plate cooled on dry ice. Data acquired using ‘LSI’ settings
without the use of a laser on the SYNAPT G2 intermediate pressure vacuum MALDI
source. Fragmentation patterns are assigned in red [294]. Blue numbers indicate the ion
abundance.
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Figure S15. Extracted mass spectra of a mixture of three proteins ionized by MAIV and
separated by IMS in the gas phase (Figure 4II.a): (a) ubiquitin (MW ~8.6 kDa), (b)
lysozyme (MW ~14.3 kDa), and (c) myoglobin (MW ~17 kDa). Blue numbers in upper
right corner of each spectrum provide an indication of ion abundance and red numbers
the charge states.
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Figure S16. MAIV-MS of (a) cocaine (MW 303 Da), (b) pesticide foramsulfuron (MW
452 Da), and (c) extracted mass spectrum of 1,2,3,4-tetra-O-acetyl-6diphenylphosphoryl-β-D-mannopyranose (MW 580 Da) doped with 1 M NaCl with 3NBN matrix acquired using LSI settings of a commercial SYNAPT G2 intermediate
pressure vacuum MALDI source without the use of a laser. Blue numbers in upper right
corner of each spectrum provide an indication of ion abundance and red numbers the
charge states.
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Figure S17. MAIV mass spectra of ubiquitin in water (MW 8561 Da) with 3-NBN in
100% ACN with 0.1% formic acid spotted on a) standard metal target plate, b) glass
plate, c) filter paper, d) kim wipe tissue, e) plastic, f) aluminum foil, g) thin layer
chromatography (TLC) plate, and h) glass plate holder. Data acquired using LSI settings
of a commercial SYNAPT G2 intermediate pressure vacuum MALDI source without the
use of a laser. Blue numbers in upper right corner of each spectrum provide an indication
of ion abundance and red numbers the charge states.

233

Table S1. Summary of matrixes tested at intermediate pressure vacuum using the
commercial MALDI source without the use of the laser. I. Compounds with 1,3substitution, respective isomers, and frequently with one NO2 functionality.
I. Name
Melting point,
Observations for angiotensin I as
analyte
C
NO2
109-111
- crystals formed
CN
- sublimed producing multiply
charged MAIV ions
2-nitrobenzonitrile
NO2

114-117

- crystals formed
- sublimed producing multiply
charged MAIV ions

144-147

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

42-44

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

55-58

- no crystals formed using solventbased sample preparation
- sublimed using solvent-free
preparation and formed multiply
charged MAIV ions

103-106

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

CN

3-nitrobenzonitrile
NO2

CN

4-nitrobenzonitrile
NO 2 O
H

2-nitrobenzaldehyde
NO 2

H
O

3-nitrobenzaldehyde
NO 2

O

H

4-nitrobenzaldehyde
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NO 2

n/a

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

96-98

- crystals formed
- only +1 analyte charge state using
MALDI settings and with laser

110-115

- crystals formed
- only +1 analyte charge state using
MALDI settings and with laser

139-141

- crystals formed
- +1 analyte charge state for both LSI
and MALDI settings using a laser in
both cases

111-114

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

140-143

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

36-38

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

OH

2-nitrophenol
NO 2

OH

3-nitrophenol
NO 2

OH

4-nitrophenol
NO 2

OH
O

3-nitrobenzoic acid
NO 2

NH2

3-nitroaniline
NO 2

NH2
O

3-nitrobenzamide
NO 2

OCH3

3-nitroanisole

235

NO 2

76-78

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

78-81

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

110-113

- crystals formed
- only +1 analyte charge state using
MALDI settings and with laser

48-53

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

98-100

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

n/a

- crystals formed
- no analyte ion signal using LSI and
MALDI settings without (MAIV)
and with a laser (LSIV)

n/a

- no crystals formed
- no signal using LSI and MALDI
settings without (MAIV) and with a
laser (LSIV)

CH3
O

3-nitroacetophenone
OH

CN

3-cyanophenol
OH

CN

4-cyanophenol
NH2

CN

3-aminobenzonitrile
O

CH3

CN

3-acetylbenzonitrile
CH3

CN

m-tolunitrile
OCH3

CN

3-methoxybenzonitrile

236

- crystals formed
- little sublimation but no analyte ion
signal using LSI and MALDI settings
without (MAIV) and with a laser
CN
(LSIV)
1,3-dicyanobenzene
1
With poor crystallization the matrix:analyte frequently sublimed/evaporated too rapidly
during the 2-min introduction period before the sample holder was at vacuum and the
mass spectrometer in operation. LSI and MALDI settings were used for data acquisition.
CN

163-165
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Table S2. Compounds known to produce triboluminescence.
II. Name
O

Melting point,
C
131-134

Observations for angiotensin I as
analyte
- good crystal formation
- no sublimation

94-95

- good crystal formation
- no sublimation

150-157

- atypical crystallization of
matrix:analyte mixture
- no sublimation

204-206

- atypical crystallization of
matrix:analyte mixture
- no sublimation

103-107

- atypical crystallization of
matrix:analyte mixture
- no sublimation

90-94

- atypical crystallization of
matrix:analyte mixture
- no sublimation

68-73

- good crystal formation
- sublimed and produced multiply
charged MAIV ions

226-229

- atypical crystallization of
matrix:analyte mixture
- no sublimation

O
O

pthalic anhyride
O

O

benzil
O
P

triphenylphosphine oxide
Br

Br

N
H

3,6-dibromocarbazole

9,10-dihydroanthracene

acenaphtene
O

O

coumarin
O
NH
S
O O

saccharin

238

O

295-300

- atypical crystallization of
matrix:analyte mixture
- no sublimation

92-94

- atypical crystallization of
matrix:analyte mixture
- no sublimation

98-100

- atypical crystallization of
matrix:analyte mixture
- no sublimation

n/a

- atypical crystallization of
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Figure S18: MAIV using the (I) intermediate pressure MALDI source: (a) Screen shot
during MAIV acquisition showing production of multiply charged ions without the use of
the laser, (b) total ion current (TIC), and (c) mass spectrum of ubiquitin (MW 8560 Da),
and (II) custom modified ESI source: (a) typical operation, (b) TIC, and (c) mass
spectrum of nicotine standard mixture with 3-NBN matrix and spotted on the glass plate.
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Figure S19: MAIV-MS of a clozapine standard (MW 326 Da) with 3-NBN matrix
acquired with (a) wet matrix:analyte and (b) dry matrix:analyte spots loaded into the
intermediate pressure vacuum MALDI source of SYNAPT G2 mass spectrometer using
LSI settings. Evaporative cooling that occurs when the solution dries in vacuum is
expected to slow sample loss during the time the sample loads. Insets show structure and
isotopic distributions of clozapine.
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Figure S20: Mass spectra of (I) 50 fmol levofloxacin (MW 361 Da) using (a) MAIV
with 3-NBN matrix and (b) MALDI using CHCA matrix acquired using the intermediate
pressure MALDI source. MAIV-MS of (II) 50 fmol of bovine insulin (MW 5730 Da)
with 3-NBN matrix using the custom modified ESI source and (III) 5 fmol clozapine
(MW 326 Da) and 20 pmol bovine insulin mixture with 3-NBN matrix using the
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer
using LSI settings. Insets show isotopic distributions with structures of (I) levofloxacin
and (III) clozapine.
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Figure S21. MAIV-MS of (a) clozapine (MW 326 Da), (b) angiotensin I (MW 1295 Da),
and (c) ubiquitin (MW 8560 Da) in 1 M NaCl solution with 3-NBN matrix. Data acquired
using the intermediate pressure vacuum MALDI source of the SYNAPT G2 mass
spectrometer using LSI settings.
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Figure S22. (I) Solvent and pH study of 1 pmol clozapine (MW 326 Da) in (a) 50:50
methanol:water and (b) water with 3-NBN in 100% ACN (1) with and (2) without acid,
and (II) pH study of 5 pmol myoglobin in water (MW ~17 kDa) with 3-NBN in 100%
ACN (1) with and (2) without acid. Data acquired using the intermediate pressure
vacuum MALDI source of the SYNAPT G2 mass spectrometer using LSI settings.
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Figure S23. MAIV-MS of 1 pmol clozapine (MW 326 Da) with 3-NBN in 100% ACN
with 0.1% formic acid. Data acquired using (a) LSI settings and (b) MALDI settings of
the intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer.
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Figure S24: MAIV-IMS-MS of nondelipified mouse brain tissue spotted with 3-NBN
matrix acquired using (I) LSI settings and (II) MALDI settings on the intermediate
pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer: (a) total mass
spectra and (b) 2-D plot of drift time vs. m/z.
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Figure S25: MAIV (I) MS and MS/MS mass spectra of small molecule mixture with 3NBN matrix in the transfer region: (II) without selection and extracted from the 2-D plot
(Figure 1.II) and (III) with precursor ion selection of (a) levofloxacin [295] (MW 361
Da), (b) fentanyl [296] (MW 337 Da), (c) clozapine [297] (MW 326 Da), (d) cocaine
[298] (MW 303 Da), and (e) benzoylecgonine [299] (MW 289 Da). Data acquired using
the custom modified ESI source of the SYNAPT G2 mass spectrometer. Insets in II show
structures of the small molecule indicating the fragmentation patterns.
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Figure S26: MAIV-IMS-MS of drug treated (90 minutes after receiving 50 mg kg-1 of
clozapine) mouse brain tissue spotted with 3-NBN matrix: (a) total mass spectrum and
(b) 2-D plot display of drift time vs. m/z. Insets in (b) show isotopic distributions and
drift times of clozapine from tissue and standard. Data acquired using LSI settings of the
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer.
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Figure S27: MAIV-IMS-MS/MS of drug clozapine in (a) treated mouse brain tissue (90
minutes after receiving 50 mg kg-1 of clozapine) spotted with 3-NBN matrix and (b) from
standard with 3-NBN matrix. Inset in (b) shows structure of clozapine indicating
fragmentation patterns. Data acquired using LSI settings of the intermediate pressure
vacuum MALDI source of the SYNAPT G2 mass spectrometer.
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Figure S28: MAIV-IMS-MS of (I) clozapine treated mouse tissue removed from glass
plate and dipped into the 3-NBN matrix solution and (II) plasma of clozapine treated
mouse with 3-NBN matrix: (a) total mass spectra and (b) 2-D plot of drift time vs. m/z.
Data acquired using LSI settings of the intermediate pressure vacuum MALDI source of
the SYNAPT G2 mass spectrometer. Insets in b show structure and isotopic distribution
of clozapine.
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Figure S29: MAIV (I.a) cetirizine mass spectra (MW 388 Da) from urine of a drug
dosed individual and (b) MS/MS of cetirizine tablet, and (II) MS/MS of standard (a)
nornicotine (exact MW 148.0995 Da) and (b) 3-NBN (exact MW 148.0267 Da) using
LSI settings. Data acquired using the (I) intermediate pressure vacuum MALDI source
and (II) custom modified ESI source of SYNAPT G2 mass spectrometer. Insets in (I)
show isotopic distribution and structure of cetirizine and (II) extracted drift time and
structures of nornicotine and 3-NBN.
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Figure S30: Extracted mass spectra of (a) beta amyloid (1-42) (MW 4511 Da), (b)
bovine insulin (MW 5730 Da), and (c) ubiquitin (MW 8560 Da) from the 2-D plot
display of drift time vs. m/z of the mixture (Figure 5) acquired in negative mode using
the custom modified ESI source of the SYNAPT G2 mass spectrometer. Insets show
isotopic distributions.
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Figure S31: MAIV-IMS-MS of a model mixture of lipids (sphingomyelin MW 702 Da),
peptides (leucine enkephalin, MW 555 Da; angiotensin II, MW 1045 Da; galanin, MW
3560 Da), and small proteins (bovine insulin MW 5730 Da, ubiquitin MW 8560 Da)
with 3-NBN matrix acquired using the intermediate pressure vacuum MALDI source of
the SYNAPT G2 mass spectrometer using LSI settings: (a) total mass spectrum, (b) 2-D
plot display of drift time vs. m/z, and (c) extracted mass spectra of the components in the
mixture. Insets in (c) show isotopic distributions.
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Figure S32: MAIV-IMS-MS (a) total mass spectrum, (b) 2-D plot display of drift time
vs. m/z, and (c) extracted mass spectra of (1) lysozyme (MW 14.3 kDa) and (2)
myoglobin (MW ~17 kDa) of the mixture (I) acquired in positive mode using the
intermediate pressure vacuum MALDI source of the SYNAPT G2 mass spectrometer
using LSI settings.
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Figure S33: Deconvoluted MAIV mass spectra of (a) big model mixture (Figure S14),
(b) protein mixture (Figure S15) and (c) human plasma (Figure S17) using the
BayeSpray software from Waters Corporation.
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Figure S34: MAIV-IMS-MS (a) total mass spectrum with an inset of the extracted mass
spectrum of both alpha and beta chains of hemoglobin, (b) 2-D plot display of drift time
vs. m/z and (c) extracted mass spectra from (b) of (1) alpha globin (MW ~ 15.1 kDa) and
(2) beta globin (MW ~15.9 kDa) of human plasma extracted from bandage with water
acquired in positive mode using the intermediate pressure vacuum MALDI source of the
SYNAPT G2 mass spectrometer using LSI settings.

256

Figure S35: MAIV-IMS-MS of isomeric mixture of beta amyloid (1-42) and (42-1) with
3-NBN matrix: (a) total mass spectrum and (b) 2-D plot display of drift time vs. m/z
using the intermediate pressure vacuum MALDI source using LSI settings. Insets in b
show extracted drift times.
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Figure S36: MAIV-IMS-MS/MS 2-D plot display of drift time vs. m/z of the isomeric
mixture of beta amyloid (1-42) and (42-1) with 3-NBN matrix acquired using the custom
modified ESI source of SYNAPT G2 with insets of the extracted MS/MS mass spectra
from the 2-D plot of beta amyloid (1-42) (red) and (42-1) (yellow) (sequence coverage
shown on top of the 2-D plot).
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Matrix-assisted laser/desorption ionization (MALDI) and electrospray ionization
(ESI) have made a huge impact in the analysis of biological materials. ESI has gained its
popularity involving liquid based analysis, efficient fragmentation, chromatographic and
electrophoretic separations but has a limitation for solubility restricted materials and
surface analysis. MALDI is applicable to large biomolecule analysis and for surface
methods useful for tissue imaging but is limited for structural characterization due to poor
fragmentation and is ill suited for liquid based separation methods. The research
presented here relates to new ionization methods that encompass the benefits of ESI and
MALDI. These novel ionization methods produce multiply charged ions similar to ESI
but directly from surfaces similar to MALDI. The formation of multiply charged ion
extends the mass range of high performance mass spectrometers with advanced features
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for structural characterization such as ultra-high mass resolution and mass accuracy, and
electron transfer dissociation. The surface method approach enables the detection,
characterization, and identification of compounds directly from native environments such
as tissue. The use of gas phase ion mobility separation reduces spectral complexity and
improves the dynamic range of the experiment. Among the three novel ionization
methods presented, MAIV has the potential to analyze fragile molecules and protein
complexes, and is applicable for both atmospheric pressure and vacuum conditions. The
laser-based method, LSII has the potential to improve the spatial resolution for tissue
imaging and LSIV to enhance sensitivity.
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